data_2mo0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mo0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.887 0.375 . . . . 71.51 110.928 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -135.42 134.26 39.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.949 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 171.66 44.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 72.03 112.48 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.9 p -83.72 145.25 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 65.15 111.097 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.56 145.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.141 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -29.19 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.14 110.88 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -175.57 137.6 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -139.55 98.85 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.25 113.39 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 64.42 110.903 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.12 -21.81 27.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.54 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.46 -51.08 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.917 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -85.23 -36.68 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.33 110.923 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.5 40.2 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.15 112.522 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -144.57 166.71 24.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 73.5 110.911 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 175.41 46.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 32.41 112.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -141.28 126.68 18.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 73.44 110.859 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.4 mt -98.28 152.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 63.35 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.887 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.842 0.353 . . . . 75.53 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG12 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -119.1 143.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.124 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -98.59 117.7 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.2 110.915 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG11 HG12 ' A' ' 26' ' ' VAL . 1.3 m -126.31 142.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.54 111.104 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -123.15 158.95 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.4 110.829 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -56.36 -22.19 29.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -95.53 20.62 9.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.01 111.161 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.41 -6.16 8.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 71.31 111.102 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.82 132.5 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.11 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.24 110.937 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 70.34 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.62 120.42 8.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 53.14 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.84 7.62 66.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 71.14 112.494 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -107.0 160.54 15.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 72.31 110.919 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -88.8 141.26 28.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.05 110.837 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.22 140.15 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 62.1 111.161 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.54 125.97 42.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 64.2 110.875 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -119.94 146.56 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 74.14 110.864 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -107.55 99.3 8.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 74.15 110.92 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.842 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.6 m -63.01 124.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.135 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.06 158.13 40.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.688 0.756 . . . . 75.53 110.85 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.4 Cg_endo -69.8 -88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.652 2.234 . . . . 71.22 112.33 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 56.78 3.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.484 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -132.02 -41.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 74.14 110.864 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.21 135.93 12.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 73.1 112.483 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.76 -34.21 14.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.739 . . . . 71.44 112.467 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -22.37 17.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 74.42 110.941 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.77 -94.38 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 62.04 112.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 114.93 3.87 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 61.13 112.394 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.842 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 11.9 tt0 -119.93 157.86 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.927 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -78.64 57.54 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 65.44 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.12 -37.8 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 75.42 110.895 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -131.08 104.27 7.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.859 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -108.48 141.71 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.11 111.103 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -132.32 143.05 49.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.9 tmm_? -78.76 135.48 37.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.52 110.879 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 63.43 111.141 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 72.3 110.866 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 26.8 mtmt -132.71 134.86 45.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.876 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.72 171.65 44.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.776 -0.726 . . . . 72.41 112.507 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 p -80.99 145.42 31.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 65.31 111.143 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.87 144.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 73.25 111.106 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.96 -31.28 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 75.24 110.879 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -175.43 139.98 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 75.42 110.916 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -133.63 99.11 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.52 110.88 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.64 101.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.902 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.81 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.15 111.053 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -70.26 -43.93 69.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.894 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -93.37 -34.72 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 72.41 110.882 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.1 45.73 2.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.75 -0.738 . . . . 72.22 112.474 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -157.64 143.24 17.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 74.04 110.976 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.76 -174.21 22.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 72.21 112.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -142.49 127.59 18.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 72.1 110.887 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.9 mt -98.5 151.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 64.41 111.097 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.899 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.836 0.35 . . . . 75.1 110.868 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.57 142.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.133 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.34 115.75 29.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 64.02 110.889 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.53 144.41 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 65.42 111.127 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.6 159.04 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.881 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -56.16 -21.76 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.892 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 m -97.0 22.57 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.24 111.143 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.67 -6.38 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.02 111.086 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.9 mp -89.66 132.43 34.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 63.45 111.132 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 62.34 110.871 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.784 0.325 . . . . 74.13 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -58.0 119.35 6.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 61.41 110.878 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.67 6.19 62.52 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.689 -0.767 . . . . 73.14 112.502 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -106.83 160.11 15.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.53 110.885 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -88.69 141.79 28.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.868 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 67' ' ' ARG . 2.6 m -158.48 140.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 74.35 111.177 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.6 tt0 -99.03 127.0 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 71.22 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -118.07 149.05 41.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 64.32 110.88 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -106.42 98.82 8.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.865 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.823 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -53.29 125.38 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 75.42 111.153 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -111.1 138.95 21.36 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 71.25 110.895 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -90.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.65 2.234 . . . . 71.35 112.325 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.72 53.84 4.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 44.21 112.515 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 -40.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 73.11 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.62 135.58 15.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 73.23 112.486 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.33 -36.85 17.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.734 . . . . 70.03 112.501 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -19.37 16.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.3 110.877 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.11 -102.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 70.23 112.439 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 113.3 3.32 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 52.45 112.33 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.823 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 pt20 -119.28 174.86 6.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.878 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.1 59.18 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 75.42 111.106 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -40.79 -44.42 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.869 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -129.0 107.63 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.01 110.864 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.78 142.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 64.45 111.13 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -132.0 141.53 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.86 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.424 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.01 136.03 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.85 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.32 111.147 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.855 0.36 . . . . 72.44 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 21.3 mtmm -127.53 134.15 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 72.3 110.926 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.81 171.53 42.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.738 . . . . 74.13 112.465 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.6 p -83.28 146.32 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 74.01 111.149 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 144.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.106 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -29.51 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.24 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -172.79 138.95 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.899 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -140.57 98.05 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.898 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.16 105.33 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.903 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.19 -30.26 43.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 71.1 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -71.46 -37.1 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.905 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.2 -40.21 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.907 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.89 5.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 73.14 112.458 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -149.96 170.74 18.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 73.4 110.913 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.99 178.46 46.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 62.23 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -142.93 125.13 15.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 71.0 110.885 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.24 150.9 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 74.32 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.923 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.862 0.363 . . . . 72.04 110.852 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -112.2 142.37 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 75.22 111.124 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.97 116.76 31.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.864 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 26' ' ' VAL . 1.9 m -122.54 140.78 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 64.11 111.133 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.15 158.49 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.44 110.848 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -56.08 -23.23 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.89 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m -95.74 22.19 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 75.21 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.18 -6.41 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 73.31 111.097 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.18 131.97 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.139 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.923 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.775 0.322 . . . . 73.45 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.8 121.46 10.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.927 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.71 68.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.31 112.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.68 160.56 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.36 . . . . 71.14 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -89.32 142.25 27.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.877 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -158.74 140.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.33 111.092 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -97.14 127.85 43.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 62.11 110.87 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.88 146.71 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 74.44 110.912 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.02 97.25 7.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.911 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.781 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 61.4 t -52.05 130.14 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 74.33 111.183 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -118.11 137.7 24.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 74.22 110.871 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -91.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 71.44 112.349 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.38 4.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.721 . . . . 73.31 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -39.98 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 75.33 110.884 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.2 136.79 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 72.41 112.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.41 -35.2 14.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 63.4 112.446 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -18.7 14.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 73.32 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.05 -103.44 0.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.481 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 110.64 2.61 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 61.21 112.33 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.781 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.2 pt20 -118.35 173.68 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.87 61.55 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 64.04 111.089 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -42.78 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.903 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 1.3 tttt -131.54 110.74 11.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.909 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.77 142.11 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 75.24 111.151 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.02 110.884 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' A' ' 47' ' ' VAL . 52.0 ttt180 -78.06 134.76 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.24 110.92 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.34 111.115 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.902 0.382 . . . . 72.43 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.6 mtmt -128.66 134.72 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 73.4 110.893 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.56 44.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.482 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 p -85.15 148.49 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.3 111.146 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.27 144.8 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 75.12 111.114 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.07 -29.65 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.899 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -176.16 137.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.929 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -136.67 99.39 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 74.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -72.37 111.39 7.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.05 110.85 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.45 -32.78 42.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 71.43 111.118 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.84 -50.81 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -77.77 -29.81 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.868 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.83 32.7 10.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 73.54 112.477 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -140.12 169.19 18.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 74.51 110.917 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.32 172.97 45.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 70.02 112.512 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -141.45 129.11 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 74.55 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.22 144.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 71.42 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.42 110.88 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 73.42 110.921 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.87 145.91 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 73.3 111.151 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.02 117.52 35.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 72.23 110.84 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.47 142.44 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 111.147 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.92 157.08 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 62.11 110.894 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -56.01 -24.55 39.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 71.31 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -93.83 20.88 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.099 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.74 -1.88 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.13 111.11 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -90.3 127.97 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 64.41 111.106 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.92 179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 64.42 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -58.68 115.99 3.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.23 110.871 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.15 7.42 54.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.15 112.49 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.97 158.95 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.54 110.889 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -88.48 141.56 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.866 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -158.85 139.86 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 73.44 111.131 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.2 tt0 -97.42 126.18 42.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 75.44 110.871 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 28.7 p90 -121.14 147.08 46.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 71.13 110.885 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 9.8 mt-10 -107.53 99.03 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 73.04 110.891 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.0 m -64.65 125.38 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.15 111.106 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -114.3 158.96 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 74.23 110.918 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -89.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.244 . . . . 74.41 112.33 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.57 57.19 3.79 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 64.43 112.438 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -132.51 -41.6 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 75.31 110.878 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.23 139.04 14.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 65.34 112.529 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -38.59 23.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 60.13 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -22.09 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 75.41 110.886 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.2 -93.16 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 71.11 112.487 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 114.42 3.7 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 54.11 112.352 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.877 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.1 tt0 -119.5 157.06 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.62 58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.11 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -43.67 3.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 63.22 110.887 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.0 mtpp -129.53 109.06 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.897 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -110.22 142.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.134 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -131.87 143.39 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 75.4 110.912 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.435 ' HA ' HG13 ' A' ' 47' ' ' VAL . 1.7 mtm105 -78.17 135.92 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.821 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.51 111.115 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.839 0.352 . . . . 75.32 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.3 mtpm? -129.24 136.72 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.875 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.9 172.08 44.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 75.55 112.438 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -82.65 151.06 26.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 72.33 111.138 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.37 147.05 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 63.34 111.137 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 -34.51 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 75.04 110.919 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -168.5 139.19 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.912 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.29 98.53 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.42 110.889 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.69 115.13 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 75.53 110.924 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.94 -33.09 24.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 70.24 111.099 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.75 -49.92 71.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.884 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -77.72 -29.67 51.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.913 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 33.4 10.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 71.12 112.484 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.7 169.95 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 74.11 110.924 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 170.81 43.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 71.11 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -141.4 125.18 16.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.11 110.886 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.85 151.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 75.23 111.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 75.02 110.942 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.832 0.349 . . . . 75.14 110.838 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 HG13 HG11 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -110.6 143.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.071 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.8 118.73 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.879 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -129.39 143.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 64.11 111.12 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -120.39 157.31 29.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 75.32 110.861 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -55.72 -24.68 36.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 75.13 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -94.43 22.74 5.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 63.44 111.169 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.19 -0.14 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.16 130.61 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.35 111.149 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 63.35 110.856 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.761 0.315 . . . . 73.24 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 124.09 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 65.2 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.03 6.41 69.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 62.51 112.509 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -102.47 157.31 17.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 70.53 110.872 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -87.93 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 73.3 110.835 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -159.11 141.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 61.33 111.12 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.3 tt0 -94.24 125.42 38.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -118.37 142.61 47.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 78.1 mt-10 -106.2 98.07 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.896 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.838 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.0 m -63.79 122.5 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 75.25 111.147 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.86 160.39 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.661 0.743 . . . . 65.31 110.845 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 75.22 112.305 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 55.7 3.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 74.22 112.446 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -130.59 -41.68 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 73.15 110.866 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.13 140.42 15.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 75.04 112.478 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.52 -44.95 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 60.23 112.479 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -85.15 -22.18 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 72.04 110.851 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -90.88 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 75.12 112.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 114.2 3.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 74.24 112.353 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.838 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -121.96 156.53 33.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.915 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.3 58.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.107 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -44.56 -36.19 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.35 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 4.2 ttpt -130.74 106.95 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.25 142.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.33 111.104 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -131.15 142.61 50.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.897 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.19 133.15 36.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.856 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.22 111.148 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.806 0.336 . . . . 74.3 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.2 mtpt -135.16 134.74 40.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.426 . . . . 73.12 110.901 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.23 171.8 44.89 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 72.41 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.5 p -81.46 146.31 30.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 73.41 111.124 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.71 145.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.43 111.084 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -97.96 -29.31 13.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.908 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -175.57 144.73 0.68 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 72.25 110.917 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -144.94 98.85 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 72.43 110.853 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -68.84 117.64 10.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.32 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.68 -24.02 21.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.51 111.121 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.38 -45.01 93.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.842 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -90.79 -37.84 13.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.944 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 42.53 2.21 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.731 -0.747 . . . . 50.44 112.505 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -144.75 168.18 20.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 70.4 110.936 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 174.43 46.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.475 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -142.32 125.34 16.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 mt -98.44 152.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.54 111.103 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.914 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.85 0.357 . . . . 72.25 110.844 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG11 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -112.61 145.25 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 74.13 111.102 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.19 116.85 33.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG12 HG11 ' A' ' 26' ' ' VAL . 1.2 m -125.14 143.39 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.18 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -121.71 159.41 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.1 110.87 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -56.63 -22.46 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 74.33 110.875 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -95.48 21.46 8.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.65 -3.63 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.45 111.086 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.24 132.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.175 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.899 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.774 0.321 . . . . 75.13 110.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.16 130.24 45.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.894 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 6.77 88.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 44.01 112.493 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.36 160.3 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 65.11 110.891 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -87.03 141.0 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 73.01 110.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.56 140.79 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.118 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 24.8 tt0 -97.65 125.75 42.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.32 110.871 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -119.54 146.05 45.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.35 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -106.07 98.22 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.91 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.842 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 21.9 m -63.66 124.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.143 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.61 160.67 35.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.618 0.723 . . . . 55.31 110.863 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.692 2.261 . . . . 75.03 112.328 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.43 57.3 3.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 73.03 112.477 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.6 -41.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 74.21 110.875 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.86 137.54 13.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.76 . . . . 71.22 112.487 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.39 18.1 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 74.44 112.477 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.7 -22.89 19.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 74.34 110.86 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -93.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 73.54 112.517 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 114.92 3.87 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 72.53 112.315 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.842 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.9 tt0 -119.7 158.0 27.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.911 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -78.94 58.25 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 65.42 111.08 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -43.56 -38.02 2.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 74.01 110.893 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -132.17 106.17 7.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.882 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.36 142.07 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.112 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -131.92 142.87 49.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.906 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.74 134.79 37.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.855 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 73.34 111.162 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 73.25 110.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.6 mtmt -126.45 134.2 51.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.892 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 171.73 43.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.24 112.536 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -85.64 142.95 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 71.15 111.16 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.78 144.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.151 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -31.76 11.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.93 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -174.72 138.56 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.54 110.917 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -138.04 99.28 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.869 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -73.01 116.58 13.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.896 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.77 -20.34 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 75.24 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.77 -54.92 35.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -84.34 -35.61 23.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.45 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.74 39.46 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 70.34 112.458 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -143.92 163.57 33.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 72.22 110.917 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.95 175.83 43.9 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.498 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -141.85 128.22 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 72.4 110.846 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.9 mt -97.7 148.77 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 62.02 111.112 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.919 179.925 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.87 0.367 . . . . 74.33 110.866 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.29 144.64 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 63.32 111.141 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -99.15 119.96 38.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 75.41 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.52 143.33 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.44 111.109 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -119.0 156.17 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 62.41 110.852 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -55.39 -25.12 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.871 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -94.22 22.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.125 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.23 -1.89 8.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.062 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.3 130.72 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 75.13 111.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.884 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.867 0.365 . . . . 70.12 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -58.46 119.03 6.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.921 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.15 6.57 58.89 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.754 -0.736 . . . . 64.23 112.494 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -105.18 159.87 15.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 64.14 110.848 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -87.82 140.58 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.842 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.1 m -157.99 139.76 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.23 111.111 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 26.6 tt0 -96.64 126.29 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.55 110.851 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -120.46 143.31 48.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.861 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -105.09 97.33 7.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.828 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.32 124.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 72.1 111.129 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.88 157.47 36.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.624 0.726 . . . . 75.33 110.93 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.227 . . . . 70.23 112.361 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.66 57.09 4.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 71.32 112.477 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -132.18 -39.34 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 75.25 110.899 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -93.63 133.62 11.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.781 -0.723 . . . . 64.21 112.483 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.57 8.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 71.44 112.528 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.51 -23.9 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 75.01 110.886 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.69 -93.12 0.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.731 . . . . 65.44 112.511 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 116.59 4.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.66 2.24 . . . . 72.4 112.349 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.828 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.3 tm0? -122.3 150.89 41.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 72.35 110.909 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.45 ' N ' ' HG2' ' A' ' 61' ' ' GLN . . . -74.52 59.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 63.14 111.135 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -46.44 -37.87 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 75.34 110.897 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 104.51 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.03 110.86 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -108.18 140.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 65.01 111.12 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -131.58 143.37 50.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.42 110.889 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 47' ' ' VAL . 6.4 ptm180 -78.87 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.891 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.164 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.803 0.335 . . . . 74.32 110.938 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.8 mtmp? -125.94 133.3 51.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.23 110.922 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.11 171.42 42.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 73.22 112.529 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -87.34 145.88 26.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 71.55 111.166 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.6 145.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.107 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -99.49 -29.79 12.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -175.72 137.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 74.11 110.937 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -135.12 97.93 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.52 110.876 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.51 92.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.844 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.95 74.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 64.54 111.111 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.11 -43.9 90.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.874 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -78.83 -38.37 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.887 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 25.9 7.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 73.23 112.485 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -140.87 169.66 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 75.42 110.978 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.94 172.39 45.06 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.746 . . . . 52.2 112.499 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 74.12 110.879 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.19 152.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 75.03 111.165 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.92 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.82 0.343 . . . . 75.34 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.42 139.5 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 74.45 111.148 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.8 115.73 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.5 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.88 144.64 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.42 111.145 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.23 156.77 31.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.4 110.828 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -54.69 -24.71 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 71.42 110.826 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -94.98 24.95 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.02 111.112 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.71 -0.38 6.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 74.13 111.127 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.43 126.74 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 74.03 111.148 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.89 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.806 0.336 . . . . 52.23 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 72.04 110.894 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.27 8.27 60.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.12 112.511 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.7 158.56 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.918 0.389 . . . . 60.53 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -88.29 140.25 29.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.806 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.82 140.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 75.43 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.7 tt0 -95.66 125.07 39.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.874 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -118.86 144.33 46.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.859 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -105.9 97.79 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 74.53 110.889 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.5 m -64.13 117.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 73.25 111.125 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -108.65 160.17 28.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.662 0.744 . . . . 73.55 110.92 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 71.23 112.325 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 55.79 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 75.45 112.522 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -130.72 -41.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 74.21 110.895 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.01 142.19 15.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 64.34 112.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.51 -47.1 29.51 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 75.53 112.504 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.8 -22.72 34.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 74.34 110.916 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.13 -89.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 62.54 112.484 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 116.51 4.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.646 2.231 . . . . 75.52 112.367 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.833 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.9 tt0 -123.79 157.6 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -77.33 57.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.31 111.109 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -44.44 -37.57 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.67 104.86 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 71.42 110.927 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -107.76 141.55 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 73.51 111.155 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -131.43 142.7 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.837 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.1 ppt_? -78.44 134.37 37.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.896 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 72.45 111.163 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.866 0.365 . . . . 75.33 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 14.9 mttp -133.06 137.88 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.956 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.96 171.51 44.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.702 -0.761 . . . . 74.42 112.461 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 p -85.55 144.12 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 74.1 111.109 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.3 144.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 71.13 111.123 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -99.48 -30.2 12.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -175.19 139.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.8 99.41 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 74.14 110.901 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -69.59 93.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 75.32 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.53 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -67.16 -35.86 80.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.845 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -94.04 -36.97 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.14 32.53 4.92 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 75.32 112.477 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -146.28 168.12 21.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.888 0.375 . . . . 74.25 110.947 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.66 179.03 46.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.746 -0.74 . . . . 71.51 112.464 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -142.35 130.69 22.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 73.13 110.895 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mt -97.09 144.21 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.5 111.117 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.9 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.826 0.346 . . . . 74.42 110.871 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.4 142.77 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.2 111.127 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.26 116.3 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.897 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -122.99 141.33 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 74.24 111.133 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -121.55 159.83 25.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 70.52 110.819 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -56.66 -22.32 33.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.853 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -94.37 19.78 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 63.21 111.12 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.83 -7.97 8.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.43 111.117 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 132.79 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.23 111.149 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.891 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.824 0.345 . . . . 65.22 110.918 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.68 117.64 4.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.875 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.88 7.06 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 55.42 112.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.15 160.41 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 75.55 110.892 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -89.05 141.78 28.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.53 110.812 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 67' ' ' ARG . 2.9 m -158.37 139.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.2 111.178 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.8 tt0 -98.17 126.4 43.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.88 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -119.72 146.65 45.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.85 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.0 98.88 8.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 75.11 110.857 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -52.04 128.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.25 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 3.0 tp10 -112.58 138.57 22.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.661 0.743 . . . . 74.25 110.874 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 72.14 112.372 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.32 53.71 4.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 72.35 112.437 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.74 -40.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 74.23 110.854 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.53 134.59 13.91 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.735 . . . . 75.24 112.504 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.66 -36.81 13.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 63.21 112.504 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -100.62 -19.31 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 65.32 110.895 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.88 -103.07 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 62.43 112.5 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 113.22 3.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.695 2.263 . . . . 74.52 112.324 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.833 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.0 pt20 -119.32 175.99 5.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.03 110.944 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.23 62.6 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 61.11 111.075 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -46.21 -38.82 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.02 110.934 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.12 104.92 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.14 110.893 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.53 141.38 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -131.65 142.08 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 71.32 110.879 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.429 ' HA ' HG11 ' A' ' 47' ' ' VAL . 22.8 ptt85 -77.62 135.64 38.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.866 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.1 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.146 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.889 0.376 . . . . 75.33 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.3 mtmm -127.05 131.17 51.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.13 172.29 39.91 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.738 -0.744 . . . . 62.23 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.5 p -86.49 141.13 29.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 73.14 111.11 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.58 144.83 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.53 111.14 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -30.59 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 70.22 110.881 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -175.9 138.9 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.945 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -131.74 99.08 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 74.32 110.934 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -68.62 90.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 55.35 110.868 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.14 67.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.44 111.078 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -65.73 -46.73 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 74.31 110.875 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -77.21 -34.13 56.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.887 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.1 19.46 14.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.481 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -138.87 173.78 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 74.31 110.876 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.82 174.59 45.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 71.43 112.465 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -141.38 125.26 17.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.11 110.845 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 mt -98.02 152.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 63.03 111.094 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.89 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.842 0.353 . . . . 75.35 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG12 HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -125.68 148.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 63.54 111.113 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.5 118.96 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.87 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG13 HG12 ' A' ' 26' ' ' VAL . 1.1 m -131.06 142.29 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 74.21 111.11 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -121.54 157.58 30.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.843 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -56.28 -24.28 42.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.883 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -93.93 20.28 7.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.2 111.147 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.91 -5.47 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.11 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -89.38 132.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 73.45 111.154 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.51 110.912 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.776 0.322 . . . . 73.44 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.03 119.77 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 71.02 110.868 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.65 64.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.512 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -106.89 160.79 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 74.11 110.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -89.37 142.31 27.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 63.35 110.87 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -159.09 140.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.086 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.9 tt0 -96.07 125.73 40.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 71.32 110.855 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 25.0 p90 -121.27 143.23 49.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.12 110.861 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.94 98.06 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 62.04 110.894 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.7 m -64.19 118.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 73.05 111.156 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.91 158.16 33.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.629 0.728 . . . . 75.33 110.909 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -88.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 2.252 . . . . 70.13 112.339 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.96 55.92 3.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 70.45 112.454 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -133.35 -41.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 74.51 110.885 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.44 134.91 12.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 73.2 112.494 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.87 -34.32 11.02 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.742 -0.742 . . . . 54.45 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -21.38 16.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 75.32 110.922 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.44 -93.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 74.25 112.518 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.6 4.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.644 2.23 . . . . 74.14 112.373 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -122.23 154.34 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.3 110.899 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.26 57.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 64.22 111.099 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -38.81 5.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 74.32 110.911 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 11.7 tttp -129.61 103.35 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.905 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.59 142.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.34 111.103 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -132.8 143.02 49.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.927 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.43 ' HA ' HG12 ' A' ' 47' ' ' VAL . 35.7 mtp180 -78.66 134.23 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.854 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.54 111.118 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.847 0.356 . . . . 75.52 110.907 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -128.41 137.62 51.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 74.24 110.872 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.57 171.45 44.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 72.45 112.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 p -81.52 156.65 25.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 72.13 111.162 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.57 143.41 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.124 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -97.35 -28.68 13.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.54 110.9 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -174.77 138.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 72.1 110.901 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -136.11 98.96 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.869 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.35 110.908 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.52 -27.85 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.082 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.67 -40.9 96.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.872 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -94.88 -37.33 11.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.35 110.938 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 46.31 1.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 72.14 112.466 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -157.53 142.94 17.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 73.44 110.905 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.62 -176.41 25.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 63.15 112.494 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -141.2 132.57 26.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.34 110.866 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -106.53 149.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 73.2 111.159 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 72.15 110.912 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.847 0.356 . . . . 70.15 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG12 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -121.68 141.46 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.02 111.146 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.31 116.29 31.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.882 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.425 HG12 HG12 ' A' ' 26' ' ' VAL . 1.1 m -121.05 145.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 75.55 111.128 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -124.64 159.36 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.88 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -55.48 -23.18 24.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.903 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -95.81 23.81 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 72.52 111.121 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 -3.0 6.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 60.21 111.094 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.74 131.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.103 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 64.54 110.897 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.781 0.324 . . . . 72.31 110.931 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.83 122.7 13.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 65.33 110.9 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.38 76.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.25 112.492 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -106.73 160.39 15.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.947 0.403 . . . . 74.43 110.838 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -89.1 141.07 28.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 73.5 110.826 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.5 140.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.01 111.136 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.2 tt0 -95.39 127.54 41.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 64.14 110.887 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -119.73 144.58 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 74.22 110.86 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.8 97.18 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.863 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.1 m -60.8 127.81 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 75.42 111.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -121.69 158.86 53.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.632 0.73 . . . . 62.13 110.903 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -88.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.732 2.288 . . . . 70.1 112.312 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.83 57.43 3.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.62 -42.01 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 75.41 110.858 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.91 138.24 13.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 71.25 112.517 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -39.88 21.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.455 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.46 -25.04 25.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 71.01 110.862 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.54 -92.67 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 65.13 112.475 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.11 3.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.677 2.251 . . . . 74.53 112.32 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.814 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -118.24 158.12 25.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.892 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -77.91 57.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 70.31 111.121 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -39.67 -43.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 64.45 110.937 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -126.63 108.35 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.918 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -108.32 141.44 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 61.23 111.152 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -131.6 142.28 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.88 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 47' ' ' VAL . 45.2 ttt-85 -79.22 134.92 36.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 64.04 110.889 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.42 111.126 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.853 0.359 . . . . 74.11 110.906 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 12.3 mtpt -133.37 133.78 42.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.898 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.55 171.53 44.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 73.44 112.453 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -85.61 142.12 29.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 72.23 111.168 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.82 144.57 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 72.12 111.118 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -30.77 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.879 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -176.51 137.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 74.45 110.913 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -134.83 98.9 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.87 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.15 93.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 62.41 110.855 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.33 -31.46 70.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.42 111.097 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -65.47 -41.41 93.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 75.43 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -83.63 -38.5 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.909 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 26.64 7.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 64.43 112.472 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.91 169.01 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 74.14 110.9 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.66 173.63 45.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 72.23 112.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -141.93 128.92 20.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 74.03 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mt -97.08 146.5 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 70.32 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 71.24 110.877 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 61.41 110.874 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.27 138.39 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.35 111.179 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.75 115.89 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.17 143.42 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.21 111.107 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.39 158.52 25.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.22 110.827 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -56.0 -25.09 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.858 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.47 22.09 5.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.17 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.18 -0.99 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.42 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mp -93.13 130.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.2 111.146 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.876 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.771 0.32 . . . . 65.1 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -59.75 118.38 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.14 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 6.62 57.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 73.55 112.527 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.66 158.4 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 70.32 110.86 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -87.5 141.54 28.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 75.52 110.874 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.57 139.97 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.01 111.091 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 28.4 tt0 -97.47 125.11 41.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 65.42 110.875 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.6 p90 -120.57 144.41 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.887 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.63 97.36 7.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.02 110.899 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.837 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -62.91 122.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 73.43 111.102 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -111.98 159.18 34.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.658 0.742 . . . . 74.11 110.921 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 71.5 112.356 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.96 57.92 4.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 74.44 112.455 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -130.52 -41.88 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 75.12 110.855 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.93 137.08 13.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 50.11 112.468 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -35.52 14.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.724 -0.75 . . . . 63.45 112.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -91.34 -25.24 19.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 73.42 110.949 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.28 -91.79 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.742 -0.742 . . . . 72.43 112.501 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 116.55 4.62 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.653 2.236 . . . . 74.11 112.354 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.837 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 tt0 -118.26 156.51 28.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.01 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 58.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 64.2 111.082 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -40.89 -42.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.911 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 16.0 tttp -134.03 108.26 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 65.22 110.901 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -107.11 141.8 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.43 111.133 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -131.75 142.75 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 73.23 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.441 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -77.96 134.89 37.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.912 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.123 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.844 0.354 . . . . 72.33 110.892 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.6 mttt -129.9 137.37 50.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.899 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.45 171.35 44.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 61.42 112.504 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -88.82 138.99 30.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 73.03 111.112 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 145.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 73.14 111.136 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -101.05 -27.78 13.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.918 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -176.01 140.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 75.2 110.891 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -135.78 99.41 4.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 73.12 110.849 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -67.66 117.4 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.3 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.41 18.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.53 111.115 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -59.93 -31.85 70.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.898 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -107.88 -33.78 7.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.92 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.95 40.37 2.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 71.13 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -142.52 173.85 11.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 74.53 110.932 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.06 174.61 46.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 74.22 112.487 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -140.58 126.65 19.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 62.52 110.89 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.44 151.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 74.44 111.127 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.05 110.951 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.917 0.389 . . . . 75.1 110.877 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -118.3 145.25 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.21 111.157 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.97 33.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 26' ' ' VAL . 1.2 m -124.97 142.32 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 74.42 111.119 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.3 161.03 24.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.857 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.03 -21.97 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.855 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -94.16 19.74 8.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 65.11 111.125 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.7 -22.03 7.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 73.31 111.099 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -71.08 127.39 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.43 111.138 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.52 110.86 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.754 0.311 . . . . 63.32 110.934 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -62.22 120.38 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 5.09 68.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.729 . . . . 73.45 112.537 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.6 158.33 15.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 75.23 110.922 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -86.92 139.39 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.44 110.829 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.4 m -158.54 139.93 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.13 111.144 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 tt0 -97.0 125.06 41.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.22 110.883 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -118.44 145.82 44.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.1 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -106.49 98.35 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.895 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.836 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.7 m -62.92 124.87 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 52.1 111.117 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.64 160.67 35.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.63 0.729 . . . . 75.1 110.879 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -88.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 73.45 112.339 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.06 57.07 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 64.05 112.465 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.51 -41.71 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 74.32 110.835 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.64 136.59 12.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 73.4 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.67 -34.83 15.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 74.22 112.501 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -22.94 18.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.339 . . . . 74.43 110.818 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.22 -93.36 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.732 . . . . 70.41 112.48 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.66 3.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.716 2.278 . . . . 74.12 112.356 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.836 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 9.4 tt0 -120.05 157.92 27.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.12 110.93 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -77.97 57.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 60.43 111.087 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.49 -38.85 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.886 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.67 104.75 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.32 110.881 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -108.15 141.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.14 111.14 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -131.33 141.9 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.2 110.848 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.52 134.85 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.0 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.51 111.115 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.872 0.368 . . . . 65.22 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 25.4 mttt -127.52 133.88 49.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.33 110.895 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.46 171.75 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.774 -0.727 . . . . 74.41 112.48 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.5 p -85.41 144.88 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 72.34 111.153 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.88 147.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 75.31 111.135 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -32.36 10.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.902 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -174.74 141.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 73.54 110.929 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -141.15 98.94 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.861 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -65.21 119.22 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.02 110.949 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.24 21.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.15 111.071 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.5 -38.41 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 63.33 110.895 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -97.88 -38.03 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 73.22 110.904 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 44.67 1.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 65.31 112.474 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.48 168.47 25.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 73.2 110.96 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.77 -179.37 45.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 72.31 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -141.01 126.27 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 74.31 110.874 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.76 150.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 54.25 111.142 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.86 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.856 0.36 . . . . 71.44 110.906 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -110.77 142.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.63 116.37 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 26' ' ' VAL . 1.3 m -121.42 142.52 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.41 111.099 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -123.53 160.07 27.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 75.24 110.849 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -56.93 -21.43 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.896 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.6 t -95.0 19.81 9.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.134 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 -24.2 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 61.42 111.061 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -70.47 124.07 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.152 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.919 179.913 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.805 0.335 . . . . 73.31 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.18 121.87 14.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.871 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.92 72.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 73.15 112.497 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.31 157.43 15.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 65.34 110.894 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -85.91 138.36 32.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.843 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 67' ' ' ARG . 4.0 m -158.22 140.39 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 65.12 111.148 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 39.7 tt0 -95.86 125.95 40.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.917 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -118.3 145.54 45.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.881 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -106.71 97.73 7.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 70.15 110.848 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.835 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.1 m -62.0 123.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 73.53 111.083 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -113.97 161.16 29.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.622 0.725 . . . . 71.04 110.883 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 74.04 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.23 57.27 4.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 74.24 112.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.418 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 4.0 mpt_? -128.96 -41.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 72.34 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.96 14.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 65.35 112.467 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.27 -41.93 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 51.55 112.463 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.44 -22.52 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 65.42 110.927 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.56 -89.87 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 72.12 112.478 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 114.82 3.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.658 2.239 . . . . 75.42 112.338 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.835 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.8 tt0 -119.23 156.55 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 74.2 110.921 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.03 57.09 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.22 111.144 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -41.74 -49.89 4.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 55.21 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.3 tttp -120.06 108.23 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.94 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -110.08 142.23 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.12 111.162 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -131.0 142.83 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.86 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.434 ' HA ' HG13 ' A' ' 47' ' ' VAL . 38.4 ptt180 -78.75 134.88 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 75.55 110.852 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 73.32 111.122 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.85 0.357 . . . . 74.42 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.0 mtpp -132.02 133.17 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.895 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.8 171.14 43.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 72.43 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.8 p -82.46 146.62 29.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 74.34 111.105 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.68 145.89 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -36.74 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 75.3 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -170.52 141.6 1.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.904 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -136.49 99.29 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 75.4 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 103.2 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 64.33 110.919 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.3 47.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.113 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.46 -47.63 69.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.883 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.21 -36.08 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.862 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.13 2.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 72.53 112.513 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -152.74 151.35 30.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 72.52 110.91 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.28 176.53 32.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 73.44 112.451 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.53 122.93 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 72.4 110.883 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mt -97.99 154.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.03 111.152 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.926 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.818 0.342 . . . . 71.12 110.835 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.69 136.05 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.121 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.71 115.4 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.44 110.938 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -124.97 143.72 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.51 111.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -122.4 158.87 28.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.867 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.96 -24.42 38.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -94.72 23.01 5.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.11 111.153 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.75 -2.02 7.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.32 111.095 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.39 131.97 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.33 111.154 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.4 110.894 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.798 0.333 . . . . 61.02 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.94 121.23 9.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.85 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.54 7.27 67.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 62.31 112.511 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -106.84 160.62 15.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.851 0.358 . . . . 75.35 110.893 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -88.74 141.96 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.883 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -158.63 140.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.14 111.142 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 33.4 tt0 -94.62 126.8 40.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.905 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -120.7 142.03 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.03 97.58 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 73.42 110.902 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.831 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.5 m -63.0 126.9 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.141 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.68 159.47 46.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.679 0.752 . . . . 73.25 110.906 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -87.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.725 2.283 . . . . 73.21 112.354 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.36 55.92 4.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 52.33 112.45 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.0 -41.76 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 75.34 110.887 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.53 137.68 13.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 34.42 112.474 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.87 -38.36 23.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 73.23 112.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.98 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 74.52 110.876 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.32 -93.96 0.15 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 73.42 112.456 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 112.77 3.16 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 75.5 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.831 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.6 tt0 -117.86 156.77 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.915 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.39 59.11 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 60.43 111.1 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -41.82 -38.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.949 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -130.85 109.63 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.863 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -108.3 141.24 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 65.45 111.13 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -131.52 141.14 49.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 72.42 110.898 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.431 ' HA ' HG12 ' A' ' 47' ' ' VAL . 15.2 ptm180 -78.67 133.45 37.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.03 110.857 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.0 mm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 62.41 111.135 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.887 0.375 . . . . 75.21 110.882 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -130.99 137.13 49.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.1 110.91 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.22 41.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.22 112.51 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p -84.91 138.04 32.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 74.42 111.13 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.95 144.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 71.03 111.106 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -99.66 -30.49 12.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.872 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -175.41 136.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 73.32 110.894 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -135.48 98.92 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.892 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -69.19 112.32 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.54 110.929 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.47 -30.13 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.41 111.113 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -62.94 -53.89 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.43 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -75.03 -32.14 61.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.914 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.1 30.84 8.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 64.25 112.482 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -139.93 169.13 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 73.21 110.926 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 173.59 46.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.491 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -140.91 126.81 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 74.53 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 mt -102.03 152.98 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.04 111.122 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.932 179.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.842 0.353 . . . . 74.14 110.846 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.433 HG11 HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -132.67 143.21 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.23 111.141 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.38 120.28 34.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.9 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG13 HG11 ' A' ' 26' ' ' VAL . 1.3 m -130.42 142.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 70.01 111.104 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -122.95 157.92 31.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.05 110.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.66 -23.51 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.848 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.0 t -94.51 19.46 9.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.14 111.173 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.36 -8.75 9.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 70.14 111.056 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.47 131.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 64.53 111.142 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.885 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.792 0.33 . . . . 74.34 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -57.06 122.38 12.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.4 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.01 5.68 67.73 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 61.22 112.506 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -106.71 160.48 15.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 73.43 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -89.82 142.34 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 70.34 110.869 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -157.71 140.2 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 75.25 111.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 tt0 -96.75 125.11 40.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.913 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -119.09 144.17 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.14 110.936 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -102.57 98.07 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.22 110.94 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.826 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.7 m -61.89 118.23 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.115 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -107.51 156.46 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.44 110.854 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.5 Cg_endo -69.78 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.717 2.278 . . . . 71.33 112.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 56.51 3.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 55.03 112.483 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -132.28 -41.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 74.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.94 134.02 12.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 65.12 112.475 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.3 7.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 70.42 112.454 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -23.2 15.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 75.33 110.939 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.51 -93.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 72.31 112.497 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 117.07 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 72.21 112.339 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.826 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 15.1 tt0 -120.99 157.38 30.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.932 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -78.59 56.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.12 111.131 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -40.68 -46.04 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.907 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.5 tttp -126.44 105.82 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.926 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -105.87 142.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.54 111.108 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -132.38 146.14 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 133.93 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.45 110.895 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.35 111.14 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.835 0.35 . . . . 71.34 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 18.3 mtmt -131.06 135.71 47.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.44 110.857 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.91 171.48 44.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.466 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -82.77 143.95 30.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 71.2 111.112 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.7 144.58 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.23 111.13 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -31.11 12.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.44 110.911 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -175.09 140.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -139.27 98.85 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.914 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -70.74 109.39 4.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.65 35.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.103 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.24 -48.19 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.43 110.889 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -87.88 -37.36 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.17 41.2 2.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 62.31 112.484 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.97 167.77 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 75.21 110.905 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.09 46.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.55 112.477 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -141.88 124.77 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 74.21 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mt -98.09 151.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 74.1 111.151 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.914 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.845 0.355 . . . . 74.24 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -112.38 146.02 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.145 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -100.44 116.68 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.43 110.886 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 26' ' ' VAL . 1.3 m -124.72 144.04 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 72.33 111.125 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -123.12 159.29 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.869 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -56.25 -21.99 27.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 74.01 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -96.11 22.12 7.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 63.44 111.138 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.6 -4.53 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 53.3 111.103 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.9 mp -89.98 132.41 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.882 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.825 0.345 . . . . 65.32 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -57.17 120.19 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.883 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.06 62.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 74.44 112.462 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -106.87 160.32 15.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 73.2 110.897 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -89.62 141.64 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.52 140.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 71.12 111.156 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -98.03 125.85 43.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.928 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -119.91 143.43 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.43 110.867 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -99.79 99.05 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.53 110.863 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.4 m -56.45 122.78 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.2 111.13 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -101.87 140.79 21.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.25 110.9 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -92.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.688 2.259 . . . . 71.33 112.373 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.15 53.95 4.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 74.24 112.479 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -39.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 71.35 110.863 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 134.43 16.83 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 71.21 112.508 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.91 -36.67 8.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 61.22 112.494 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.66 -14.36 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 75.34 110.873 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.52 -104.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 53.44 112.486 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.652 2.235 . . . . 73.5 112.326 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.841 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.7 pt20 -115.16 171.03 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.55 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.6 61.62 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 65.43 111.142 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -42.02 -46.37 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 74.55 110.885 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 107.14 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 72.35 110.895 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -104.6 141.03 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 75.4 111.116 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -132.02 142.18 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.51 110.838 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.427 ' HA ' HG13 ' A' ' 47' ' ' VAL . 62.1 ttt180 -77.57 134.2 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.876 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.0 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 75.31 111.13 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.898 0.38 . . . . 75.23 110.871 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.8 mtpt -127.23 134.11 50.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.13 110.884 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.53 172.37 44.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.787 -0.721 . . . . 74.43 112.538 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 76.2 p -83.39 144.93 29.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 75.41 111.161 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.21 145.15 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 75.53 111.116 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -31.06 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.885 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -175.69 137.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.884 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.2 99.19 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.34 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -74.16 113.04 10.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 65.11 110.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.76 -34.43 30.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 72.01 111.116 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -56.6 -48.48 77.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.855 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.28 -28.91 26.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 74.51 110.922 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.38 19.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 75.42 112.468 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -133.59 169.21 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 72.42 110.906 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.25 173.59 45.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 65.21 112.487 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -142.39 128.4 19.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 73.31 110.903 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.6 mt -97.7 149.24 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.081 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.42 110.914 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.836 0.35 . . . . 62.34 110.877 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.73 144.93 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.31 111.174 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.93 122.18 41.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.907 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 m -132.87 141.81 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 71.14 111.15 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -115.78 155.4 27.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -54.88 -25.06 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.886 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -93.74 23.62 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 74.23 111.121 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.24 -1.2 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 65.33 111.039 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.21 126.4 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.42 111.12 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.912 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.831 0.348 . . . . 73.03 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.06 118.81 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 65.44 110.858 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.77 4.17 58.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.754 . . . . 71.22 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -101.6 155.51 18.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 72.44 110.879 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -85.63 140.86 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.889 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.77 140.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 21.7 tt0 -98.07 126.35 43.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.854 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -118.42 146.88 44.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 75.51 110.883 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 96.32 6.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 74.4 110.893 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.83 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.1 m -63.4 123.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.3 111.114 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -115.55 160.33 35.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.674 0.749 . . . . 75.32 110.875 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 61.14 112.338 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.7 57.01 3.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.74 . . . . 70.41 112.507 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 5.0 mpt_? -132.79 -41.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 74.04 110.865 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 134.53 12.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 75.54 112.508 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.89 -33.93 10.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.31 112.475 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.32 -22.35 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 73.44 110.851 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.37 -92.5 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.691 -0.766 . . . . 73.12 112.476 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 115.06 3.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.267 . . . . 63.12 112.346 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.83 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -118.92 154.29 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.879 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.85 56.5 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.43 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.38 -47.08 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 71.54 110.92 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.54 108.33 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.92 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -110.21 141.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 72.54 111.156 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -131.3 143.24 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.866 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 47' ' ' VAL . 18.2 mmm-85 -78.06 135.78 37.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.855 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.33 111.121 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 74.31 110.908 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 mtpt -130.32 133.44 46.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.52 110.932 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.86 171.63 44.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.479 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -85.63 142.96 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.334 . . . . 73.23 111.163 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.81 144.06 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 73.53 111.156 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -29.41 13.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.51 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -177.41 145.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 74.13 110.958 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -138.13 103.37 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 72.5 110.876 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -72.36 106.72 4.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 73.25 110.886 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.02 -35.95 41.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.12 111.081 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -57.17 -42.58 81.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.889 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -86.77 -33.68 19.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.901 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 22.46 16.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 55.45 112.499 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -130.56 176.39 8.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.958 0.409 . . . . 75.41 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.98 44.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.521 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -141.27 125.25 17.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 75.43 110.872 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mt -98.06 151.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 72.51 111.095 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 72.55 110.941 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.864 0.364 . . . . 71.44 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG13 HG11 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -108.59 143.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.34 111.184 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.36 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 64.24 110.874 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG11 HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -128.75 143.3 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.125 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -118.1 157.14 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.865 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -54.83 -25.45 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.9 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 t -93.62 25.0 3.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 71.43 111.129 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.26 -1.08 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 62.33 111.121 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.92 123.3 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 74.24 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.859 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.843 0.354 . . . . 72.23 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.45 120.19 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.874 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.14 3.2 60.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 74.35 112.437 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.41 156.71 16.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.22 110.909 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -84.71 139.22 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.42 110.888 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.8 m -158.43 140.17 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.115 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -94.28 126.34 39.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 75.3 110.919 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 16.8 p90 -119.89 143.52 47.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.843 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 5.4 mm-40 -105.62 98.5 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.904 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.858 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.8 m -63.21 125.46 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.57 160.73 29.38 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 73.03 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -90.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 65.34 112.354 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.91 58.93 4.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 73.01 112.453 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -41.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 74.24 110.906 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.81 136.1 13.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 63.14 112.525 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.93 -31.81 8.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.04 112.463 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -100.41 -22.6 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 73.1 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.58 -91.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 75.03 112.468 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.667 2.244 . . . . 74.41 112.328 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.858 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -119.36 154.81 33.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.903 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.1 61.16 3.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.111 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -46.75 -41.4 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.13 110.884 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 56.2 mmtt -125.6 110.74 14.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.35 110.909 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -111.97 141.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 74.54 111.133 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -130.87 141.87 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.871 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HA ' HG12 ' A' ' 47' ' ' VAL . 23.6 mtp180 -78.38 134.28 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.23 110.918 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.4 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 72.51 111.155 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 71.24 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.3 mtmt -129.45 129.25 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 64.3 110.891 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.85 41.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 55.01 112.446 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -85.04 145.97 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 70.01 111.147 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.72 144.54 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.31 111.154 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -99.25 -30.08 12.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.875 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -175.34 137.17 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.893 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.33 98.88 3.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.51 110.861 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -65.98 115.96 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.12 110.888 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.05 -25.34 23.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.41 111.077 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.98 -40.57 75.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.879 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -87.02 -38.77 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.918 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.55 34.74 4.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 71.41 112.487 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.87 169.0 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 71.43 110.913 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.66 177.06 46.15 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 64.23 112.525 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.99 126.29 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 75.45 110.869 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 mt -99.87 152.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.095 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.929 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.851 0.357 . . . . 73.01 110.874 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.433 HG12 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -134.26 144.59 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 71.23 111.131 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.11 119.04 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.85 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG12 HG12 ' A' ' 26' ' ' VAL . 1.3 m -127.73 140.27 49.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 73.31 111.103 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -119.98 157.78 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 72.13 110.854 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -56.43 -23.93 41.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.915 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -93.93 19.96 8.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 64.42 111.153 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.07 -7.93 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 55.24 111.088 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -87.09 132.24 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.23 111.095 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 70.04 110.873 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.785 0.326 . . . . 73.51 110.861 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.49 121.29 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 74.3 110.842 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.58 65.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.487 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -106.57 159.93 15.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 65.32 110.854 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -87.91 141.53 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 75.12 110.82 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.63 139.77 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 71.52 111.146 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.76 125.67 42.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 72.13 110.854 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.2 p90 -120.99 144.6 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 64.45 110.895 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.43 99.2 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.877 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.904 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -62.8 121.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 75.01 111.168 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.419 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -103.38 148.98 36.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.666 0.746 . . . . 75.43 110.892 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 64.52 112.383 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 58.13 5.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 73.35 112.491 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -40.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 74.22 110.911 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.19 142.3 21.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 62.43 112.501 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.56 -38.05 27.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.768 -0.73 . . . . 72.41 112.504 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -100.45 -17.74 17.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 74.11 110.901 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.12 -98.44 0.21 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 61.15 112.471 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 111.77 2.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 64.44 112.292 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.904 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -119.46 165.79 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.31 110.911 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.67 58.79 4.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.079 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 10.0 ttpt -43.66 -38.81 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.918 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -133.9 104.94 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.898 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -106.6 142.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 73.05 111.125 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.8 141.29 48.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.896 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 47' ' ' VAL . 29.6 ttt180 -77.39 134.58 38.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.846 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.55 111.115 179.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.826 0.346 . . . . 64.53 110.865 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -122.0 148.84 44.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -135.42 134.26 39.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.949 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 171.66 44.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 72.03 112.48 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.9 p -83.72 145.25 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 65.15 111.097 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.56 145.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.141 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -29.19 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.14 110.88 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -175.57 137.6 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -139.55 98.85 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.25 113.39 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 64.42 110.903 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.12 -21.81 27.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.54 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.46 -51.08 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.917 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -85.23 -36.68 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.33 110.923 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.5 40.2 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.15 112.522 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -144.57 166.71 24.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 73.5 110.911 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 175.41 46.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 32.41 112.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -141.28 126.68 18.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 73.44 110.859 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.4 mt -98.28 152.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 63.35 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -124.86 140.48 52.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.887 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.21 -165.96 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 73.21 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -49.52 -29.83 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -107.76 -34.45 6.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 74.1 110.886 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 66.15 1.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 72.43 112.489 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -91.59 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.685 2.257 . . . . 73.33 112.375 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 168.07 101.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 75.53 110.874 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG12 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -119.1 143.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.124 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -98.59 117.7 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.2 110.915 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG11 HG12 ' A' ' 26' ' ' VAL . 1.3 m -126.31 142.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.54 111.104 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -123.15 158.95 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.4 110.829 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -56.36 -22.19 29.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.899 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -95.53 20.62 9.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.01 111.161 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.41 -6.16 8.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 71.31 111.102 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.82 132.5 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.11 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.38 86.19 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.24 110.937 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.3 -179.35 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.45 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.23 74.81 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.841 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.56 -117.62 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 73.33 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -89.92 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 74.42 110.88 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.2 mtm-85 -57.76 100.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.863 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -178.14 159.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 71.31 111.151 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.1 mt -108.91 -175.36 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.14 110.908 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -128.32 127.91 43.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 70.34 110.858 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.62 120.42 8.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 53.14 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.84 7.62 66.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 71.14 112.494 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -107.0 160.54 15.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 72.31 110.919 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -88.8 141.26 28.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.05 110.837 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.22 140.15 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 62.1 111.161 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.54 125.97 42.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 64.2 110.875 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -119.94 146.56 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 74.14 110.864 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -107.55 99.3 8.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 74.15 110.92 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.842 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.6 m -63.01 124.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.135 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.06 158.13 40.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.688 0.756 . . . . 75.53 110.85 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.4 Cg_endo -69.8 -88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.652 2.234 . . . . 71.22 112.33 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 56.78 3.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.484 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -132.02 -41.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 74.14 110.864 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.21 135.93 12.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 73.1 112.483 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.76 -34.21 14.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.739 . . . . 71.44 112.467 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -22.37 17.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 74.42 110.941 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.77 -94.38 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 62.04 112.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 114.93 3.87 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 61.13 112.394 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.842 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 11.9 tt0 -119.93 157.86 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.927 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -78.64 57.54 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 65.44 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.12 -37.8 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 75.42 110.895 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -131.08 104.27 7.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.859 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -108.48 141.71 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.11 111.103 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -132.32 143.05 49.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.9 tmm_? -78.76 135.48 37.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.52 110.879 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 63.43 111.141 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.827 0.346 . . . . 75.04 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -129.35 152.45 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 72.3 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 26.8 mtmt -132.71 134.86 45.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.876 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.72 171.65 44.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.776 -0.726 . . . . 72.41 112.507 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 p -80.99 145.42 31.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 65.31 111.143 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.87 144.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 73.25 111.106 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.96 -31.28 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 75.24 110.879 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -175.43 139.98 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 75.42 110.916 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -133.63 99.11 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.52 110.88 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.64 101.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.902 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.81 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.15 111.053 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -70.26 -43.93 69.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.894 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -93.37 -34.72 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 72.41 110.882 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.1 45.73 2.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.75 -0.738 . . . . 72.22 112.474 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -157.64 143.24 17.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 74.04 110.976 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.76 -174.21 22.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 72.21 112.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -142.49 127.59 18.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 72.1 110.887 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.9 mt -98.5 151.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 64.41 111.097 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -127.64 131.65 49.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.899 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -95.93 -165.18 1.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.939 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -48.93 -31.55 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 74.55 110.857 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -106.79 -27.69 10.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.13 110.919 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.62 68.83 1.51 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 72.5 112.507 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -90.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.733 2.289 . . . . 72.23 112.343 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.7 96.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.868 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.57 142.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.133 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.34 115.75 29.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 64.02 110.889 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.53 144.41 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 65.42 111.127 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.6 159.04 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.881 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -56.16 -21.76 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.892 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 m -97.0 22.57 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.24 111.143 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.67 -6.38 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.02 111.086 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.9 mp -89.66 132.43 34.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 63.45 111.132 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -116.49 86.52 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 62.34 110.871 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.3 179.57 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 74.3 111.118 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -87.23 78.12 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.31 110.864 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.46 -118.17 3.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 72.55 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -64.35 110.16 2.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 73.54 110.894 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -75.07 76.34 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 74.04 110.841 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.6 p -149.44 170.2 19.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.04 111.146 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 mt -114.59 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.913 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -124.46 127.72 47.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.897 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -58.0 119.35 6.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 61.41 110.878 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.67 6.19 62.52 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.689 -0.767 . . . . 73.14 112.502 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -106.83 160.11 15.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.53 110.885 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -88.69 141.79 28.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.868 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 67' ' ' ARG . 2.6 m -158.48 140.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 74.35 111.177 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.6 tt0 -99.03 127.0 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 71.22 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -118.07 149.05 41.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 64.32 110.88 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -106.42 98.82 8.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.865 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.823 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -53.29 125.38 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 75.42 111.153 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -111.1 138.95 21.36 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 71.25 110.895 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -90.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.65 2.234 . . . . 71.35 112.325 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.72 53.84 4.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 44.21 112.515 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 -40.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 73.11 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.62 135.58 15.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 73.23 112.486 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.33 -36.85 17.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.734 . . . . 70.03 112.501 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -19.37 16.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.3 110.877 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.11 -102.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 70.23 112.439 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 113.3 3.32 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 52.45 112.33 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.823 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 pt20 -119.28 174.86 6.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.878 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.1 59.18 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 75.42 111.106 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -40.79 -44.42 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.869 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -129.0 107.63 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.01 110.864 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.78 142.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 64.45 111.13 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -132.0 141.53 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.86 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.01 136.03 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.85 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.32 111.147 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.348 . . . . 70.21 110.85 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -135.02 153.96 51.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.887 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 21.3 mtmm -127.53 134.15 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 72.3 110.926 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.81 171.53 42.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.738 . . . . 74.13 112.465 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.6 p -83.28 146.32 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 74.01 111.149 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 144.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 75.21 111.106 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -29.51 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.24 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -172.79 138.95 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.899 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -140.57 98.05 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.898 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.16 105.33 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.903 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.19 -30.26 43.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 71.1 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -71.46 -37.1 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.905 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.2 -40.21 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.907 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.89 5.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 73.14 112.458 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -149.96 170.74 18.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 73.4 110.913 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.99 178.46 46.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 62.23 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -142.93 125.13 15.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 71.0 110.885 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.24 150.9 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 74.32 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -122.94 127.13 48.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.923 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.67 -167.54 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.43 110.958 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -46.72 -35.07 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 64.43 110.925 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -103.76 -17.52 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.874 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.32 64.43 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 71.42 112.496 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.712 2.274 . . . . 73.43 112.345 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.66 95.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 72.04 110.852 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -112.2 142.37 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 75.22 111.124 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.97 116.76 31.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.864 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 26' ' ' VAL . 1.9 m -122.54 140.78 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 64.11 111.133 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -119.15 158.49 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.44 110.848 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -56.08 -23.23 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.89 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m -95.74 22.19 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 75.21 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.18 -6.41 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 73.31 111.097 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.18 131.97 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.139 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.85 86.41 2.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.923 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.92 179.72 5.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.31 111.083 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -96.49 74.46 2.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 75.04 110.838 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.12 -117.76 0.82 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 65.11 112.498 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.71 120.07 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 75.03 110.903 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -59.52 97.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 71.34 110.901 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 t -178.24 159.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 73.22 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 mt -108.78 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.922 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -127.95 128.91 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.898 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.8 121.46 10.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.927 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.71 68.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.31 112.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.68 160.56 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.36 . . . . 71.14 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -89.32 142.25 27.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.877 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -158.74 140.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.33 111.092 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -97.14 127.85 43.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 62.11 110.87 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.88 146.71 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 74.44 110.912 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.02 97.25 7.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.911 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.781 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 61.4 t -52.05 130.14 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 74.33 111.183 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -118.11 137.7 24.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 74.22 110.871 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -91.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 71.44 112.349 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.38 4.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.721 . . . . 73.31 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -39.98 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 75.33 110.884 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.2 136.79 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 72.41 112.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.41 -35.2 14.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 63.4 112.446 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -18.7 14.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 73.32 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.05 -103.44 0.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.481 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 110.64 2.61 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 61.21 112.33 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.781 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.2 pt20 -118.35 173.68 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.87 61.55 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 64.04 111.089 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 -42.78 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.903 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 1.3 tttt -131.54 110.74 11.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.909 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.77 142.11 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 75.24 111.151 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.02 110.884 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' A' ' 47' ' ' VAL . 52.0 ttt180 -78.06 134.76 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.24 110.92 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 mm . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.34 111.115 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.812 0.339 . . . . 71.45 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -129.98 153.73 48.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 72.43 110.875 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.6 mtmt -128.66 134.72 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 73.4 110.893 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.56 44.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.482 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 p -85.15 148.49 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 73.3 111.146 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.27 144.8 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 75.12 111.114 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.07 -29.65 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.899 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -176.16 137.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.929 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -136.67 99.39 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 74.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -72.37 111.39 7.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.05 110.85 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.45 -32.78 42.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 71.43 111.118 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.84 -50.81 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -77.77 -29.81 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.868 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.83 32.7 10.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 73.54 112.477 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -140.12 169.19 18.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 74.51 110.917 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.32 172.97 45.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 70.02 112.512 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -141.45 129.11 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 74.55 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 mt -97.22 144.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 71.42 111.103 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.71 112.35 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.42 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -77.99 -166.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 71.1 110.884 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -48.03 -33.71 8.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 73.3 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -106.23 -22.4 12.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 72.33 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.8 69.7 1.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 55.22 112.501 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -89.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 65.34 112.307 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.33 96.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.42 110.921 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.87 145.91 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 73.3 111.151 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.02 117.52 35.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 72.23 110.84 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.47 142.44 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 111.147 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -116.92 157.08 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 62.11 110.894 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -56.01 -24.55 39.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 71.31 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -93.83 20.88 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.099 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.74 -1.88 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.13 111.11 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -90.3 127.97 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 64.41 111.106 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.45 85.83 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.92 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.23 166.35 13.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.15 111.084 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.83 74.91 10.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.5 110.896 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.44 -117.64 3.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 74.34 112.502 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -67.93 109.94 3.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 73.33 110.843 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -76.4 117.84 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.862 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.1 t -177.84 154.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 75.21 111.133 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mp -110.2 170.04 8.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 71.24 110.906 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -121.06 126.39 49.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.868 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -58.68 115.99 3.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.23 110.871 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.15 7.42 54.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.15 112.49 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.97 158.95 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.54 110.889 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -88.48 141.56 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.866 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -158.85 139.86 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 73.44 111.131 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.2 tt0 -97.42 126.18 42.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 75.44 110.871 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 28.7 p90 -121.14 147.08 46.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 71.13 110.885 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 9.8 mt-10 -107.53 99.03 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 73.04 110.891 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.0 m -64.65 125.38 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.15 111.106 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -114.3 158.96 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 74.23 110.918 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -89.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.244 . . . . 74.41 112.33 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.57 57.19 3.79 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 64.43 112.438 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -132.51 -41.6 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 75.31 110.878 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.23 139.04 14.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 65.34 112.529 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -38.59 23.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 60.13 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -22.09 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 75.41 110.886 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.2 -93.16 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 71.11 112.487 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 114.42 3.7 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 54.11 112.352 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.877 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.1 tt0 -119.5 157.06 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.62 58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.11 111.079 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -43.67 3.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 63.22 110.887 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 5.0 mtpp -129.53 109.06 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.897 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -110.22 142.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.134 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -131.87 143.39 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 75.4 110.912 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.435 ' HA ' HG13 ' A' ' 47' ' ' VAL . 1.7 mtm105 -78.17 135.92 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.821 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.51 111.115 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.817 0.341 . . . . 75.3 110.874 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -134.87 156.48 48.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.32 110.877 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.3 mtpm? -129.24 136.72 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.875 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.9 172.08 44.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 75.55 112.438 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -82.65 151.06 26.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 72.33 111.138 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.37 147.05 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 63.34 111.137 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 -34.51 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 75.04 110.919 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -168.5 139.19 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.912 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.29 98.53 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.42 110.889 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.69 115.13 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 75.53 110.924 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.94 -33.09 24.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 70.24 111.099 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.75 -49.92 71.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.884 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -77.72 -29.67 51.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.913 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 33.4 10.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 71.12 112.484 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.7 169.95 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 74.11 110.924 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 170.81 43.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 71.11 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -141.4 125.18 16.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.11 110.886 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 mt -98.85 151.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 75.23 111.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -124.12 121.53 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 75.02 110.942 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.69 -166.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.911 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.05 -34.45 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 73.21 110.899 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -105.4 -18.58 14.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.918 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.7 64.73 3.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.741 . . . . 70.13 112.505 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.254 . . . . 73.31 112.364 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.69 94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.838 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 HG13 HG11 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -110.6 143.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.071 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.8 118.73 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.879 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -129.39 143.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 64.11 111.12 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -120.39 157.31 29.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 75.32 110.861 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -55.72 -24.68 36.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 75.13 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -94.43 22.74 5.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 63.44 111.169 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.19 -0.14 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.16 130.61 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 74.35 111.149 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -116.88 86.68 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 63.35 110.856 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.68 179.83 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 74.25 111.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -110.21 93.6 4.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.874 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.31 -117.63 3.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 62.42 112.508 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.11 110.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 73.5 110.887 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -76.7 78.5 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 75.14 110.836 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -172.13 167.06 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.34 111.157 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.69 172.51 6.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.931 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -125.8 126.6 44.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.903 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 124.09 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 65.2 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.03 6.41 69.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 62.51 112.509 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -102.47 157.31 17.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 70.53 110.872 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -87.93 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 73.3 110.835 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -159.11 141.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 61.33 111.12 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.3 tt0 -94.24 125.42 38.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -118.37 142.61 47.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 78.1 mt-10 -106.2 98.07 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.896 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.838 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.0 m -63.79 122.5 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 75.25 111.147 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.86 160.39 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.661 0.743 . . . . 65.31 110.845 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 75.22 112.305 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 55.7 3.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 74.22 112.446 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -130.59 -41.68 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 73.15 110.866 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.13 140.42 15.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 75.04 112.478 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.52 -44.95 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 60.23 112.479 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -85.15 -22.18 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 72.04 110.851 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -90.88 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 75.12 112.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 114.2 3.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 74.24 112.353 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.838 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -121.96 156.53 33.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.915 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.3 58.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.107 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -44.56 -36.19 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.35 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 4.2 ttpt -130.74 106.95 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.25 142.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.33 111.104 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -131.15 142.61 50.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.897 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.19 133.15 36.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.856 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.22 111.148 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 74.04 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -132.07 152.95 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.924 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.2 mtpt -135.16 134.74 40.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.426 . . . . 73.12 110.901 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.23 171.8 44.89 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 72.41 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.5 p -81.46 146.31 30.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 73.41 111.124 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.71 145.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.43 111.084 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -97.96 -29.31 13.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.908 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -175.57 144.73 0.68 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 72.25 110.917 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -144.94 98.85 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 72.43 110.853 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -68.84 117.64 10.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.32 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.68 -24.02 21.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.51 111.121 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.38 -45.01 93.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.842 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -90.79 -37.84 13.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.944 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 42.53 2.21 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.731 -0.747 . . . . 50.44 112.505 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -144.75 168.18 20.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 70.4 110.936 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 174.43 46.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.475 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -142.32 125.34 16.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 mt -98.44 152.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.54 111.103 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -127.83 135.05 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -100.24 -165.76 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 70.01 110.907 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -48.19 -32.14 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.35 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -104.69 -26.76 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.86 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.66 66.86 2.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 63.44 112.521 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -90.22 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.695 2.264 . . . . 71.4 112.354 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.93 96.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.25 110.844 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG11 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -112.61 145.25 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 74.13 111.102 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.19 116.85 33.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG12 HG11 ' A' ' 26' ' ' VAL . 1.2 m -125.14 143.39 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.18 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -121.71 159.41 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.1 110.87 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -56.63 -22.46 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 74.33 110.875 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -95.48 21.46 8.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.65 -3.63 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.45 111.086 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.24 132.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.175 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.37 86.27 2.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.899 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.88 -179.33 3.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 74.52 111.117 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.04 77.09 4.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 72.21 110.864 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.9 -117.62 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 73.1 112.493 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -57.67 137.51 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.363 . . . . 73.53 110.916 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -96.92 94.09 7.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 75.45 110.848 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 t -174.59 157.26 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 75.03 111.133 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.75 -178.03 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.912 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -121.37 127.44 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.866 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.16 130.24 45.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.894 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 6.77 88.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 44.01 112.493 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.36 160.3 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 65.11 110.891 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -87.03 141.0 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 73.01 110.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.56 140.79 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.118 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 24.8 tt0 -97.65 125.75 42.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.32 110.871 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -119.54 146.05 45.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.35 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -106.07 98.22 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.91 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.842 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 21.9 m -63.66 124.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.143 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.61 160.67 35.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.618 0.723 . . . . 55.31 110.863 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.692 2.261 . . . . 75.03 112.328 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.43 57.3 3.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 73.03 112.477 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.6 -41.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 74.21 110.875 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.86 137.54 13.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.76 . . . . 71.22 112.487 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.39 18.1 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 74.44 112.477 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.7 -22.89 19.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 74.34 110.86 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -93.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 73.54 112.517 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 114.92 3.87 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 72.53 112.315 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.842 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.9 tt0 -119.7 158.0 27.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.911 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -78.94 58.25 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 65.42 111.08 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -43.56 -38.02 2.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 74.01 110.893 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -132.17 106.17 7.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.882 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.36 142.07 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.112 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -131.92 142.87 49.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.906 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.44 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.74 134.79 37.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.855 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 73.34 111.162 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 75.4 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -130.27 153.02 49.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.896 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.6 mtmt -126.45 134.2 51.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.892 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 171.73 43.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.24 112.536 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -85.64 142.95 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 71.15 111.16 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.78 144.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.151 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -31.76 11.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.93 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -174.72 138.56 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.54 110.917 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -138.04 99.28 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.869 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -73.01 116.58 13.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.896 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.77 -20.34 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 75.24 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.77 -54.92 35.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -84.34 -35.61 23.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.45 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.74 39.46 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 70.34 112.458 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -143.92 163.57 33.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 72.22 110.917 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.95 175.83 43.9 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.498 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -141.85 128.22 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 72.4 110.846 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.9 mt -97.7 148.77 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 62.02 111.112 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -121.19 117.01 26.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.919 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.91 -166.92 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.924 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.66 -34.13 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.51 110.888 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -105.82 -17.46 14.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 72.53 110.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.24 65.93 3.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 50.22 112.509 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 63.01 112.35 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.45 90.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.866 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.29 144.64 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 63.32 111.141 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -99.15 119.96 38.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 75.41 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.52 143.33 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.44 111.109 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -119.0 156.17 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 62.41 110.852 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -55.39 -25.12 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.871 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -94.22 22.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.125 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.23 -1.89 8.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.062 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.3 130.72 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 75.13 111.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.78 86.14 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.884 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.25 175.36 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 70.13 111.086 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.23 74.64 10.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.01 110.9 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.71 -117.45 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 55.23 112.474 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -69.89 110.03 4.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.844 0.354 . . . . 75.12 110.874 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.56 101.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.867 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.5 m -161.7 150.13 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 65.52 111.115 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.02 170.6 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.89 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -123.3 126.69 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 70.12 110.861 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -58.46 119.03 6.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.921 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.15 6.57 58.89 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.754 -0.736 . . . . 64.23 112.494 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -105.18 159.87 15.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 64.14 110.848 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -87.82 140.58 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.842 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.1 m -157.99 139.76 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.23 111.111 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 26.6 tt0 -96.64 126.29 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.55 110.851 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -120.46 143.31 48.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.861 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -105.09 97.33 7.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.828 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.32 124.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 72.1 111.129 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.88 157.47 36.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.624 0.726 . . . . 75.33 110.93 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.227 . . . . 70.23 112.361 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.66 57.09 4.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 71.32 112.477 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -132.18 -39.34 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 75.25 110.899 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -93.63 133.62 11.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.781 -0.723 . . . . 64.21 112.483 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.57 8.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 71.44 112.528 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.51 -23.9 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 75.01 110.886 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.69 -93.12 0.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.731 . . . . 65.44 112.511 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 116.59 4.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.66 2.24 . . . . 72.4 112.349 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.828 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.3 tm0? -122.3 150.89 41.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 72.35 110.909 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.45 ' N ' ' HG2' ' A' ' 61' ' ' GLN . . . -74.52 59.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 63.14 111.135 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -46.44 -37.87 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 75.34 110.897 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 104.51 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.03 110.86 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -108.18 140.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 65.01 111.12 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -131.58 143.37 50.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.42 110.889 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 47' ' ' VAL . 6.4 ptm180 -78.87 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.891 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.164 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.849 0.357 . . . . 73.51 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -132.37 151.11 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.32 110.938 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.8 mtmp? -125.94 133.3 51.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.23 110.922 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.11 171.42 42.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 73.22 112.529 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -87.34 145.88 26.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 71.55 111.166 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.6 145.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.107 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.8 tptt -99.49 -29.79 12.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -175.72 137.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 74.11 110.937 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -135.12 97.93 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.52 110.876 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.51 92.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.844 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.95 74.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 64.54 111.111 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.11 -43.9 90.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.874 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -78.83 -38.37 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.887 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 25.9 7.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 73.23 112.485 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -140.87 169.66 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 75.42 110.978 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.94 172.39 45.06 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.746 . . . . 52.2 112.499 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 74.12 110.879 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.19 152.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 75.03 111.165 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -123.9 124.03 41.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.92 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -166.9 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.924 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -47.68 -33.58 7.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 75.21 110.915 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -106.77 -16.6 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.21 110.867 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.41 63.55 4.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 75.01 112.534 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.697 2.265 . . . . 71.2 112.355 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.68 101.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.922 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 p -117.42 139.5 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 74.45 111.148 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.8 115.73 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.5 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.88 144.64 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.42 111.145 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.23 156.77 31.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.4 110.828 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -54.69 -24.71 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 71.42 110.826 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -94.98 24.95 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.02 111.112 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.71 -0.38 6.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 74.13 111.127 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.43 126.74 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 74.03 111.148 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -112.98 86.36 2.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.81 -179.73 3.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.057 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -99.1 74.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.886 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.54 -118.42 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 75.51 112.525 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.2 114.02 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 74.44 110.928 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -77.82 90.43 4.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 64.52 110.871 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.94 164.35 28.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 70.13 111.105 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.69 153.92 30.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.909 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -109.94 125.94 53.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 52.23 110.901 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 72.04 110.894 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.27 8.27 60.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.12 112.511 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.7 158.56 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.918 0.389 . . . . 60.53 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -88.29 140.25 29.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.806 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.82 140.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 75.43 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.7 tt0 -95.66 125.07 39.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.874 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -118.86 144.33 46.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.859 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -105.9 97.79 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 74.53 110.889 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.5 m -64.13 117.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 73.25 111.125 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -108.65 160.17 28.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.662 0.744 . . . . 73.55 110.92 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 71.23 112.325 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 55.79 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 75.45 112.522 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -130.72 -41.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 74.21 110.895 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.01 142.19 15.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 64.34 112.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.51 -47.1 29.51 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 75.53 112.504 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.8 -22.72 34.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 74.34 110.916 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.13 -89.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 62.54 112.484 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 116.51 4.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.646 2.231 . . . . 75.52 112.367 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.833 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.9 tt0 -123.79 157.6 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -77.33 57.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.31 111.109 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -44.44 -37.57 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.67 104.86 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 71.42 110.927 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -107.76 141.55 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 73.51 111.155 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -131.43 142.7 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.837 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.1 ppt_? -78.44 134.37 37.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.43 110.896 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 72.45 111.163 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.85 0.357 . . . . 74.44 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -125.52 152.18 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 75.33 110.915 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 14.9 mttp -133.06 137.88 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.956 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.96 171.51 44.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.702 -0.761 . . . . 74.42 112.461 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 p -85.55 144.12 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 74.1 111.109 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.3 144.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 71.13 111.123 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -99.48 -30.2 12.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -175.19 139.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.8 99.41 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 74.14 110.901 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -69.59 93.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 75.32 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.53 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -67.16 -35.86 80.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.845 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -94.04 -36.97 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.14 32.53 4.92 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 75.32 112.477 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -146.28 168.12 21.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.888 0.375 . . . . 74.25 110.947 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.66 179.03 46.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.746 -0.74 . . . . 71.51 112.464 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -142.35 130.69 22.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 73.13 110.895 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mt -97.09 144.21 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.5 111.117 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.25 110.99 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.9 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.64 -167.34 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 54.23 110.912 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -49.69 -31.92 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.956 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -106.68 -21.48 13.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 71.32 110.862 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.47 69.33 1.37 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 73.03 112.48 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.634 2.223 . . . . 74.41 112.369 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.78 94.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.4 142.77 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 73.2 111.127 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.26 116.3 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.897 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -122.99 141.33 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 74.24 111.133 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -121.55 159.83 25.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 70.52 110.819 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -56.66 -22.32 33.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.853 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -94.37 19.78 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 63.21 111.12 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.83 -7.97 8.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.43 111.117 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 132.79 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.23 111.149 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -112.98 86.11 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.35 178.64 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 75.15 111.07 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.91 75.32 7.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 62.34 110.887 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.72 -117.66 3.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 73.35 112.503 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.3 110.05 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 73.51 110.869 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -76.7 67.33 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 71.51 110.842 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.4 p -146.24 166.09 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 71.43 111.175 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.6 mt -108.91 -175.93 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.922 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -126.1 127.99 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 65.22 110.918 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.68 117.64 4.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.875 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.88 7.06 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 55.42 112.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.15 160.41 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 75.55 110.892 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -89.05 141.78 28.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.53 110.812 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 67' ' ' ARG . 2.9 m -158.37 139.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.2 111.178 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.8 tt0 -98.17 126.4 43.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.88 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -119.72 146.65 45.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.85 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.0 98.88 8.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 75.11 110.857 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -52.04 128.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.25 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 3.0 tp10 -112.58 138.57 22.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.661 0.743 . . . . 74.25 110.874 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 72.14 112.372 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.32 53.71 4.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 72.35 112.437 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.74 -40.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 74.23 110.854 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.53 134.59 13.91 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.735 . . . . 75.24 112.504 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.66 -36.81 13.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 63.21 112.504 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -100.62 -19.31 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 65.32 110.895 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.88 -103.07 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 62.43 112.5 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 113.22 3.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.695 2.263 . . . . 74.52 112.324 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.833 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.0 pt20 -119.32 175.99 5.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.03 110.944 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.23 62.6 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 61.11 111.075 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -46.21 -38.82 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.02 110.934 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.12 104.92 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.14 110.893 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -108.53 141.38 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -131.65 142.08 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 71.32 110.879 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.429 ' HA ' HG11 ' A' ' 47' ' ' VAL . 22.8 ptt85 -77.62 135.64 38.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.866 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.1 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.146 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttm . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.799 0.333 . . . . 72.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -127.36 155.8 43.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 75.33 110.928 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.3 mtmm -127.05 131.17 51.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.13 172.29 39.91 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.738 -0.744 . . . . 62.23 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.5 p -86.49 141.13 29.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 73.14 111.11 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.58 144.83 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.53 111.14 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -30.59 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 70.22 110.881 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -175.9 138.9 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.945 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -131.74 99.08 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 74.32 110.934 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -68.62 90.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 55.35 110.868 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.14 67.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.44 111.078 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -65.73 -46.73 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 74.31 110.875 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -77.21 -34.13 56.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.887 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.1 19.46 14.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.481 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -138.87 173.78 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 74.31 110.876 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.82 174.59 45.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 71.43 112.465 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -141.38 125.26 17.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.11 110.845 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 mt -98.02 152.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 63.03 111.094 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.42 128.76 55.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.89 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.51 150.71 48.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 71.12 110.895 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.32 -6.59 58.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -115.32 2.15 13.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 74.13 110.907 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.22 77.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 74.21 112.501 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -161.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 75.35 112.366 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.1 t0 55.44 77.2 0.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 75.35 110.875 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG12 HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -125.68 148.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 63.54 111.113 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.5 118.96 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.87 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG13 HG12 ' A' ' 26' ' ' VAL . 1.1 m -131.06 142.29 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 74.21 111.11 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -121.54 157.58 30.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.843 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -56.28 -24.28 42.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.883 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p -93.93 20.28 7.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.2 111.147 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.91 -5.47 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.11 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -89.38 132.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 73.45 111.154 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -113.85 86.36 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.51 110.912 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.21 177.19 6.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 74.43 111.118 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.58 75.36 4.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.882 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.06 1.75 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 71.54 112.515 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -75.66 112.75 12.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 73.01 110.872 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -67.86 99.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 73.21 110.904 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -177.43 162.58 1.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.13 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 mt -108.87 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -129.07 129.67 45.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.909 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.03 119.77 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 71.02 110.868 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.65 64.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.512 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -106.89 160.79 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 74.11 110.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -89.37 142.31 27.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 63.35 110.87 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -159.09 140.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.086 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.9 tt0 -96.07 125.73 40.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 71.32 110.855 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 25.0 p90 -121.27 143.23 49.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.12 110.861 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.94 98.06 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 62.04 110.894 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.7 m -64.19 118.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 73.05 111.156 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.91 158.16 33.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.629 0.728 . . . . 75.33 110.909 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -88.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 2.252 . . . . 70.13 112.339 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.96 55.92 3.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 70.45 112.454 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -133.35 -41.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 74.51 110.885 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.44 134.91 12.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 73.2 112.494 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.87 -34.32 11.02 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.742 -0.742 . . . . 54.45 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -21.38 16.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 75.32 110.922 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.44 -93.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 74.25 112.518 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.6 4.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.644 2.23 . . . . 74.14 112.373 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -122.23 154.34 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.3 110.899 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.26 57.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 64.22 111.099 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -38.81 5.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 74.32 110.911 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 11.7 tttp -129.61 103.35 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.905 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -106.59 142.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.34 111.103 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -132.8 143.02 49.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.927 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.43 ' HA ' HG12 ' A' ' 47' ' ' VAL . 35.7 mtp180 -78.66 134.23 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.854 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.54 111.118 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.819 0.342 . . . . 71.21 110.881 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -131.97 155.83 47.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 75.52 110.907 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -128.41 137.62 51.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 74.24 110.872 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.57 171.45 44.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 72.45 112.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 p -81.52 156.65 25.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 72.13 111.162 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.57 143.41 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.124 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -97.35 -28.68 13.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.54 110.9 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -174.77 138.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 72.1 110.901 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -136.11 98.96 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.869 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.35 110.908 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.52 -27.85 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.082 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.67 -40.9 96.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.872 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -94.88 -37.33 11.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.35 110.938 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 46.31 1.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 72.14 112.466 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -157.53 142.94 17.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 73.44 110.905 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.62 -176.41 25.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 63.15 112.494 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -141.2 132.57 26.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.34 110.866 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -106.53 149.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 73.2 111.159 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.36 116.75 8.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 72.15 110.912 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -82.85 -162.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.902 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.14 -35.6 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.888 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -91.68 -30.79 16.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.886 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.36 64.32 4.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 73.44 112.495 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.728 2.285 . . . . 62.24 112.322 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.53 100.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 70.15 110.866 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG12 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -121.68 141.46 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.02 111.146 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.31 116.29 31.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.882 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.425 HG12 HG12 ' A' ' 26' ' ' VAL . 1.1 m -121.05 145.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 75.55 111.128 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -124.64 159.36 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.88 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -55.48 -23.18 24.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.903 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -95.81 23.81 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 72.52 111.121 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 -3.0 6.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 60.21 111.094 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.74 131.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.103 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.27 86.26 2.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 64.54 110.897 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.3 -179.51 4.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 74.24 111.102 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.5 74.97 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.862 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.61 -117.65 1.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 62.23 112.481 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -84.98 118.52 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 74.54 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 104.1 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.45 110.859 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 t -178.13 159.81 1.33 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.107 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 25.9 mt -108.92 -176.31 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 72.52 110.9 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -126.12 127.84 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.931 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.83 122.7 13.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 65.33 110.9 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.38 76.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.25 112.492 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -106.73 160.39 15.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.947 0.403 . . . . 74.43 110.838 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -89.1 141.07 28.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 73.5 110.826 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.5 140.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.01 111.136 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.2 tt0 -95.39 127.54 41.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 64.14 110.887 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -119.73 144.58 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 74.22 110.86 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.8 97.18 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.863 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.1 m -60.8 127.81 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 75.42 111.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -121.69 158.86 53.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.632 0.73 . . . . 62.13 110.903 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -88.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.732 2.288 . . . . 70.1 112.312 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.83 57.43 3.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.62 -42.01 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 75.41 110.858 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.91 138.24 13.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 71.25 112.517 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -39.88 21.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 74.33 112.455 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.46 -25.04 25.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 71.01 110.862 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.54 -92.67 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 65.13 112.475 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.11 3.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.677 2.251 . . . . 74.53 112.32 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.814 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -118.24 158.12 25.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.892 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -77.91 57.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 70.31 111.121 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -39.67 -43.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 64.45 110.937 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -126.63 108.35 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.918 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -108.32 141.44 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 61.23 111.152 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -131.6 142.28 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.88 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HA ' HG12 ' A' ' 47' ' ' VAL . 45.2 ttt-85 -79.22 134.92 36.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 64.04 110.889 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.42 111.126 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.833 0.349 . . . . 75.23 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -123.53 149.24 45.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.906 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 12.3 mtpt -133.37 133.78 42.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.898 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.55 171.53 44.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 73.44 112.453 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -85.61 142.12 29.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 72.23 111.168 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.82 144.57 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 72.12 111.118 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -30.77 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.879 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -176.51 137.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 74.45 110.913 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -134.83 98.9 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.87 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.15 93.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 62.41 110.855 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.33 -31.46 70.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.42 111.097 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -65.47 -41.41 93.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 75.43 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -83.63 -38.5 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.909 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 26.64 7.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 64.43 112.472 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.91 169.01 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 74.14 110.9 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.66 173.63 45.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 72.23 112.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -141.93 128.92 20.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 74.03 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mt -97.08 146.5 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 70.32 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -121.69 123.21 41.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 71.24 110.877 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.41 -167.06 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 73.13 110.871 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.23 -33.61 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.926 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -106.36 -22.69 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.14 110.885 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.13 67.89 1.82 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 62.13 112.444 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -89.69 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 72.41 112.343 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 169.9 95.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 61.41 110.874 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.27 138.39 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.35 111.179 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.75 115.89 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.17 143.42 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.21 111.107 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.39 158.52 25.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.22 110.827 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -56.0 -25.09 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.858 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.47 22.09 5.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.17 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.18 -0.99 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.42 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mp -93.13 130.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.2 111.146 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.62 86.48 2.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.876 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.43 -179.11 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 72.2 111.128 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.94 75.01 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 73.11 110.887 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.67 -117.64 3.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.797 -0.716 . . . . 73.45 112.523 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -74.11 110.06 8.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 73.14 110.867 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -68.16 108.13 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 75.25 110.923 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -160.67 148.5 16.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 74.2 111.144 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.23 152.96 24.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.54 110.906 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -112.57 126.2 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 65.1 110.905 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -59.75 118.38 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 73.14 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 6.62 57.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 73.55 112.527 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.66 158.4 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 70.32 110.86 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -87.5 141.54 28.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 75.52 110.874 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.57 139.97 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.01 111.091 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 28.4 tt0 -97.47 125.11 41.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 65.42 110.875 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.6 p90 -120.57 144.41 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.887 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.63 97.36 7.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.02 110.899 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.837 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -62.91 122.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 73.43 111.102 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -111.98 159.18 34.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.658 0.742 . . . . 74.11 110.921 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 71.5 112.356 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.96 57.92 4.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 74.44 112.455 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -130.52 -41.88 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 75.12 110.855 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.93 137.08 13.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 50.11 112.468 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -35.52 14.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.724 -0.75 . . . . 63.45 112.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -91.34 -25.24 19.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 73.42 110.949 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.28 -91.79 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.742 -0.742 . . . . 72.43 112.501 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 116.55 4.62 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.653 2.236 . . . . 74.11 112.354 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.837 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 tt0 -118.26 156.51 28.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.01 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.54 58.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 64.2 111.082 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -40.89 -42.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.911 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 16.0 tttp -134.03 108.26 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 65.22 110.901 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -107.11 141.8 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.43 111.133 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -131.75 142.75 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 73.23 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.441 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -77.96 134.89 37.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.912 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.5 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.123 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.867 0.365 . . . . 74.5 110.849 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -129.35 155.66 45.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.892 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.6 mttt -129.9 137.37 50.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.899 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.45 171.35 44.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 61.42 112.504 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -88.82 138.99 30.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 73.03 111.112 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 145.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 73.14 111.136 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -101.05 -27.78 13.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.918 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -176.01 140.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 75.2 110.891 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -135.78 99.41 4.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 73.12 110.849 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -67.66 117.4 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.3 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.41 18.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.53 111.115 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -59.93 -31.85 70.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.898 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -107.88 -33.78 7.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.92 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.95 40.37 2.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 71.13 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -142.52 173.85 11.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 74.53 110.932 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.06 174.61 46.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 74.22 112.487 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -140.58 126.65 19.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 62.52 110.89 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.44 151.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 74.44 111.127 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.63 132.75 49.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.05 110.951 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -98.01 -164.84 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 73.02 110.903 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -48.85 -31.44 7.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.875 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.33 -26.41 11.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 75.34 110.87 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.0 66.88 2.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 64.51 112.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -90.59 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 73.14 112.345 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 169.39 100.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 75.1 110.877 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -118.3 145.25 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.21 111.157 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.97 33.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 26' ' ' VAL . 1.2 m -124.97 142.32 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 74.42 111.119 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.3 161.03 24.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.857 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.03 -21.97 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.855 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -94.16 19.74 8.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 65.11 111.125 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.7 -22.03 7.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 73.31 111.099 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -71.08 127.39 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.43 111.138 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.2 84.78 7.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.52 110.86 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.99 154.44 51.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.31 111.129 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.35 72.98 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.926 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.83 152.51 9.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 73.31 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -51.56 115.54 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 73.24 110.905 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 mmt-85 -153.09 -175.75 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.86 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.2 p -131.61 -167.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.32 111.18 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -107.16 177.17 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 73.05 110.926 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 63.32 110.934 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -62.22 120.38 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 5.09 68.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.729 . . . . 73.45 112.537 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.6 158.33 15.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 75.23 110.922 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -86.92 139.39 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.44 110.829 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.4 m -158.54 139.93 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.13 111.144 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 tt0 -97.0 125.06 41.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 75.22 110.883 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -118.44 145.82 44.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.1 110.902 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -106.49 98.35 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.895 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.836 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.7 m -62.92 124.87 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 52.1 111.117 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.64 160.67 35.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.63 0.729 . . . . 75.1 110.879 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -88.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 73.45 112.339 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.06 57.07 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 64.05 112.465 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.51 -41.71 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 74.32 110.835 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.64 136.59 12.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 73.4 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.67 -34.83 15.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 74.22 112.501 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -22.94 18.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.339 . . . . 74.43 110.818 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.22 -93.36 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.732 . . . . 70.41 112.48 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.66 3.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.716 2.278 . . . . 74.12 112.356 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.836 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 9.4 tt0 -120.05 157.92 27.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.12 110.93 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -77.97 57.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 60.43 111.087 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.49 -38.85 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.886 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.67 104.75 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.32 110.881 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -108.15 141.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.14 111.14 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -131.33 141.9 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.2 110.848 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.52 134.85 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.0 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.51 111.115 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 mtp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.863 0.363 . . . . 75.24 110.853 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -127.97 154.89 45.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 65.22 110.875 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 25.4 mttt -127.52 133.88 49.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.33 110.895 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.46 171.75 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.774 -0.727 . . . . 74.41 112.48 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.5 p -85.41 144.88 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 72.34 111.153 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.88 147.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 75.31 111.135 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -32.36 10.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.902 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -174.74 141.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 73.54 110.929 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -141.15 98.94 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.861 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -65.21 119.22 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.02 110.949 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.24 21.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.15 111.071 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.5 -38.41 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 63.33 110.895 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -97.88 -38.03 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 73.22 110.904 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 44.67 1.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 65.31 112.474 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.48 168.47 25.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 73.2 110.96 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.77 -179.37 45.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 72.31 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -141.01 126.27 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 74.31 110.874 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.2 mt -98.76 150.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 54.25 111.142 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -121.75 125.8 47.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.86 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -166.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.908 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -46.92 -34.1 5.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -105.88 -19.85 13.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.52 110.896 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.2 64.57 3.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 73.43 112.487 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -88.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 65.15 112.326 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 94.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.906 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -110.77 142.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.63 116.37 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 26' ' ' VAL . 1.3 m -121.42 142.52 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.41 111.099 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -123.53 160.07 27.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 75.24 110.849 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -56.93 -21.43 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.896 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.6 t -95.0 19.81 9.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.134 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 -24.2 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 61.42 111.061 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -70.47 124.07 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.152 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.41 84.42 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.919 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.49 144.4 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 53.24 111.135 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.49 73.11 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 72.02 110.859 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.17 166.25 13.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 71.33 112.482 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -57.07 109.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 75.1 110.943 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -144.49 -170.73 3.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.12 110.855 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 t -146.24 -170.35 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.138 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -107.25 164.01 12.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.909 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -109.68 125.66 52.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.899 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.18 121.87 14.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.871 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.92 72.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 73.15 112.497 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.31 157.43 15.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 65.34 110.894 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -85.91 138.36 32.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.843 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 67' ' ' ARG . 4.0 m -158.22 140.39 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 65.12 111.148 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 39.7 tt0 -95.86 125.95 40.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.917 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -118.3 145.54 45.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.881 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -106.71 97.73 7.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 70.15 110.848 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.835 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.1 m -62.0 123.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 73.53 111.083 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -113.97 161.16 29.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.622 0.725 . . . . 71.04 110.883 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 74.04 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.23 57.27 4.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 74.24 112.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.418 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 4.0 mpt_? -128.96 -41.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 72.34 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.96 14.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 65.35 112.467 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.27 -41.93 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 51.55 112.463 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.44 -22.52 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 65.42 110.927 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.56 -89.87 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 72.12 112.478 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 114.82 3.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.658 2.239 . . . . 75.42 112.338 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.835 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.8 tt0 -119.23 156.55 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 74.2 110.921 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.03 57.09 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.22 111.144 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -41.74 -49.89 4.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 55.21 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.3 tttp -120.06 108.23 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.94 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -110.08 142.23 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 75.12 111.162 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -131.0 142.83 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.86 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.434 ' HA ' HG13 ' A' ' 47' ' ' VAL . 38.4 ptt180 -78.75 134.88 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 75.55 110.852 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.3 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 73.32 111.122 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.865 0.364 . . . . 74.11 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -120.75 150.82 40.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.42 110.892 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.0 mtpp -132.02 133.17 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.895 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.8 171.14 43.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 72.43 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.8 p -82.46 146.62 29.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 74.34 111.105 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.68 145.89 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.117 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -36.74 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 75.3 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -170.52 141.6 1.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.904 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -136.49 99.29 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 75.4 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 103.2 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 64.33 110.919 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.3 47.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.113 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.46 -47.63 69.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.883 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.21 -36.08 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.862 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.13 2.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 72.53 112.513 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -152.74 151.35 30.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 72.52 110.91 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.28 176.53 32.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 73.44 112.451 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.53 122.93 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 72.4 110.883 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mt -97.99 154.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.03 111.152 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -130.38 147.08 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.926 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.63 -165.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.925 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -48.56 -32.3 7.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 61.25 110.891 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -102.35 -29.85 11.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 64.15 110.852 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.98 2.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 42.25 112.472 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.728 2.285 . . . . 74.31 112.323 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p30 168.71 100.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 71.12 110.835 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 p -113.69 136.05 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.121 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.71 115.4 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.44 110.938 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -124.97 143.72 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.51 111.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -122.4 158.87 28.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.867 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.96 -24.42 38.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -94.72 23.01 5.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.11 111.153 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.75 -2.02 7.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.32 111.095 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -91.39 131.97 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.33 111.154 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.22 86.5 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.4 110.894 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.34 179.93 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 74.45 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.12 74.91 7.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 54.13 110.886 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.49 -118.69 3.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 71.2 112.494 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.3 112.61 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 73.13 110.875 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 65.4 mtt85 -77.79 66.59 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.879 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.0 p -146.61 167.06 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 62.44 111.175 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -110.03 -176.5 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.919 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -127.43 126.92 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 61.02 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.94 121.23 9.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.85 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.54 7.27 67.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 62.31 112.511 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -106.84 160.62 15.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.851 0.358 . . . . 75.35 110.893 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -88.74 141.96 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.883 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -158.63 140.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.14 111.142 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 33.4 tt0 -94.62 126.8 40.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.905 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -120.7 142.03 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.851 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.03 97.58 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 73.42 110.902 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.831 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.5 m -63.0 126.9 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.141 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.68 159.47 46.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.679 0.752 . . . . 73.25 110.906 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -87.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.725 2.283 . . . . 73.21 112.354 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.36 55.92 4.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 52.33 112.45 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.0 -41.76 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 75.34 110.887 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.53 137.68 13.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 34.42 112.474 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.87 -38.36 23.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 73.23 112.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.98 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 74.52 110.876 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.32 -93.96 0.15 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 73.42 112.456 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 112.77 3.16 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 75.5 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.831 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.6 tt0 -117.86 156.77 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.915 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.39 59.11 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 60.43 111.1 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -41.82 -38.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.949 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -130.85 109.63 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.863 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.2 t -108.3 141.24 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 65.45 111.13 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -131.52 141.14 49.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 72.42 110.898 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.431 ' HA ' HG12 ' A' ' 47' ' ' VAL . 15.2 ptm180 -78.67 133.45 37.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.03 110.857 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.0 mm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 62.41 111.135 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.816 0.341 . . . . 72.44 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -123.37 156.29 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.21 110.882 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -130.99 137.13 49.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.1 110.91 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.22 41.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.22 112.51 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p -84.91 138.04 32.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 74.42 111.13 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.95 144.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 71.03 111.106 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -99.66 -30.49 12.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.872 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -175.41 136.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 73.32 110.894 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -135.48 98.92 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.892 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -69.19 112.32 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.54 110.929 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.47 -30.13 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.41 111.113 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -62.94 -53.89 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.43 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -75.03 -32.14 61.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.914 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.1 30.84 8.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 64.25 112.482 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -139.93 169.13 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 73.21 110.926 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 173.59 46.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.491 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -140.91 126.81 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 74.53 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 mt -102.03 152.98 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.04 111.122 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -110.73 134.52 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.932 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.4 149.04 52.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 72.41 110.877 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -87.02 -6.4 58.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.847 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -118.98 -5.78 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.875 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.03 74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 74.15 112.511 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -161.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 74.15 112.374 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 51.78 82.27 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.846 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.433 HG11 HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -132.67 143.21 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.23 111.141 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.38 120.28 34.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.9 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG13 HG11 ' A' ' 26' ' ' VAL . 1.3 m -130.42 142.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 70.01 111.104 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -122.95 157.92 31.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.05 110.869 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.66 -23.51 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.848 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.0 t -94.51 19.46 9.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.14 111.173 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.36 -8.75 9.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 70.14 111.056 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.47 131.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 64.53 111.142 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -115.37 86.32 2.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.885 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.41 -179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.093 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.95 74.55 3.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.12 110.893 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.33 -117.58 1.74 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 64.13 112.473 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -77.0 110.22 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 70.04 110.895 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -66.2 102.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 75.44 110.887 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -176.9 159.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.165 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.9 mt -108.72 -175.8 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 74.21 110.925 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.0 128.05 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.899 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -57.06 122.38 12.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.4 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.01 5.68 67.73 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 61.22 112.506 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -106.71 160.48 15.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 73.43 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -89.82 142.34 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 70.34 110.869 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -157.71 140.2 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 75.25 111.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 tt0 -96.75 125.11 40.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.913 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -119.09 144.17 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.14 110.936 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -102.57 98.07 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.22 110.94 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.826 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.7 m -61.89 118.23 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.115 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -107.51 156.46 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.44 110.854 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.5 Cg_endo -69.78 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.717 2.278 . . . . 71.33 112.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 56.51 3.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 55.03 112.483 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -132.28 -41.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 74.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.94 134.02 12.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 65.12 112.475 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.3 7.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 70.42 112.454 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -23.2 15.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 75.33 110.939 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.51 -93.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 72.31 112.497 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 117.07 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 72.21 112.339 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.826 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 15.1 tt0 -120.99 157.38 30.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.932 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 61' ' ' GLN . . . -78.59 56.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.12 111.131 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -40.68 -46.04 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.907 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.5 tttp -126.44 105.82 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.926 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -105.87 142.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.54 111.108 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -132.38 146.14 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HA ' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 133.93 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.45 110.895 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.35 111.14 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.843 0.354 . . . . 74.34 110.836 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -132.59 154.17 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.912 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 18.3 mtmt -131.06 135.71 47.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.44 110.857 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.91 171.48 44.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.466 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -82.77 143.95 30.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 71.2 111.112 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.7 144.58 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.23 111.13 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -31.11 12.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.44 110.911 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -175.09 140.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -139.27 98.85 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.914 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -70.74 109.39 4.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.65 35.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.103 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.24 -48.19 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.43 110.889 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -87.88 -37.36 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.17 41.2 2.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 62.31 112.484 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.97 167.77 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 75.21 110.905 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.09 46.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.55 112.477 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -141.88 124.77 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 74.21 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mt -98.09 151.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 74.1 111.151 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -127.66 130.9 49.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.914 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -96.2 -164.93 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.949 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.02 -31.79 5.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.86 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -106.39 -23.93 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 73.21 110.863 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.18 67.13 2.11 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.698 -0.763 . . . . 54.52 112.46 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 65.44 112.345 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.96 95.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.877 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -112.38 146.02 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.145 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -100.44 116.68 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.43 110.886 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.41 HG12 HG12 ' A' ' 26' ' ' VAL . 1.3 m -124.72 144.04 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 72.33 111.125 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -123.12 159.29 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.869 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -56.25 -21.99 27.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 74.01 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -96.11 22.12 7.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 63.44 111.138 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.6 -4.53 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 53.3 111.103 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.9 mp -89.98 132.41 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.65 86.56 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.882 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.46 -179.37 4.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 70.42 111.079 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -87.95 74.33 8.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 75.21 110.848 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.7 -117.68 2.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 73.41 112.499 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -63.17 120.1 10.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 73.52 110.848 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -81.55 70.35 8.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 75.12 110.852 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 p -147.39 163.05 37.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 73.02 111.119 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.44 -178.26 3.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 72.31 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -126.82 127.22 44.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.32 110.897 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -57.17 120.19 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.883 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.06 62.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 74.44 112.462 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -106.87 160.32 15.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 73.2 110.897 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -89.62 141.64 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.52 140.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 71.12 111.156 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -98.03 125.85 43.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.928 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -119.91 143.43 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 71.43 110.867 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -99.79 99.05 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.53 110.863 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.4 m -56.45 122.78 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.2 111.13 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -101.87 140.79 21.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.25 110.9 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -92.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.688 2.259 . . . . 71.33 112.373 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.15 53.95 4.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 74.24 112.479 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -39.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 71.35 110.863 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 134.43 16.83 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 71.21 112.508 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.91 -36.67 8.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 61.22 112.494 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.66 -14.36 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 75.34 110.873 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.52 -104.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 53.44 112.486 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.652 2.235 . . . . 73.5 112.326 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.841 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.7 pt20 -115.16 171.03 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.55 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.6 61.62 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 65.43 111.142 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -42.02 -46.37 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 74.55 110.885 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 107.14 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 72.35 110.895 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -104.6 141.03 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 75.4 111.116 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -132.02 142.18 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.51 110.838 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.427 ' HA ' HG13 ' A' ' 47' ' ' VAL . 62.1 ttt180 -77.57 134.2 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.876 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.0 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 75.31 111.13 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.36 . . . . 75.24 110.867 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -123.78 152.42 42.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.871 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.8 mtpt -127.23 134.11 50.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.13 110.884 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.53 172.37 44.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.787 -0.721 . . . . 74.43 112.538 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 76.2 p -83.39 144.93 29.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 75.41 111.161 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.21 145.15 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 75.53 111.116 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -31.06 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.885 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -175.69 137.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.884 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.2 99.19 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.34 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -74.16 113.04 10.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 65.11 110.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.76 -34.43 30.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 72.01 111.116 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -56.6 -48.48 77.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.855 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.28 -28.91 26.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 74.51 110.922 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.38 19.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 75.42 112.468 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -133.59 169.21 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 72.42 110.906 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.25 173.59 45.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 65.21 112.487 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -142.39 128.4 19.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 73.31 110.903 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.6 mt -97.7 149.24 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.081 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -121.74 119.33 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.42 110.914 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.54 -167.23 1.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.03 110.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -47.75 -34.24 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 73.43 110.905 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.34 -18.2 14.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 74.25 110.889 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.19 66.29 2.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 73.53 112.499 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -89.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 73.15 112.347 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.7 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 62.34 110.877 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.73 144.93 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.31 111.174 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.93 122.18 41.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.907 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 m -132.87 141.81 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 71.14 111.15 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -115.78 155.4 27.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -54.88 -25.06 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.886 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -93.74 23.62 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 74.23 111.121 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.24 -1.2 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 65.33 111.039 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.21 126.4 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.42 111.12 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.18 86.65 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.912 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.16 -179.86 3.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 75.52 111.11 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.18 75.58 6.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.908 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.79 -117.62 3.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 74.44 112.487 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -78.83 110.17 13.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 75.1 110.87 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -63.86 134.6 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 65.21 110.885 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -177.19 144.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 65.14 111.135 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.04 148.56 30.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.869 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -115.75 125.94 53.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.03 110.861 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.06 118.81 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 65.44 110.858 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.77 4.17 58.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.754 . . . . 71.22 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -101.6 155.51 18.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 72.44 110.879 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -85.63 140.86 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.889 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.77 140.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 21.7 tt0 -98.07 126.35 43.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.854 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -118.42 146.88 44.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 75.51 110.883 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 96.32 6.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 74.4 110.893 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.83 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.1 m -63.4 123.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.3 111.114 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -115.55 160.33 35.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.674 0.749 . . . . 75.32 110.875 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 61.14 112.338 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.7 57.01 3.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.74 . . . . 70.41 112.507 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 5.0 mpt_? -132.79 -41.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 74.04 110.865 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 134.53 12.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 75.54 112.508 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.89 -33.93 10.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.31 112.475 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.32 -22.35 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 73.44 110.851 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.37 -92.5 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.691 -0.766 . . . . 73.12 112.476 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 115.06 3.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.267 . . . . 63.12 112.346 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.83 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -118.92 154.29 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.879 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.85 56.5 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.43 111.128 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.38 -47.08 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 71.54 110.92 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.54 108.33 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.92 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -110.21 141.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 72.54 111.156 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -131.3 143.24 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.866 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HA ' HG12 ' A' ' 47' ' ' VAL . 18.2 mmm-85 -78.06 135.78 37.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.855 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.8 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.33 111.121 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.801 0.334 . . . . 63.31 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -124.05 151.42 43.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 74.31 110.908 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 mtpt -130.32 133.44 46.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.52 110.932 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.86 171.63 44.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.479 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -85.63 142.96 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.334 . . . . 73.23 111.163 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.81 144.06 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 73.53 111.156 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -29.41 13.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.51 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -177.41 145.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 74.13 110.958 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -138.13 103.37 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 72.5 110.876 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -72.36 106.72 4.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 73.25 110.886 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.02 -35.95 41.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.12 111.081 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -57.17 -42.58 81.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.889 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -86.77 -33.68 19.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.901 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 22.46 16.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 55.45 112.499 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -130.56 176.39 8.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.958 0.409 . . . . 75.41 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.98 44.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.521 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -141.27 125.25 17.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 75.43 110.872 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mt -98.06 151.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 72.51 111.095 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.71 123.03 40.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 72.55 110.941 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.52 -165.96 1.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.9 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.88 -35.28 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.862 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.44 -16.19 14.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 74.54 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.87 64.45 4.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 73.5 112.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -88.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 73.41 112.321 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 t70 172.61 93.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.44 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG13 HG11 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -108.59 143.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.34 111.184 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.36 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 64.24 110.874 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG11 HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -128.75 143.3 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.125 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -118.1 157.14 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.865 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -54.83 -25.45 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.9 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 t -93.62 25.0 3.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 71.43 111.129 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.26 -1.08 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 62.33 111.121 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mp -88.92 123.3 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 74.24 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -116.27 86.64 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.859 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.52 -179.7 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 63.14 111.103 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.7 73.1 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 64.2 110.879 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.69 101.74 1.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.773 -0.727 . . . . 70.13 112.491 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -64.3 133.74 53.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 74.21 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -179.63 -71.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -175.63 179.48 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.154 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tp -108.17 -176.76 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.3 110.884 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -118.58 125.51 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 72.23 110.867 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.45 120.19 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.874 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.14 3.2 60.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 74.35 112.437 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.41 156.71 16.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.22 110.909 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -84.71 139.22 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.42 110.888 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.8 m -158.43 140.17 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.115 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -94.28 126.34 39.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 75.3 110.919 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 16.8 p90 -119.89 143.52 47.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.843 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 5.4 mm-40 -105.62 98.5 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.904 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.858 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.8 m -63.21 125.46 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.57 160.73 29.38 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 73.03 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -90.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 65.34 112.354 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.91 58.93 4.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 73.01 112.453 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -41.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 74.24 110.906 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.81 136.1 13.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 63.14 112.525 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.93 -31.81 8.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.04 112.463 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -100.41 -22.6 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 73.1 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.58 -91.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 75.03 112.468 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.667 2.244 . . . . 74.41 112.328 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.858 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -119.36 154.81 33.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.903 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.1 61.16 3.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.111 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -46.75 -41.4 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.13 110.884 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 56.2 mmtt -125.6 110.74 14.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.35 110.909 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -111.97 141.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 74.54 111.133 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -130.87 141.87 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.871 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HA ' HG12 ' A' ' 47' ' ' VAL . 23.6 mtp180 -78.38 134.28 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 74.23 110.918 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.4 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 72.51 111.155 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 74.2 110.895 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -123.94 148.85 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.24 110.894 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.3 mtmt -129.45 129.25 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 64.3 110.891 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.85 41.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 55.01 112.446 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -85.04 145.97 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 70.01 111.147 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.72 144.54 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.31 111.154 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -99.25 -30.08 12.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.875 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -175.34 137.17 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.893 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.33 98.88 3.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 75.51 110.861 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -65.98 115.96 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.12 110.888 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.05 -25.34 23.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.41 111.077 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.98 -40.57 75.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.879 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -87.02 -38.77 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 74.23 110.918 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.55 34.74 4.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 71.41 112.487 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -146.87 169.0 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 71.43 110.913 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.66 177.06 46.15 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 64.23 112.525 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.99 126.29 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 75.45 110.869 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 mt -99.87 152.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.095 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -116.58 126.11 52.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.929 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.3 155.94 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.911 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.94 -5.48 58.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 64.1 110.878 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -111.52 -1.86 15.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 71.21 110.887 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.39 80.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.474 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -161.67 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 74.15 112.352 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.72 80.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 73.01 110.874 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.433 HG12 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -134.26 144.59 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 71.23 111.131 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.11 119.04 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.85 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG12 HG12 ' A' ' 26' ' ' VAL . 1.3 m -127.73 140.27 49.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 73.31 111.103 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -119.98 157.78 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 72.13 110.854 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -56.43 -23.93 41.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.915 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -93.93 19.96 8.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 64.42 111.153 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.07 -7.93 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 55.24 111.088 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -87.09 132.24 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.23 111.095 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -117.11 86.56 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 70.04 110.873 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.2 177.75 6.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.21 111.12 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -101.23 90.57 4.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.893 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.86 -118.06 1.88 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 71.15 112.504 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.05 110.08 19.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.53 110.908 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.28 96.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.22 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 t -178.6 162.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.21 111.158 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.27 -178.42 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 62.44 110.92 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -127.0 127.32 44.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.861 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.49 121.29 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 74.3 110.842 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.58 65.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.487 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -106.57 159.93 15.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 65.32 110.854 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -87.91 141.53 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 75.12 110.82 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.63 139.77 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 71.52 111.146 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.76 125.67 42.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 72.13 110.854 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.2 p90 -120.99 144.6 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 64.45 110.895 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.43 99.2 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.877 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.904 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -62.8 121.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 75.01 111.168 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.419 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -103.38 148.98 36.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.666 0.746 . . . . 75.43 110.892 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 64.52 112.383 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 58.13 5.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 73.35 112.491 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -40.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 74.22 110.911 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.19 142.3 21.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 62.43 112.501 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.56 -38.05 27.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.768 -0.73 . . . . 72.41 112.504 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -100.45 -17.74 17.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 74.11 110.901 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.12 -98.44 0.21 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 61.15 112.471 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 111.77 2.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 64.44 112.292 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.904 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -119.46 165.79 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.31 110.911 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.67 58.79 4.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.079 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 10.0 ttpt -43.66 -38.81 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.918 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -133.9 104.94 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.898 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 1.1 t -106.6 142.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 73.05 111.125 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.8 141.29 48.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.896 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 47' ' ' VAL . 29.6 ttt180 -77.39 134.58 38.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.846 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.55 111.115 179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.887 0.375 . . . . 65.11 110.928 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -135.42 134.26 39.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.949 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 171.66 44.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 72.03 112.48 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.9 p -83.72 145.25 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 65.15 111.097 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.443 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -85.56 145.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.141 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.3 -29.19 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 62.45 110.88 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -175.57 137.6 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 63.31 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -139.55 98.85 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.25 113.39 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 64.42 110.903 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.12 -21.81 27.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.54 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.46 -51.08 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.917 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -85.23 -36.68 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.923 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.5 40.2 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.15 112.522 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 20.4 p90 -144.57 166.71 24.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 73.5 110.911 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 175.41 46.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 32.41 112.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -141.28 126.68 18.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 61.51 110.859 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.527 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.4 mt -98.28 152.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 63.35 111.133 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.402 ' N ' HG22 ' A' ' 18' ' ' ILE . 12.0 mm100 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 63.41 110.887 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.842 0.353 . . . . 75.53 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -119.1 143.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.23 111.124 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -98.59 117.7 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.13 110.915 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -126.31 142.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 72.44 111.104 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.524 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.4 m170 -123.15 158.95 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.4 110.829 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG23 ' A' ' 31' ' ' THR . 7.5 p90 -56.36 -22.19 29.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -95.53 20.62 9.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.01 111.161 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.41 -6.16 8.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 70.52 111.102 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -88.82 132.5 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.53 111.11 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.24 110.937 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 70.34 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.62 120.42 8.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 45.41 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.84 7.62 66.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 52.34 112.494 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -107.0 160.54 15.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 63.31 110.919 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m-70 -88.8 141.26 28.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.05 110.837 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.22 140.15 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 50.41 111.161 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.54 125.97 42.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 64.2 110.875 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.7 p90 -119.94 146.56 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 74.14 110.864 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -107.55 99.3 8.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 73.05 110.92 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.6 m -63.01 124.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.135 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.06 158.13 40.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.688 0.756 . . . . 75.53 110.85 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.4 Cg_endo -69.8 -88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.652 2.234 . . . . 53.51 112.33 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 56.78 3.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.484 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -132.02 -41.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 74.14 110.864 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.21 135.93 12.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 73.1 112.483 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.76 -34.21 14.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.739 . . . . 71.44 112.467 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -22.37 17.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 74.25 110.941 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.77 -94.38 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 41.44 112.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 114.93 3.87 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 61.13 112.394 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 11.9 tt0 -119.93 157.86 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.927 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.785 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.64 57.54 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 65.44 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.12 -37.8 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.51 110.895 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -131.08 104.27 7.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 62.31 110.859 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.785 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.48 141.71 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 60.44 111.103 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -132.32 143.05 49.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.9 tmm_? -78.76 135.48 37.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.13 110.879 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 62.14 111.141 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 72.3 110.866 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 26.8 mtmt -132.71 134.86 45.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.876 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.72 171.65 44.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.776 -0.726 . . . . 72.41 112.507 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 p -80.99 145.42 31.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 50.02 111.143 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.87 144.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 73.25 111.106 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -96.96 -31.28 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 72.51 110.879 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -175.43 139.98 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.916 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HE1' HD11 ' A' ' 33' ' ' ILE . 65.3 t80 -133.63 99.11 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.52 110.88 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.64 101.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.902 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.81 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.13 111.053 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -70.26 -43.93 69.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 64.03 110.894 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -93.37 -34.72 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 72.01 110.882 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.1 45.73 2.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.75 -0.738 . . . . 54.42 112.474 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -157.64 143.24 17.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 74.04 110.976 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.76 -174.21 22.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 72.21 112.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -142.49 127.59 18.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 72.1 110.887 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.9 mt -98.5 151.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 64.41 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 7.4 mm100 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.899 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.836 0.35 . . . . 73.22 110.868 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.57 142.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.133 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.34 115.75 29.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 63.35 110.889 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.793 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.5 m -121.53 144.41 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 65.42 111.127 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.519 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -123.6 159.04 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.881 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -56.16 -21.76 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.892 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 m -97.0 22.57 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.24 111.143 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.67 -6.38 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 62.22 111.086 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.9 mp -89.66 132.43 34.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 51.43 111.132 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 33.51 110.871 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.784 0.325 . . . . 74.13 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -58.0 119.35 6.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 52.04 110.878 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.67 6.19 62.52 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.689 -0.767 . . . . 63.41 112.502 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -106.83 160.11 15.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.53 110.885 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.8 m-70 -88.69 141.79 28.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.868 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.6 m -158.48 140.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 71.25 111.177 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.6 tt0 -99.03 127.0 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 71.22 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.8 p90 -118.07 149.05 41.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 64.32 110.88 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -106.42 98.82 8.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.865 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.838 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -53.29 125.38 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 54.12 111.153 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.6 tp10 -111.1 138.95 21.36 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 71.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -90.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.65 2.234 . . . . 64.21 112.325 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.72 53.84 4.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 42.3 112.515 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 -40.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 70.14 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.62 135.58 15.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 73.23 112.486 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.33 -36.85 17.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.734 . . . . 62.35 112.501 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -19.37 16.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.21 110.877 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.11 -102.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 44.43 112.439 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 113.3 3.32 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 42.21 112.33 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.838 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -119.28 174.86 6.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.878 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -91.1 59.18 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.12 111.106 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 13.9 tppt? -40.79 -44.42 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.869 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -129.0 107.63 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 63.4 110.864 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.78 142.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 63.21 111.13 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -132.0 141.53 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.86 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.758 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.01 136.03 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.85 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.9 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.32 111.147 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.855 0.36 . . . . 72.44 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 21.3 mtmm -127.53 134.15 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 72.3 110.926 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.81 171.53 42.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.738 . . . . 61.44 112.465 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.6 p -83.28 146.32 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 74.01 111.149 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 144.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.106 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -29.51 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.24 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -172.79 138.95 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.899 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 33' ' ' ILE . 62.8 t80 -140.57 98.05 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 70.22 110.898 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.16 105.33 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 54.11 110.903 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.19 -30.26 43.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.3 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -71.46 -37.1 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.905 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.2 -40.21 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.907 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.89 5.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 44.32 112.458 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -149.96 170.74 18.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 73.4 110.913 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.99 178.46 46.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 62.23 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -142.93 125.13 15.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 63.42 110.885 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.563 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.2 mt -98.24 150.9 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 74.32 111.111 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.923 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.862 0.363 . . . . 72.04 110.852 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.2 142.37 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 75.22 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.97 116.76 31.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.864 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.9 m -122.54 140.78 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 62.14 111.133 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.7 m-70 -119.15 158.49 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -56.08 -23.23 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 70.13 110.89 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m -95.74 22.19 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 75.21 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.18 -6.41 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 55.11 111.097 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -89.18 131.97 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.139 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.923 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.775 0.322 . . . . 65.43 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.8 121.46 10.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.927 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.71 68.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.31 112.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.68 160.56 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.36 . . . . 71.14 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.6 m-70 -89.32 142.25 27.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.877 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -158.74 140.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.33 111.092 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -97.14 127.85 43.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 60.01 110.87 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.88 146.71 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 65.34 110.912 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.02 97.25 7.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.911 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 61.4 t -52.05 130.14 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 73.34 111.183 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.1 tp10 -118.11 137.7 24.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 74.22 110.871 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -91.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 71.44 112.349 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.38 4.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.721 . . . . 73.31 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -39.98 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 75.33 110.884 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.2 136.79 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 72.41 112.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.41 -35.2 14.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 63.4 112.446 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -18.7 14.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 73.32 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.05 -103.44 0.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.481 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' CB ' HG13 ' A' ' 51' ' ' VAL . 53.3 Cg_endo -69.79 110.64 2.61 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 61.21 112.33 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.793 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.2 pt20 -118.35 173.68 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.11 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -90.87 61.55 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 55.42 111.089 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -39.12 -42.78 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.903 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 1.3 tttt -131.54 110.74 11.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.909 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.77 142.11 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 73.4 111.151 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.02 110.884 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 52.0 ttt180 -78.06 134.76 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 64.45 110.92 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.34 111.115 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.902 0.382 . . . . 72.43 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.6 mtmt -128.66 134.72 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 62.21 110.893 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.56 44.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.482 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 p -85.15 148.49 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 45.32 111.146 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.27 144.8 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 73.23 111.114 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.07 -29.65 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.899 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -176.16 137.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.929 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -136.67 99.39 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 74.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -72.37 111.39 7.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.85 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.45 -32.78 42.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 71.43 111.118 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.84 -50.81 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -77.77 -29.81 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 70.52 110.868 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.83 32.7 10.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 73.54 112.477 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -140.12 169.19 18.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 64.31 110.917 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.32 172.97 45.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 70.02 112.512 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -141.45 129.11 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 74.55 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 49' ' ' PHE . 27.8 mt -97.22 144.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 53.51 111.103 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.34 110.88 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 73.42 110.921 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -116.87 145.91 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 72.04 111.151 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.02 117.52 35.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 30.42 110.84 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.676 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.47 142.44 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 55.23 111.147 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.436 ' O ' HD12 ' A' ' 33' ' ' ILE . 7.4 m170 -116.92 157.08 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 55.22 110.894 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -56.01 -24.55 39.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 63.35 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -93.83 20.88 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.099 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.74 -1.88 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 64.21 111.11 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG13 HG11 ' A' ' 65' ' ' VAL . 4.7 mp -90.3 127.97 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 63.52 111.106 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.92 179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 64.42 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -58.68 115.99 3.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.871 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.15 7.42 54.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.15 112.49 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.97 158.95 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.54 110.889 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.533 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.7 m-70 -88.48 141.56 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.32 110.866 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -158.85 139.86 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 73.44 111.131 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.2 tt0 -97.42 126.18 42.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 75.44 110.871 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.7 p90 -121.14 147.08 46.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 55.22 110.885 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 9.8 mt-10 -107.53 99.03 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 70.34 110.891 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.0 m -64.65 125.38 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.14 111.106 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -114.3 158.96 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 71.4 110.918 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -89.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.244 . . . . 74.41 112.33 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.57 57.19 3.79 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 64.43 112.438 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 5.9 tpp180 -132.51 -41.6 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 75.31 110.878 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.23 139.04 14.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 62.45 112.529 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -38.59 23.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 60.02 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -22.09 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 75.41 110.886 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.2 -93.16 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 71.11 112.487 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 114.42 3.7 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 52.31 112.352 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.1 tt0 -119.5 157.06 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 72.12 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.62 58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.11 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -43.67 3.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 60.33 110.887 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.0 mtpp -129.53 109.06 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.897 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.22 142.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.3 111.134 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -131.87 143.39 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.912 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.7 mtm105 -78.17 135.92 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.821 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.51 111.115 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.839 0.352 . . . . 75.32 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.3 mtpm? -129.24 136.72 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.875 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.9 172.08 44.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 75.55 112.438 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -82.65 151.06 26.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 64.24 111.138 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.37 147.05 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 63.34 111.137 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -98.95 -34.51 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.3 110.919 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -168.5 139.19 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.912 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.29 98.53 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 74.31 110.889 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.69 115.13 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 74.14 110.924 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.94 -33.09 24.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 70.24 111.099 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.75 -49.92 71.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.884 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -77.72 -29.67 51.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.913 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 33.4 10.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 71.12 112.484 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.7 169.95 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 74.11 110.924 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 170.81 43.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 63.21 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -141.4 125.18 16.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 71.23 110.886 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -98.85 151.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 75.23 111.142 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 10.3 mm100 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 70.45 110.942 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.832 0.349 . . . . 60.41 110.838 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.6 143.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.071 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.8 118.73 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.879 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -129.39 143.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 64.11 111.12 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 33' ' ' ILE . 13.9 m170 -120.39 157.31 29.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 75.32 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -55.72 -24.68 36.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 62.21 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -94.43 22.74 5.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 61.34 111.169 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.19 -0.14 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 50.21 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.8 mp -91.16 130.61 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 72.04 111.149 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 55.01 110.856 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.6 m120 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.761 0.315 . . . . 73.24 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 124.09 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 55.52 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.03 6.41 69.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 62.51 112.509 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -102.47 157.31 17.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 70.53 110.872 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.3 m-70 -87.93 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 71.11 110.835 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -159.11 141.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 61.33 111.12 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.3 tt0 -94.24 125.42 38.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -118.37 142.61 47.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 64.22 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 78.1 mt-10 -106.2 98.07 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.896 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.0 m -63.79 122.5 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.147 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.86 160.39 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.661 0.743 . . . . 62.32 110.845 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 75.22 112.305 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 55.7 3.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 74.22 112.446 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -130.59 -41.68 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 73.15 110.866 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.13 140.42 15.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 75.04 112.478 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.52 -44.95 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 55.45 112.479 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -85.15 -22.18 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 72.04 110.851 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -90.88 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 75.12 112.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 114.2 3.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 74.24 112.353 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.856 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -121.96 156.53 33.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.915 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.709 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.3 58.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -44.56 -36.19 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 4.2 ttpt -130.74 106.95 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.709 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.25 142.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 54.51 111.104 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -131.15 142.61 50.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.897 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.757 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.19 133.15 36.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.856 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.806 0.336 . . . . 73.1 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.2 mtpt -135.16 134.74 40.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.426 . . . . 62.22 110.901 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.23 171.8 44.89 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 72.41 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.5 p -81.46 146.31 30.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 73.41 111.124 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.71 145.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.43 111.084 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -97.96 -29.31 13.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 65.32 110.908 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -175.57 144.73 0.68 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 72.25 110.917 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -144.94 98.85 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 72.43 110.853 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -68.84 117.64 10.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 74.44 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.68 -24.02 21.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.51 111.121 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.38 -45.01 93.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.842 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -90.79 -37.84 13.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.944 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 42.53 2.21 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.731 -0.747 . . . . 50.44 112.505 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -144.75 168.18 20.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 70.4 110.936 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 174.43 46.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.475 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -142.32 125.34 16.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.3 mt -98.44 152.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.54 111.103 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 18' ' ' ILE . 8.9 mm100 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 64.21 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.85 0.357 . . . . 60.4 110.844 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -112.61 145.25 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 74.13 111.102 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.19 116.85 33.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -125.14 143.39 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 61.23 111.18 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.3 m170 -121.71 159.41 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 60.21 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -56.63 -22.46 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 62.12 110.875 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -95.48 21.46 8.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.65 -3.63 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.45 111.086 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 29' ' ' HIS . 5.0 mp -90.24 132.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.175 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.899 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.774 0.321 . . . . 75.13 110.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.16 130.24 45.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 72.34 110.894 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 6.77 88.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 44.01 112.493 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.36 160.3 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 54.22 110.891 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.5 m-70 -87.03 141.0 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 73.01 110.857 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.56 140.79 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.118 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 24.8 tt0 -97.65 125.75 42.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 64.21 110.871 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.1 p90 -119.54 146.05 45.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.35 110.907 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -106.07 98.22 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.91 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 21.9 m -63.66 124.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 71.51 111.143 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.61 160.67 35.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.618 0.723 . . . . 34.21 110.863 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.692 2.261 . . . . 72.12 112.328 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.43 57.3 3.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 73.03 112.477 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.6 -41.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 71.51 110.875 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.86 137.54 13.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.76 . . . . 71.22 112.487 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.39 18.1 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 24.05 112.477 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.7 -22.89 19.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 74.34 110.86 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -93.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 73.54 112.517 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 114.92 3.87 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 61.21 112.315 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.9 tt0 -119.7 158.0 27.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.911 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.94 58.25 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 65.42 111.08 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -43.56 -38.02 2.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.893 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -132.17 106.17 7.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.882 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.769 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.36 142.07 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 61.45 111.112 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -131.92 142.87 49.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.906 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.74 134.79 37.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 71.34 110.855 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.6 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 73.34 111.162 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 64.35 110.896 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.6 mtmt -126.45 134.2 51.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.892 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 171.73 43.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.24 112.536 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -85.64 142.95 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 71.15 111.16 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.78 144.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.151 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -31.76 11.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 50.21 110.93 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -174.72 138.56 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.54 110.917 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -138.04 99.28 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.869 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -73.01 116.58 13.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.896 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.77 -20.34 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 75.24 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.77 -54.92 35.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -84.34 -35.61 23.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.74 39.46 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 70.34 112.458 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -143.92 163.57 33.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 72.14 110.917 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.95 175.83 43.9 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 74.32 112.498 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -141.85 128.22 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 72.4 110.846 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.9 mt -97.7 148.77 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 60.22 111.112 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.919 179.925 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.87 0.367 . . . . 74.33 110.866 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.628 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -107.29 144.64 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 54.51 111.141 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -99.15 119.96 38.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 64.13 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -130.52 143.33 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.44 111.109 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.499 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m170 -119.0 156.17 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 62.41 110.852 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.626 ' CZ ' HG23 ' A' ' 31' ' ' THR . 3.3 p90 -55.39 -25.12 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.871 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.626 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.5 p -94.22 22.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 71.15 111.125 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.23 -1.89 8.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 73.32 111.062 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 65' ' ' VAL . 4.8 mp -92.3 130.72 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 71.24 111.158 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 72.42 110.884 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.867 0.365 . . . . 63.43 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -58.46 119.03 6.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 45.11 110.921 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.15 6.57 58.89 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.754 -0.736 . . . . 64.23 112.494 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -105.18 159.87 15.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 64.14 110.848 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -87.82 140.58 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.11 110.842 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.1 m -157.99 139.76 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.23 111.111 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 26.6 tt0 -96.64 126.29 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.851 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 18' ' ' ILE . 20.5 p90 -120.46 143.31 48.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.861 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -105.09 97.33 7.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.32 124.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 62.5 111.129 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -108.88 157.47 36.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.624 0.726 . . . . 70.42 110.93 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.227 . . . . 60.3 112.361 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.66 57.09 4.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 51.34 112.477 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 7.1 tpt180 -132.18 -39.34 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 60.25 110.899 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -93.63 133.62 11.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.781 -0.723 . . . . 61.21 112.483 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.57 8.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 71.44 112.528 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.51 -23.9 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 75.01 110.886 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.69 -93.12 0.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.731 . . . . 51.24 112.511 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 116.59 4.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.66 2.24 . . . . 71.05 112.349 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.843 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.3 tm0? -122.3 150.89 41.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.23 110.909 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -74.52 59.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 55.43 111.135 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -46.44 -37.87 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.5 110.897 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 104.51 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.03 110.86 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.79 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.18 140.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 63.53 111.12 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -131.58 143.37 50.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.2 110.889 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 6.4 ptm180 -78.87 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.891 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.164 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.803 0.335 . . . . 62.21 110.938 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.8 mtmp? -125.94 133.3 51.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.13 110.922 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.11 171.42 42.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 64.31 112.529 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -87.34 145.88 26.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 71.55 111.166 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.6 145.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.107 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.8 tptt -99.49 -29.79 12.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 64.34 110.918 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -175.72 137.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 64.45 110.937 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -135.12 97.93 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.52 110.876 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.51 92.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 70.12 110.844 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.95 74.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 51.31 111.111 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.11 -43.9 90.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.874 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -78.83 -38.37 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.887 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 25.9 7.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 62.3 112.485 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -140.87 169.66 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 75.42 110.978 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.94 172.39 45.06 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.746 . . . . 52.2 112.499 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 74.03 110.879 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.504 ' CD1' HG11 ' A' ' 28' ' ' VAL . 26.2 mt -98.19 152.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 73.35 111.165 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 11.9 mm100 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.31 110.92 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.82 0.343 . . . . 75.34 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.657 ' CG2' HG12 ' A' ' 51' ' ' VAL . 2.2 p -117.42 139.5 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 74.45 111.148 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.8 115.73 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 35.42 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -125.88 144.64 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 65.34 111.145 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.456 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m-70 -121.23 156.77 31.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.4 110.828 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -54.69 -24.71 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 71.21 110.826 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -94.98 24.95 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.22 111.112 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.71 -0.38 6.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 74.13 111.127 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -91.43 126.74 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 61.13 111.148 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 70.11 110.89 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.806 0.336 . . . . 52.23 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 72.04 110.894 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.27 8.27 60.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.12 112.511 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.7 158.56 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.918 0.389 . . . . 60.53 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.538 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-70 -88.29 140.25 29.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.806 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.82 140.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 75.43 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.7 tt0 -95.66 125.07 39.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.874 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CD1' HG21 ' A' ' 18' ' ' ILE . 25.5 p90 -118.86 144.33 46.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.859 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.1 mm-40 -105.9 97.79 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 74.53 110.889 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.849 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.5 m -64.13 117.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 43.3 111.125 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -108.65 160.17 28.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.662 0.744 . . . . 73.55 110.92 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 51.34 112.325 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 55.79 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 73.25 112.522 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -130.72 -41.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 73.1 110.895 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.01 142.19 15.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 64.34 112.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.51 -47.1 29.51 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 71.32 112.504 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.8 -22.72 34.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 74.34 110.916 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.13 -89.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 62.54 112.484 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 116.51 4.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.646 2.231 . . . . 75.52 112.367 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.9 tt0 -123.79 157.6 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.33 57.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.31 111.109 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -44.44 -37.57 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 62.51 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -130.67 104.86 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 71.42 110.927 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -107.76 141.55 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.12 111.155 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -131.43 142.7 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.837 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.765 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.1 ppt_? -78.44 134.37 37.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.896 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.571 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.2 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 70.32 111.163 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.866 0.365 . . . . 74.13 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 14.9 mttp -133.06 137.88 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.956 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.96 171.51 44.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.702 -0.761 . . . . 74.42 112.461 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 p -85.55 144.12 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 74.1 111.109 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.3 144.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 54.44 111.123 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -99.48 -30.2 12.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 71.04 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -175.19 139.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.8 99.41 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 74.14 110.901 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -69.59 93.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.03 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.53 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 62.02 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -67.16 -35.86 80.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.845 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -94.04 -36.97 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.14 32.53 4.92 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 74.45 112.477 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -146.28 168.12 21.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.888 0.375 . . . . 74.25 110.947 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.66 179.03 46.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.746 -0.74 . . . . 71.51 112.464 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -142.35 130.69 22.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 71.31 110.895 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.594 HD13 ' CD1' ' A' ' 49' ' ' PHE . 28.5 mt -97.09 144.21 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 74.02 111.117 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.9 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.826 0.346 . . . . 74.42 110.871 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.4 142.77 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.35 111.127 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.26 116.3 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.897 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.766 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.6 m -122.99 141.33 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 71.23 111.133 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -121.55 159.83 25.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 70.52 110.819 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -56.66 -22.32 33.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.853 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -94.37 19.78 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.12 111.12 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.83 -7.97 8.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.43 111.117 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -88.66 132.79 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.23 111.149 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.891 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.824 0.345 . . . . 61.35 110.918 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.68 117.64 4.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.875 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.88 7.06 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 44.54 112.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.15 160.41 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 75.55 110.892 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.521 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.4 m-70 -89.05 141.78 28.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.53 110.812 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.9 m -158.37 139.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 53.12 111.178 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.8 tt0 -98.17 126.4 43.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.88 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 18' ' ' ILE . 34.5 p90 -119.72 146.65 45.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.85 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 38.4 mt-10 -105.0 98.88 8.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 75.11 110.857 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -52.04 128.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 72.23 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.477 ' H ' ' H ' ' A' ' 61' ' ' GLN . 3.0 tp10 -112.58 138.57 22.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.661 0.743 . . . . 74.25 110.874 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 72.14 112.372 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.32 53.71 4.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 72.35 112.437 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -134.74 -40.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 71.52 110.854 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.53 134.59 13.91 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.735 . . . . 75.24 112.504 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.66 -36.81 13.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 41.44 112.504 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -100.62 -19.31 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 61.01 110.895 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.88 -103.07 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 52.11 112.5 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 113.22 3.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.695 2.263 . . . . 71.4 112.324 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.0 pt20 -119.32 175.99 5.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.03 110.944 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -93.23 62.6 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.43 111.075 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -46.21 -38.82 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.22 110.934 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 5.7 tmtt? -132.12 104.92 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.14 110.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.53 141.38 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 70.23 111.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -131.65 142.08 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 71.32 110.879 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.764 ' HA ' HG12 ' A' ' 47' ' ' VAL . 22.8 ptt85 -77.62 135.64 38.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.866 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.1 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.146 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.889 0.376 . . . . 62.32 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.3 mtmm -127.05 131.17 51.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.13 172.29 39.91 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.738 -0.744 . . . . 54.13 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.5 p -86.49 141.13 29.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 64.22 111.11 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -81.58 144.83 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.04 111.14 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -30.59 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 70.22 110.881 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -175.9 138.9 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.945 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.436 ' HE1' HD11 ' A' ' 33' ' ' ILE . 62.2 t80 -131.74 99.08 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -68.62 90.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 55.35 110.868 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.14 67.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.04 111.078 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -65.73 -46.73 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 63.15 110.875 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -77.21 -34.13 56.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.887 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.1 19.46 14.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 60.12 112.481 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -138.87 173.78 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 65.35 110.876 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.82 174.59 45.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 52.25 112.465 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -141.38 125.26 17.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 60.45 110.845 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 HG12 HG23 ' A' ' 6' ' ' VAL . 25.2 mt -98.02 152.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 62.23 111.094 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.89 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.842 0.353 . . . . 75.35 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.624 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -125.68 148.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 60.31 111.113 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.5 118.96 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.87 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -131.06 142.29 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 73.0 111.11 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 4.5 m170 -121.54 157.58 30.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.843 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CZ ' HG23 ' A' ' 31' ' ' THR . 6.1 p90 -56.28 -24.28 42.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.883 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -93.93 20.28 7.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.2 111.147 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.91 -5.47 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.11 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.5 mp -89.38 132.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 72.21 111.154 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.11 110.912 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.776 0.322 . . . . 73.44 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.03 119.77 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 54.41 110.868 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.65 64.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.512 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -106.89 160.79 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 74.11 110.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.535 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -89.37 142.31 27.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 61.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -159.09 140.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.086 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.9 tt0 -96.07 125.73 40.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.34 110.855 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 25.0 p90 -121.27 143.23 49.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.12 110.861 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.94 98.06 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 55.34 110.894 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.7 m -64.19 118.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 73.05 111.156 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.91 158.16 33.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.629 0.728 . . . . 71.41 110.909 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -88.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 2.252 . . . . 70.13 112.339 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.96 55.92 3.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 70.45 112.454 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -133.35 -41.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 74.51 110.885 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.44 134.91 12.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 53.12 112.494 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.87 -34.32 11.02 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.742 -0.742 . . . . 54.45 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -21.38 16.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.34 110.922 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.44 -93.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 74.25 112.518 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.6 4.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.644 2.23 . . . . 71.32 112.373 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -122.23 154.34 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.3 110.899 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.779 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.26 57.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 64.22 111.099 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -38.81 5.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.911 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 11.7 tttp -129.61 103.35 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.905 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.779 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.59 142.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.34 111.103 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -132.8 143.02 49.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.927 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 35.7 mtp180 -78.66 134.23 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.854 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.1 111.118 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.847 0.356 . . . . 51.44 110.907 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -128.41 137.62 51.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 52.42 110.872 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.57 171.45 44.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 63.32 112.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 p -81.52 156.65 25.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 70.14 111.162 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -99.57 143.41 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 63.31 111.124 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -97.35 -28.68 13.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.9 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -174.77 138.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 72.1 110.901 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.473 ' CE1' HD11 ' A' ' 33' ' ' ILE . 69.7 t80 -136.11 98.96 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.869 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.35 110.908 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.52 -27.85 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.082 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.67 -40.9 96.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.872 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -94.88 -37.33 11.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 55.32 110.938 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 46.31 1.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 53.11 112.466 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -157.53 142.94 17.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 72.12 110.905 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.62 -176.41 25.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 63.15 112.494 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -141.2 132.57 26.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 74.21 110.866 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.7 mt -106.53 149.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 73.2 111.159 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 64.53 110.912 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.847 0.356 . . . . 53.4 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.688 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -121.68 141.46 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.02 111.146 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.31 116.29 31.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.882 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -121.05 145.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 75.55 111.128 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 m-70 -124.64 159.36 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.88 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -55.48 -23.18 24.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.903 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -95.81 23.81 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 72.52 111.121 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.23 -3.0 6.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 60.21 111.094 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.517 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -91.74 131.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.103 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 62.51 110.897 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.781 0.324 . . . . 62.32 110.931 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.83 122.7 13.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 61.54 110.9 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.38 76.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 63.03 112.492 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -106.73 160.39 15.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.947 0.403 . . . . 74.43 110.838 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -89.1 141.07 28.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 73.5 110.826 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.5 140.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.01 111.136 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.2 tt0 -95.39 127.54 41.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 64.14 110.887 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -119.73 144.58 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 74.22 110.86 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -106.8 97.18 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.863 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.829 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.1 m -60.8 127.81 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 75.42 111.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -121.69 158.86 53.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.632 0.73 . . . . 55.34 110.903 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -88.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.732 2.288 . . . . 64.21 112.312 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.83 57.43 3.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 73.22 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.62 -42.01 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 75.41 110.858 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.91 138.24 13.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 71.25 112.517 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -39.88 21.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 54.22 112.455 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.46 -25.04 25.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 71.01 110.862 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.54 -92.67 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 65.13 112.475 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.11 3.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.677 2.251 . . . . 71.13 112.32 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.829 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -118.24 158.12 25.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.892 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.91 57.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 70.31 111.121 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -39.67 -43.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 53.23 110.937 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.8 mttt -126.63 108.35 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.918 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.695 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.32 141.44 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 52.52 111.152 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -131.6 142.28 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 62.14 110.88 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.749 ' HA ' HG12 ' A' ' 47' ' ' VAL . 45.2 ttt-85 -79.22 134.92 36.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 62.41 110.889 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.3 111.126 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.853 0.359 . . . . 52.33 110.906 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 12.3 mtpt -133.37 133.78 42.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.898 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.55 171.53 44.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 73.44 112.453 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -85.61 142.12 29.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 72.23 111.168 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.82 144.57 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 64.12 111.118 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -30.77 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.879 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -176.51 137.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.913 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -134.83 98.9 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.87 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.15 93.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 62.41 110.855 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.33 -31.46 70.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.42 111.097 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -65.47 -41.41 93.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 65.43 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -83.63 -38.5 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.909 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 26.64 7.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 61.51 112.472 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.91 169.01 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 74.14 110.9 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.66 173.63 45.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 51.14 112.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -141.93 128.92 20.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 61.22 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 49' ' ' PHE . 29.1 mt -97.08 146.5 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 42.2 111.094 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 64.34 110.877 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 60.32 110.874 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.478 ' CG2' HG12 ' A' ' 51' ' ' VAL . 3.1 p -113.27 138.39 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.35 111.179 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.75 115.89 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.17 143.42 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.12 111.107 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -118.39 158.52 25.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 63.4 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -56.0 -25.09 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.858 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.47 22.09 5.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.17 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.18 -0.99 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 52.22 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 65' ' ' VAL . 5.0 mp -93.13 130.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.2 111.146 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.876 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.771 0.32 . . . . 60.11 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -59.75 118.38 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.25 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 6.62 57.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 73.32 112.527 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.66 158.4 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 70.32 110.86 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.531 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.0 m-70 -87.5 141.54 28.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 62.03 110.874 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.57 139.97 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.091 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 28.4 tt0 -97.47 125.11 41.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 65.42 110.875 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 18' ' ' ILE . 27.6 p90 -120.57 144.41 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.887 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.63 97.36 7.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.02 110.899 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.852 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -62.91 122.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 73.11 111.102 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -111.98 159.18 34.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.658 0.742 . . . . 74.11 110.921 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 71.5 112.356 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.96 57.92 4.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 74.44 112.455 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -130.52 -41.88 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.34 110.855 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.93 137.08 13.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 50.11 112.468 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -35.52 14.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.724 -0.75 . . . . 61.44 112.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -91.34 -25.24 19.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 73.42 110.949 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.28 -91.79 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.742 -0.742 . . . . 72.43 112.501 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 116.55 4.62 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.653 2.236 . . . . 71.12 112.354 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.852 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 tt0 -118.26 156.51 28.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.01 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.54 58.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 41.4 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -40.89 -42.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.21 110.911 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 16.0 tttp -134.03 108.26 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.33 110.901 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -107.11 141.8 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.133 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -131.75 142.75 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.3 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -77.96 134.89 37.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.912 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.5 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.123 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.844 0.354 . . . . 64.31 110.892 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.6 mttt -129.9 137.37 50.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.899 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.45 171.35 44.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 61.42 112.504 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -88.82 138.99 30.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 65.11 111.112 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 145.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 64.3 111.136 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -101.05 -27.78 13.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.918 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -176.01 140.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 65.34 110.891 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -135.78 99.41 4.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 73.12 110.849 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -67.66 117.4 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.3 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.41 18.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.53 111.115 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -59.93 -31.85 70.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.898 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -107.88 -33.78 7.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.92 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.95 40.37 2.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 71.13 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.3 p90 -142.52 173.85 11.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 74.34 110.932 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.06 174.61 46.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 74.22 112.487 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -140.58 126.65 19.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 62.52 110.89 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 28' ' ' VAL . 24.2 mt -98.44 151.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 71.45 111.127 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.0 110.951 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.917 0.389 . . . . 75.1 110.877 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -118.3 145.25 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.21 111.157 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.97 33.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 71.23 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -124.97 142.32 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 74.42 111.119 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -122.3 161.03 24.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.02 110.857 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.03 -21.97 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.855 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -94.16 19.74 8.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.31 111.125 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.7 -22.03 7.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 73.31 111.099 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -71.08 127.39 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 71.5 111.138 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.51 110.86 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.754 0.311 . . . . 63.32 110.934 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -62.22 120.38 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 5.09 68.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.729 . . . . 73.45 112.537 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.6 158.33 15.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 75.23 110.922 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.0 m-70 -86.92 139.39 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.44 110.829 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.4 m -158.54 139.93 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.13 111.144 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 tt0 -97.0 125.06 41.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.883 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.5 p90 -118.44 145.82 44.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.1 110.902 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -106.49 98.35 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 53.4 110.895 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.7 m -62.92 124.87 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 45.43 111.117 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.64 160.67 35.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.63 0.729 . . . . 75.1 110.879 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -88.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 73.45 112.339 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.06 57.07 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 61.23 112.465 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.51 -41.71 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 74.32 110.835 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.64 136.59 12.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 60.24 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.67 -34.83 15.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 42.34 112.501 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -22.94 18.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.339 . . . . 74.43 110.818 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.22 -93.36 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.732 . . . . 62.14 112.48 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.66 3.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.716 2.278 . . . . 74.12 112.356 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.855 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 9.4 tt0 -120.05 157.92 27.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 72.34 110.93 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.805 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.97 57.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 60.43 111.087 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.49 -38.85 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.67 104.75 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.22 110.881 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.805 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.15 141.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 53.41 111.14 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -131.33 141.9 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.2 110.848 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.756 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.52 134.85 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 71.12 111.115 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.872 0.368 . . . . 63.11 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 25.4 mttt -127.52 133.88 49.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.01 110.895 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.46 171.75 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.774 -0.727 . . . . 74.41 112.48 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.5 p -85.41 144.88 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 72.34 111.153 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -84.88 147.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 75.31 111.135 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.08 -32.36 10.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.04 110.902 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -174.74 141.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 73.54 110.929 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -141.15 98.94 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.861 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -65.21 119.22 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.01 110.949 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.24 21.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 61.34 111.071 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.5 -38.41 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 63.33 110.895 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -97.88 -38.03 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 70.53 110.904 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 44.67 1.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 65.31 112.474 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.48 168.47 25.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 73.2 110.96 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.77 -179.37 45.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 72.24 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -141.01 126.27 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 70.13 110.874 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 6' ' ' VAL . 23.2 mt -98.76 150.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 54.25 111.142 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 11.1 mm100 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.86 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.856 0.36 . . . . 71.44 110.906 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.77 142.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.23 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.63 116.37 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -121.42 142.52 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.41 111.099 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.472 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -123.53 160.07 27.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 75.24 110.849 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -56.93 -21.43 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.896 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.6 t -95.0 19.81 9.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.134 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.67 -24.2 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 52.31 111.061 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -70.47 124.07 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.152 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.919 179.913 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.805 0.335 . . . . 73.31 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.18 121.87 14.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.01 110.871 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.92 72.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 64.03 112.497 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.31 157.43 15.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 62.3 110.894 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.2 m-70 -85.91 138.36 32.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.843 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.0 m -158.22 140.39 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 55.45 111.148 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 39.7 tt0 -95.86 125.95 40.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.917 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -118.3 145.54 45.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.881 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -106.71 97.73 7.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 63.32 110.848 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.1 m -62.0 123.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 71.54 111.083 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -113.97 161.16 29.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.622 0.725 . . . . 71.04 110.883 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 74.04 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.23 57.27 4.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 74.24 112.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 4.0 mpt_? -128.96 -41.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 71.12 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.96 14.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 65.24 112.467 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.27 -41.93 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 51.55 112.463 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.44 -22.52 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 55.55 110.927 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.56 -89.87 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 61.43 112.478 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 114.82 3.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.658 2.239 . . . . 64.55 112.338 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.851 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.8 tt0 -119.23 156.55 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 71.2 110.921 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.738 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.03 57.09 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.22 111.144 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -41.74 -49.89 4.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 32.44 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.3 tttp -120.06 108.23 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.94 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.726 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.08 142.23 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.42 111.162 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -131.0 142.83 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.44 110.86 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HA ' HG12 ' A' ' 47' ' ' VAL . 38.4 ptt180 -78.75 134.88 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 75.04 110.852 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 43.3 111.122 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.85 0.357 . . . . 74.42 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.0 mtpp -132.02 133.17 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 55.33 110.895 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.8 171.14 43.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 72.43 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.8 p -82.46 146.62 29.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 71.01 111.105 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.69 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -87.68 145.89 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.117 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -36.74 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 64.41 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -170.52 141.6 1.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.904 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -136.49 99.29 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 75.05 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 103.2 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 52.24 110.919 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.3 47.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 54.34 111.113 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.46 -47.63 69.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.883 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.21 -36.08 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.862 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.13 2.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 53.4 112.513 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -152.74 151.35 30.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 64.12 110.91 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.28 176.53 32.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 73.44 112.451 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.53 122.93 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.43 110.883 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 6' ' ' VAL . 17.6 mt -97.99 154.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.03 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 18' ' ' ILE . 6.0 mm100 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.818 0.342 . . . . 61.33 110.835 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' CD2' ' A' ' 49' ' ' PHE . 3.4 p -113.69 136.05 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 54.41 111.121 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.71 115.4 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.41 110.938 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -124.97 143.72 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.03 111.133 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' HD12 ' A' ' 33' ' ' ILE . 18.0 m170 -122.4 158.87 28.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 62.32 110.867 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.96 -24.42 38.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -94.72 23.01 5.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.44 111.153 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.75 -2.02 7.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.32 111.095 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 65' ' ' VAL . 4.8 mp -91.39 131.97 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.31 111.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.894 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.798 0.333 . . . . 61.02 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.94 121.23 9.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.85 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.54 7.27 67.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 24.42 112.511 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -106.84 160.62 15.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.851 0.358 . . . . 75.35 110.893 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -88.74 141.96 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -158.63 140.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 54.31 111.142 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 33.4 tt0 -94.62 126.8 40.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 63.41 110.905 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG21 ' A' ' 26' ' ' VAL . 14.0 p90 -120.7 142.03 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 73.15 110.851 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.03 97.58 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 73.42 110.902 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.846 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.5 m -63.0 126.9 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.141 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.68 159.47 46.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.679 0.752 . . . . 73.25 110.906 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -87.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.725 2.283 . . . . 71.53 112.354 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.36 55.92 4.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 52.33 112.45 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.0 -41.76 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 72.14 110.887 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.53 137.68 13.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 12.14 112.474 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.87 -38.36 23.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 73.23 112.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.98 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 70.04 110.876 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.32 -93.96 0.15 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 73.42 112.456 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 112.77 3.16 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 42.52 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.846 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.6 tt0 -117.86 156.77 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.915 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.39 59.11 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 60.43 111.1 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -41.82 -38.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 54.11 110.949 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -130.85 109.63 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 52.51 110.863 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.3 141.24 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 65.45 111.13 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -131.52 141.14 49.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.898 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 15.2 ptm180 -78.67 133.45 37.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 62.2 110.857 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.135 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.887 0.375 . . . . 72.51 110.882 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -130.99 137.13 49.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.91 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.22 41.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.22 112.51 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p -84.91 138.04 32.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 74.42 111.13 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.95 144.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 71.03 111.106 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -99.66 -30.49 12.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.872 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -175.41 136.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 73.32 110.894 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -135.48 98.92 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.892 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -69.19 112.32 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.54 110.929 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.47 -30.13 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.41 111.113 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -62.94 -53.89 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 64.44 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -75.03 -32.14 61.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.914 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.1 30.84 8.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 64.25 112.482 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -139.93 169.13 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 64.13 110.926 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.67 173.59 46.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.754 -0.736 . . . . 74.4 112.491 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -140.91 126.81 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 74.53 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.756 HG12 HG23 ' A' ' 6' ' ' VAL . 24.4 mt -102.03 152.98 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.04 111.122 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' ILE . 59.3 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.932 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.842 0.353 . . . . 74.14 110.846 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.612 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -132.67 143.21 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.23 111.141 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.38 120.28 34.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -130.42 142.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 70.01 111.104 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 6.2 m170 -122.95 157.92 31.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 71.41 110.869 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.66 -23.51 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.35 110.848 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.0 t -94.51 19.46 9.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.173 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -120.36 -8.75 9.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 44.31 111.056 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG23 HG12 ' A' ' 65' ' ' VAL . 4.6 mp -85.47 131.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 62.22 111.142 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 72.0 110.885 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.792 0.33 . . . . 74.34 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -57.06 122.38 12.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.4 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.01 5.68 67.73 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 61.22 112.506 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -106.71 160.48 15.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 65.31 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.497 ' O ' HG13 ' A' ' 47' ' ' VAL . 13.4 m-70 -89.82 142.34 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 63.3 110.869 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -157.71 140.2 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 70.34 111.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 tt0 -96.75 125.11 40.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 62.42 110.913 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -119.09 144.17 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.14 110.936 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.426 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -102.57 98.07 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.22 110.94 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.7 m -61.89 118.23 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.115 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -107.51 156.46 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.44 110.854 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.5 Cg_endo -69.78 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.717 2.278 . . . . 55.21 112.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 56.51 3.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 40.41 112.483 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -132.28 -41.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 71.21 110.871 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.94 134.02 12.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 65.12 112.475 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.3 7.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 70.42 112.454 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -23.2 15.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 65.24 110.939 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.51 -93.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 72.31 112.497 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 117.07 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 72.21 112.339 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 15.1 tt0 -120.99 157.38 30.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.932 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.788 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.59 56.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.12 111.131 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -40.68 -46.04 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.907 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.5 tttp -126.44 105.82 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.926 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.788 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -105.87 142.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.54 111.108 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -132.38 146.14 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 133.93 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.895 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 63.41 111.14 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.835 0.35 . . . . 71.34 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 18.3 mtmt -131.06 135.71 47.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.857 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.91 171.48 44.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.466 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -82.77 143.95 30.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 71.2 111.112 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.7 144.58 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.03 111.13 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -31.11 12.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 74.04 110.911 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -175.09 140.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 73.04 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -139.27 98.85 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.914 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -70.74 109.39 4.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.65 35.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 53.44 111.103 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.24 -48.19 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.43 110.889 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -87.88 -37.36 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 71.11 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.17 41.2 2.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 61.02 112.484 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.97 167.77 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 75.21 110.905 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.09 46.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.31 112.477 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -141.88 124.77 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 72.12 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.8 mt -98.09 151.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 74.1 111.151 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.2 110.914 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.845 0.355 . . . . 71.41 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -112.38 146.02 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.145 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -100.44 116.68 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.43 110.886 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -124.72 144.04 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 71.44 111.125 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.9 m170 -123.12 159.29 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.05 110.869 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -56.25 -21.99 27.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -96.11 22.12 7.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 42.15 111.138 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.6 -4.53 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 50.42 111.103 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.9 mp -89.98 132.41 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 64.11 111.118 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.882 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.825 0.345 . . . . 65.32 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -57.17 120.19 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.883 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.06 62.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 74.44 112.462 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -106.87 160.32 15.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 73.2 110.897 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.9 m-70 -89.62 141.64 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.9 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.52 140.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 70.22 111.156 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -98.03 125.85 43.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.928 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.1 p90 -119.91 143.43 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 70.42 110.867 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 2.3 mt-10 -99.79 99.05 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.53 110.863 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.4 m -56.45 122.78 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 62.51 111.13 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.8 tt0 -101.87 140.79 21.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.25 110.9 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.68 -92.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.688 2.259 . . . . 55.11 112.373 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.15 53.95 4.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 74.24 112.479 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -39.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 71.35 110.863 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 134.43 16.83 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 71.21 112.508 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.91 -36.67 8.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 61.11 112.494 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.66 -14.36 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 72.31 110.873 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.52 -104.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 52.35 112.486 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 53.1 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.652 2.235 . . . . 63.04 112.326 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.7 pt20 -115.16 171.03 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.55 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -85.6 61.62 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 54.35 111.142 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 14.3 ttmt -42.02 -46.37 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 74.55 110.885 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 107.14 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 72.35 110.895 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.6 141.03 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 75.4 111.116 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -132.02 142.18 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.838 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.76 ' HA ' HG12 ' A' ' 47' ' ' VAL . 62.1 ttt180 -77.57 134.2 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.876 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 67' ' ' ARG . 9.0 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 62.23 111.13 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.898 0.38 . . . . 75.23 110.871 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.8 mtpt -127.23 134.11 50.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.884 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.53 172.37 44.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.787 -0.721 . . . . 74.43 112.538 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 76.2 p -83.39 144.93 29.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 75.41 111.161 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.21 145.15 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 75.53 111.116 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -31.06 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 71.45 110.885 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -175.69 137.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.884 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.2 99.19 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -74.16 113.04 10.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 65.11 110.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.76 -34.43 30.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 72.01 111.116 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -56.6 -48.48 77.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.855 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.28 -28.91 26.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 72.51 110.922 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.38 19.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 75.42 112.468 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -133.59 169.21 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 55.31 110.906 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.25 173.59 45.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 65.21 112.487 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -142.39 128.4 19.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 73.31 110.903 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.6 mt -97.7 149.24 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 61.44 111.081 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.42 110.914 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.836 0.35 . . . . 61.21 110.877 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -106.73 144.93 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.31 111.174 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.93 122.18 41.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.907 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -132.87 141.81 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 63.41 111.15 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -115.78 155.4 27.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -54.88 -25.06 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.886 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -93.74 23.62 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.121 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.24 -1.2 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 65.33 111.039 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.479 HG13 HG11 ' A' ' 65' ' ' VAL . 4.3 mp -90.21 126.4 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.42 111.12 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.912 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.831 0.348 . . . . 73.03 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.06 118.81 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 65.44 110.858 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.77 4.17 58.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.754 . . . . 71.22 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -101.6 155.51 18.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 72.44 110.879 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.534 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.9 m-70 -85.63 140.86 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.889 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.77 140.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 21.7 tt0 -98.07 126.35 43.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.854 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' HD13 ' A' ' 18' ' ' ILE . 22.8 p90 -118.42 146.88 44.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 65.32 110.883 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -105.97 96.32 6.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 74.31 110.893 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.1 m -63.4 123.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.3 111.114 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -115.55 160.33 35.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.674 0.749 . . . . 73.34 110.875 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 52.34 112.338 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.7 57.01 3.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.74 . . . . 33.24 112.507 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 5.0 mpt_? -132.79 -41.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 64.21 110.865 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 134.53 12.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 75.54 112.508 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.89 -33.93 10.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.31 112.475 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.32 -22.35 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 73.44 110.851 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.37 -92.5 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.691 -0.766 . . . . 73.12 112.476 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 115.06 3.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.267 . . . . 63.12 112.346 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -118.92 154.29 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.879 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -76.85 56.5 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.43 111.128 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.38 -47.08 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 52.33 110.92 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -126.54 108.33 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 70.41 110.92 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -110.21 141.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 72.54 111.156 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -131.3 143.24 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.866 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.755 ' HA ' HG12 ' A' ' 47' ' ' VAL . 18.2 mmm-85 -78.06 135.78 37.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.855 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.8 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.33 111.121 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 74.23 110.908 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 mtpt -130.32 133.44 46.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.01 110.932 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.86 171.63 44.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.479 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -85.63 142.96 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.334 . . . . 73.23 111.163 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -77.81 144.06 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 61.05 111.156 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -29.41 13.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.51 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -177.41 145.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 74.04 110.958 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -138.13 103.37 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 72.5 110.876 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -72.36 106.72 4.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.13 110.886 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.02 -35.95 41.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.12 111.081 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -57.17 -42.58 81.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.889 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -86.77 -33.68 19.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.901 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 22.46 16.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 55.45 112.499 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -130.56 176.39 8.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.958 0.409 . . . . 75.41 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.98 44.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.521 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -141.27 125.25 17.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 75.43 110.872 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 6' ' ' VAL . 21.0 mt -98.06 151.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 72.51 111.095 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 72.55 110.941 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.864 0.364 . . . . 71.44 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.59 143.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 64.34 111.184 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.36 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 54.32 110.874 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -128.75 143.3 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.125 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -118.1 157.14 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.865 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -54.83 -25.45 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.9 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 t -93.62 25.0 3.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 52.4 111.129 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.26 -1.08 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 31.34 111.121 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 65' ' ' VAL . 4.0 mp -88.92 123.3 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 53.02 111.132 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.859 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.843 0.354 . . . . 70.04 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.45 120.19 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.874 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.14 3.2 60.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 74.35 112.437 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.41 156.71 16.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.22 110.909 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.0 m-70 -84.71 139.22 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.42 110.888 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.8 m -158.43 140.17 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.115 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -94.28 126.34 39.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 75.3 110.919 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 16.8 p90 -119.89 143.52 47.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 65.41 110.843 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.62 98.5 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.904 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.874 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.8 m -63.21 125.46 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.3 mm-40 -112.57 160.73 29.38 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 73.03 110.906 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -90.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 62.12 112.354 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.91 58.93 4.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 73.01 112.453 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -41.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 61.22 110.906 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.81 136.1 13.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 44.43 112.525 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.93 -31.81 8.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 65.03 112.463 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -100.41 -22.6 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 73.1 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.58 -91.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 75.03 112.468 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.667 2.244 . . . . 72.11 112.328 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.874 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -119.36 154.81 33.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.53 110.903 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -80.1 61.16 3.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.41 111.111 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -46.75 -41.4 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.13 110.884 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 56.2 mmtt -125.6 110.74 14.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.35 110.909 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -111.97 141.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 62.35 111.133 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -130.87 141.87 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 70.11 110.871 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.753 ' HA ' HG12 ' A' ' 47' ' ' VAL . 23.6 mtp180 -78.38 134.28 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.54 110.918 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.4 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 63.31 111.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 71.24 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.3 mtmt -129.45 129.25 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 41.21 110.891 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.85 41.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 40.04 112.446 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -85.04 145.97 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 70.01 111.147 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -86.72 144.54 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.154 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.0 tppt? -99.25 -30.08 12.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.875 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -175.34 137.17 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 70.44 110.893 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.33 98.88 3.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 73.1 110.861 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -65.98 115.96 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.12 110.888 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.05 -25.34 23.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 63.33 111.077 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.98 -40.57 75.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.879 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -87.02 -38.77 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 64.11 110.918 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.55 34.74 4.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 71.41 112.487 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 2.8 p90 -146.87 169.0 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 71.43 110.913 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.66 177.06 46.15 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 64.23 112.525 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.99 126.29 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 75.45 110.869 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 6' ' ' VAL . 26.4 mt -99.87 152.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 65.34 111.095 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 13.5 mm100 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.12 110.929 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.851 0.357 . . . . 73.01 110.874 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -134.26 144.59 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 40.23 111.131 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.11 119.04 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.53 110.85 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -127.73 140.27 49.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 71.12 111.103 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.537 ' O ' HD12 ' A' ' 33' ' ' ILE . 14.3 m170 -119.98 157.78 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 72.13 110.854 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' HG23 ' A' ' 31' ' ' THR . 2.5 p90 -56.43 -23.93 41.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.915 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.617 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.0 p -93.93 19.96 8.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 64.42 111.153 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.07 -7.93 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 42.34 111.088 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.537 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -87.09 132.24 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 73.14 111.095 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 62.01 110.873 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.785 0.326 . . . . 73.51 110.861 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.49 121.29 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 74.3 110.842 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.58 65.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.487 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -106.57 159.93 15.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 65.24 110.854 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.1 m-70 -87.91 141.53 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 63.44 110.82 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.63 139.77 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 70.22 111.146 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.76 125.67 42.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 61.1 110.854 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.2 p90 -120.99 144.6 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.895 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.43 99.2 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.877 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -62.8 121.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 72.13 111.168 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -103.38 148.98 36.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.666 0.746 . . . . 75.43 110.892 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 64.52 112.383 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 58.13 5.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 73.35 112.491 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -135.38 -40.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 61.21 110.911 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 61' ' ' GLN . . . -83.19 142.3 21.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 62.43 112.501 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.56 -38.05 27.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.768 -0.73 . . . . 64.22 112.504 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -100.45 -17.74 17.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 73.03 110.901 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.12 -98.44 0.21 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 61.15 112.471 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 111.77 2.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 55.34 112.292 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -119.46 165.79 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.31 110.911 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -82.67 58.79 4.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 64.54 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 10.0 ttpt -43.66 -38.81 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.918 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -133.9 104.94 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 53.22 110.898 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.801 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -106.6 142.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 52.02 111.125 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.8 141.29 48.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.1 110.896 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 29.6 ttt180 -77.39 134.58 38.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.846 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.3 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.55 111.115 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.826 0.346 . . . . 52.33 110.865 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -122.0 148.84 44.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 65.11 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -135.42 134.26 39.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.949 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 171.66 44.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 72.03 112.48 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.9 p -83.72 145.25 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 65.15 111.097 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.443 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -85.56 145.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.141 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.3 -29.19 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 62.45 110.88 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -175.57 137.6 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 63.31 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -139.55 98.85 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.25 113.39 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 64.42 110.903 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.12 -21.81 27.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.54 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.46 -51.08 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.917 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -85.23 -36.68 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.923 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.5 40.2 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.15 112.522 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 20.4 p90 -144.57 166.71 24.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 73.5 110.911 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 175.41 46.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 32.41 112.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -141.28 126.68 18.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 61.51 110.859 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.527 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.4 mt -98.28 152.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 63.35 111.133 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.402 ' N ' HG22 ' A' ' 18' ' ' ILE . 12.0 mm100 -124.86 140.48 52.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 63.41 110.887 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.21 -165.96 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 65.2 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -49.52 -29.83 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -107.76 -34.45 6.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 74.1 110.886 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 66.15 1.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 72.43 112.489 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -91.59 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.685 2.257 . . . . 73.33 112.375 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 168.07 101.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 75.53 110.874 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -119.1 143.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.23 111.124 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -98.59 117.7 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.13 110.915 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -126.31 142.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 72.44 111.104 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.524 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.4 m170 -123.15 158.95 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.4 110.829 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG23 ' A' ' 31' ' ' THR . 7.5 p90 -56.36 -22.19 29.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -95.53 20.62 9.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.01 111.161 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.41 -6.16 8.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 70.52 111.102 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -88.82 132.5 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.53 111.11 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.38 86.19 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.24 110.937 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.3 -179.35 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.45 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.23 74.81 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.841 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.56 -117.62 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 73.33 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 40' ' ' THR . 34.6 m-85 -89.92 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 73.35 110.88 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.2 mtm-85 -57.76 100.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.3 110.863 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 38' ' ' PHE . 1.8 t -178.14 159.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 71.31 111.151 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD21 HG11 ' A' ' 65' ' ' VAL . 15.1 mt -108.91 -175.36 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.14 110.908 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -128.32 127.91 43.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 70.34 110.858 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.62 120.42 8.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 45.41 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.84 7.62 66.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 52.34 112.494 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -107.0 160.54 15.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 63.31 110.919 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m-70 -88.8 141.26 28.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.05 110.837 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.22 140.15 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 50.41 111.161 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.54 125.97 42.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 64.2 110.875 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.7 p90 -119.94 146.56 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 74.14 110.864 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -107.55 99.3 8.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 73.05 110.92 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.6 m -63.01 124.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.135 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.06 158.13 40.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.688 0.756 . . . . 75.53 110.85 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.4 Cg_endo -69.8 -88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.652 2.234 . . . . 53.51 112.33 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 56.78 3.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.484 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -132.02 -41.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 74.14 110.864 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.21 135.93 12.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 73.1 112.483 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.76 -34.21 14.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.739 . . . . 71.44 112.467 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -22.37 17.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 74.25 110.941 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.77 -94.38 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 41.44 112.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 114.93 3.87 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 61.13 112.394 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 11.9 tt0 -119.93 157.86 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.927 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.785 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.64 57.54 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 65.44 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.12 -37.8 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.51 110.895 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -131.08 104.27 7.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 62.31 110.859 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.785 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.48 141.71 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 60.44 111.103 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -132.32 143.05 49.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.9 tmm_? -78.76 135.48 37.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.13 110.879 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 62.14 111.141 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.827 0.346 . . . . 43.14 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -129.35 152.45 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 72.3 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 26.8 mtmt -132.71 134.86 45.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.876 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.72 171.65 44.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.776 -0.726 . . . . 72.41 112.507 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 p -80.99 145.42 31.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 50.02 111.143 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.87 144.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 73.25 111.106 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -96.96 -31.28 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 72.51 110.879 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -175.43 139.98 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.916 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HE1' HD11 ' A' ' 33' ' ' ILE . 65.3 t80 -133.63 99.11 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.52 110.88 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.64 101.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.902 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.81 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.13 111.053 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -70.26 -43.93 69.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 64.03 110.894 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -93.37 -34.72 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 72.01 110.882 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.1 45.73 2.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.75 -0.738 . . . . 54.42 112.474 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -157.64 143.24 17.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 74.04 110.976 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.76 -174.21 22.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 72.21 112.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -142.49 127.59 18.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 72.1 110.887 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.9 mt -98.5 151.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 64.41 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 7.4 mm100 -127.64 131.65 49.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -95.93 -165.18 1.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.939 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -48.93 -31.55 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 64.51 110.857 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -106.79 -27.69 10.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.13 110.919 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.62 68.83 1.51 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 72.5 112.507 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -90.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.733 2.289 . . . . 72.23 112.343 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.7 96.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.868 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.57 142.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.133 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.34 115.75 29.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 63.35 110.889 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.793 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.5 m -121.53 144.41 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 65.42 111.127 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.519 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -123.6 159.04 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.881 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -56.16 -21.76 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.892 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 m -97.0 22.57 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.24 111.143 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.67 -6.38 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 62.22 111.086 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.9 mp -89.66 132.43 34.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 51.43 111.132 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -116.49 86.52 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 33.51 110.871 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.3 179.57 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 74.3 111.118 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -87.23 78.12 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 45.3 110.864 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.46 -118.17 3.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 52.41 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -64.35 110.16 2.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 71.43 110.894 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -75.07 76.34 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 74.04 110.841 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.6 p -149.44 170.2 19.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.04 111.146 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD22 HG11 ' A' ' 47' ' ' VAL . 17.6 mt -114.59 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -124.46 127.72 47.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 74.13 110.897 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -58.0 119.35 6.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 52.04 110.878 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.67 6.19 62.52 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.689 -0.767 . . . . 63.41 112.502 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -106.83 160.11 15.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.53 110.885 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.8 m-70 -88.69 141.79 28.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.868 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.6 m -158.48 140.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 71.25 111.177 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.6 tt0 -99.03 127.0 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 71.22 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.8 p90 -118.07 149.05 41.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 64.32 110.88 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -106.42 98.82 8.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 70.24 110.865 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.838 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -53.29 125.38 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 54.12 111.153 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.6 tp10 -111.1 138.95 21.36 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 71.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -90.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.65 2.234 . . . . 64.21 112.325 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.72 53.84 4.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 42.3 112.515 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 -40.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 70.14 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.62 135.58 15.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 73.23 112.486 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.33 -36.85 17.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.734 . . . . 62.35 112.501 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -19.37 16.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.21 110.877 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.11 -102.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 44.43 112.439 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 113.3 3.32 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 42.21 112.33 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.838 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -119.28 174.86 6.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.878 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -91.1 59.18 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.12 111.106 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 13.9 tppt? -40.79 -44.42 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 71.54 110.869 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -129.0 107.63 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 63.4 110.864 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.78 142.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 63.21 111.13 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -132.0 141.53 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.86 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.758 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.01 136.03 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.85 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.9 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.32 111.147 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.348 . . . . 63.44 110.85 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -135.02 153.96 51.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.887 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 21.3 mtmm -127.53 134.15 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 72.3 110.926 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.81 171.53 42.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.738 . . . . 61.44 112.465 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.6 p -83.28 146.32 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 74.01 111.149 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 144.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.106 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -29.51 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.24 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -172.79 138.95 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.899 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 33' ' ' ILE . 62.8 t80 -140.57 98.05 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 70.22 110.898 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.16 105.33 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 54.11 110.903 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.19 -30.26 43.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.3 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -71.46 -37.1 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.905 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.2 -40.21 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.907 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.89 5.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 44.32 112.458 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -149.96 170.74 18.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 73.4 110.913 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.99 178.46 46.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 62.23 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -142.93 125.13 15.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 63.42 110.885 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.2 mt -98.24 150.9 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 74.32 111.111 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -122.94 127.13 48.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.923 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.67 -167.54 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.43 110.958 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -46.72 -35.07 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 64.43 110.925 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -103.76 -17.52 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.874 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.32 64.43 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 71.42 112.496 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.712 2.274 . . . . 73.43 112.345 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.66 95.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 72.04 110.852 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.2 142.37 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 75.22 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.97 116.76 31.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.864 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.9 m -122.54 140.78 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 62.14 111.133 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.7 m-70 -119.15 158.49 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -56.08 -23.23 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 70.13 110.89 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m -95.74 22.19 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 75.21 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.18 -6.41 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 55.11 111.097 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -89.18 131.97 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.139 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.85 86.41 2.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.923 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.92 179.72 5.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.31 111.083 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -96.49 74.46 2.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 75.04 110.838 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.12 -117.76 0.82 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 65.11 112.498 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 40' ' ' THR . 10.6 m-85 -94.71 120.07 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 75.03 110.903 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -59.52 97.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.54 110.901 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 38' ' ' PHE . 2.0 t -178.24 159.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.141 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.82 HD13 HG21 ' A' ' 47' ' ' VAL . 13.0 mt -108.78 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 75.34 110.922 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -127.95 128.91 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.43 110.898 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.8 121.46 10.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.927 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.71 68.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.31 112.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.68 160.56 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.36 . . . . 71.14 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.6 m-70 -89.32 142.25 27.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.877 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.82 HG21 HD13 ' A' ' 41' ' ' LEU . 2.4 m -158.74 140.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.33 111.092 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -97.14 127.85 43.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 60.01 110.87 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.88 146.71 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 65.34 110.912 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.02 97.25 7.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.911 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 61.4 t -52.05 130.14 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 73.34 111.183 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.1 tp10 -118.11 137.7 24.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 74.22 110.871 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -91.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 71.44 112.349 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.38 4.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.721 . . . . 73.31 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -39.98 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 75.33 110.884 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.2 136.79 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 72.41 112.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.41 -35.2 14.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 63.4 112.446 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -18.7 14.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 73.32 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.05 -103.44 0.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.481 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' CB ' HG13 ' A' ' 51' ' ' VAL . 53.3 Cg_endo -69.79 110.64 2.61 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 61.21 112.33 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.793 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.2 pt20 -118.35 173.68 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.11 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -90.87 61.55 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 55.42 111.089 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -39.12 -42.78 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 71.13 110.903 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 1.3 tttt -131.54 110.74 11.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.909 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.721 HG11 HD21 ' A' ' 41' ' ' LEU . 1.1 t -108.77 142.11 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 73.4 111.151 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.02 110.884 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 52.0 ttt180 -78.06 134.76 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 64.45 110.92 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.34 111.115 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.812 0.339 . . . . 64.2 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -129.98 153.73 48.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 72.43 110.875 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.6 mtmt -128.66 134.72 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 62.21 110.893 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.56 44.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.482 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 p -85.15 148.49 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 45.32 111.146 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.27 144.8 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 73.23 111.114 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.07 -29.65 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.899 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -176.16 137.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.929 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -136.67 99.39 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 74.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -72.37 111.39 7.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.85 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.45 -32.78 42.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 71.43 111.118 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.84 -50.81 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -77.77 -29.81 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 70.52 110.868 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.83 32.7 10.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 73.54 112.477 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -140.12 169.19 18.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 64.31 110.917 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.32 172.97 45.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 70.02 112.512 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -141.45 129.11 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 74.55 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 49' ' ' PHE . 27.8 mt -97.22 144.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 53.51 111.103 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.71 112.35 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.34 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -77.99 -166.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 71.1 110.884 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -48.03 -33.71 8.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 73.3 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -106.23 -22.4 12.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 72.33 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.8 69.7 1.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 55.22 112.501 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -89.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 63.45 112.307 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.33 96.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.42 110.921 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -116.87 145.91 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 72.04 111.151 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.02 117.52 35.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 30.42 110.84 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.676 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.47 142.44 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 55.23 111.147 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.436 ' O ' HD12 ' A' ' 33' ' ' ILE . 7.4 m170 -116.92 157.08 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 55.22 110.894 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -56.01 -24.55 39.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 63.35 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -93.83 20.88 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.099 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.74 -1.88 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 64.21 111.11 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.631 HG12 HD13 ' A' ' 41' ' ' LEU . 4.7 mp -90.3 127.97 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 63.52 111.106 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.45 85.83 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.92 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' HB1' ' HE ' ' A' ' 67' ' ' ARG . . . -120.23 166.35 13.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.15 111.084 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.83 74.91 10.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.52 110.896 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.44 -117.64 3.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 74.21 112.502 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -67.93 109.94 3.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 73.33 110.843 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -76.4 117.84 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.05 110.862 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.1 t -177.84 154.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 75.21 111.133 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 33' ' ' ILE . 3.4 mp -110.2 170.04 8.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 62.43 110.906 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -121.06 126.39 49.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.868 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -58.68 115.99 3.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.871 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.15 7.42 54.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.15 112.49 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.97 158.95 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.54 110.889 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.533 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.7 m-70 -88.48 141.56 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.32 110.866 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -158.85 139.86 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 73.44 111.131 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.2 tt0 -97.42 126.18 42.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 75.44 110.871 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.7 p90 -121.14 147.08 46.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 55.22 110.885 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 9.8 mt-10 -107.53 99.03 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 70.34 110.891 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.0 m -64.65 125.38 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.14 111.106 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -114.3 158.96 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 71.4 110.918 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -89.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.244 . . . . 74.41 112.33 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.57 57.19 3.79 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 64.43 112.438 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 5.9 tpp180 -132.51 -41.6 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 75.31 110.878 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.23 139.04 14.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 62.45 112.529 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -38.59 23.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 60.02 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -22.09 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 75.41 110.886 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.2 -93.16 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 71.11 112.487 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 114.42 3.7 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 52.31 112.352 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.1 tt0 -119.5 157.06 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 72.12 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.62 58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.11 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -43.67 3.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 60.33 110.887 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.0 mtpp -129.53 109.06 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.897 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.22 142.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.3 111.134 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -131.87 143.39 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.912 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.7 mtm105 -78.17 135.92 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.821 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.51 111.115 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.817 0.341 . . . . 75.3 110.874 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -134.87 156.48 48.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.32 110.877 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.3 mtpm? -129.24 136.72 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.875 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.9 172.08 44.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 75.55 112.438 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -82.65 151.06 26.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 64.24 111.138 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.37 147.05 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 63.34 111.137 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -98.95 -34.51 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.3 110.919 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -168.5 139.19 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.912 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.425 ' HE2' ' HG1' ' A' ' 40' ' ' THR . 68.3 t80 -138.29 98.53 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 74.31 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.69 115.13 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 74.14 110.924 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.94 -33.09 24.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 70.24 111.099 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.75 -49.92 71.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.884 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -77.72 -29.67 51.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.913 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 33.4 10.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 71.12 112.484 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.7 169.95 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 74.11 110.924 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 170.81 43.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 63.21 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -141.4 125.18 16.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 71.23 110.886 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -98.85 151.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 75.23 111.142 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 10.3 mm100 -124.12 121.53 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 70.45 110.942 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -86.69 -166.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.911 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.05 -34.45 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.899 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -105.4 -18.58 14.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.918 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.7 64.73 3.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.741 . . . . 70.13 112.505 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.254 . . . . 73.31 112.364 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.69 94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 60.41 110.838 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.6 143.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.071 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.8 118.73 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.879 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -129.39 143.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 64.11 111.12 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 33' ' ' ILE . 13.9 m170 -120.39 157.31 29.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 75.32 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -55.72 -24.68 36.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 62.21 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -94.43 22.74 5.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 61.34 111.169 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.19 -0.14 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 50.21 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.8 mp -91.16 130.61 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 72.04 111.149 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -116.88 86.68 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 55.01 110.856 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.68 179.83 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.22 111.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -110.21 93.6 4.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.874 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.31 -117.63 3.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 54.34 112.508 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.11 110.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 64.24 110.887 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -76.7 78.5 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 75.14 110.836 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.425 ' HG1' ' HE2' ' A' ' 9' ' ' PHE . 8.8 t -172.13 167.06 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 62.23 111.157 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.042 HD21 HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -108.69 172.51 6.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.931 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.8 126.6 44.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.903 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 124.09 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 55.52 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.03 6.41 69.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 62.51 112.509 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -102.47 157.31 17.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 70.53 110.872 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.3 m-70 -87.93 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 71.11 110.835 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.042 HG21 HD21 ' A' ' 41' ' ' LEU . 3.1 m -159.11 141.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 61.33 111.12 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.3 tt0 -94.24 125.42 38.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -118.37 142.61 47.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 64.22 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 78.1 mt-10 -106.2 98.07 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.896 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.0 m -63.79 122.5 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.147 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.86 160.39 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.661 0.743 . . . . 62.32 110.845 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 75.22 112.305 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 55.7 3.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 74.22 112.446 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -130.59 -41.68 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 73.15 110.866 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.13 140.42 15.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 75.04 112.478 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.52 -44.95 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 55.45 112.479 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -85.15 -22.18 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 72.04 110.851 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -90.88 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 75.12 112.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 114.2 3.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 74.24 112.353 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.856 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -121.96 156.53 33.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.915 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.709 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.3 58.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -44.56 -36.19 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 4.2 ttpt -130.74 106.95 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.709 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.25 142.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 54.51 111.104 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -131.15 142.61 50.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.897 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.757 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.19 133.15 36.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.856 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 44.14 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -132.07 152.95 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.1 110.924 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.2 mtpt -135.16 134.74 40.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.426 . . . . 62.22 110.901 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.23 171.8 44.89 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 72.41 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.5 p -81.46 146.31 30.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 73.41 111.124 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.791 HG21 ' CD1' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -87.71 145.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.43 111.084 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -97.96 -29.31 13.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 65.32 110.908 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -175.57 144.73 0.68 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 72.25 110.917 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' HD21 ' A' ' 41' ' ' LEU . 71.7 t80 -144.94 98.85 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 72.43 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -68.84 117.64 10.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 74.44 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.68 -24.02 21.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.51 111.121 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.38 -45.01 93.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.22 110.842 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -90.79 -37.84 13.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.34 110.944 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 42.53 2.21 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.731 -0.747 . . . . 50.44 112.505 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -144.75 168.18 20.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 70.4 110.936 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 174.43 46.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.475 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -142.32 125.34 16.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.3 mt -98.44 152.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.54 111.103 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 18' ' ' ILE . 8.9 mm100 -127.83 135.05 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 64.21 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -100.24 -165.76 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 70.01 110.907 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -48.19 -32.14 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 60.22 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -104.69 -26.76 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 64.02 110.86 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.66 66.86 2.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 63.44 112.521 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -90.22 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.695 2.264 . . . . 71.4 112.354 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.93 96.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 60.4 110.844 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -112.61 145.25 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 74.13 111.102 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.19 116.85 33.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -125.14 143.39 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 61.23 111.18 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.3 m170 -121.71 159.41 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 60.21 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -56.63 -22.46 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 62.12 110.875 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -95.48 21.46 8.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.65 -3.63 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.45 111.086 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 29' ' ' HIS . 5.0 mp -90.24 132.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.175 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.37 86.27 2.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.899 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.88 -179.33 3.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 74.52 111.117 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.04 77.09 4.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 72.21 110.864 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.9 -117.62 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 73.1 112.493 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -57.67 137.51 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.363 . . . . 73.53 110.916 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -96.92 94.09 7.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.848 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 t -174.59 157.26 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.12 111.133 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.791 ' CD1' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.75 -178.03 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.912 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -121.37 127.44 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.866 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.16 130.24 45.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 72.34 110.894 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 6.77 88.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 44.01 112.493 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.36 160.3 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 54.22 110.891 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.5 m-70 -87.03 141.0 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 73.01 110.857 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.56 140.79 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.118 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 24.8 tt0 -97.65 125.75 42.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 64.21 110.871 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.1 p90 -119.54 146.05 45.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.35 110.907 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -106.07 98.22 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.91 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 21.9 m -63.66 124.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 71.51 111.143 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.61 160.67 35.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.618 0.723 . . . . 34.21 110.863 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.692 2.261 . . . . 72.12 112.328 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.43 57.3 3.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 73.03 112.477 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.6 -41.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 71.51 110.875 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.86 137.54 13.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.76 . . . . 71.22 112.487 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.39 18.1 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 24.05 112.477 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.7 -22.89 19.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 74.34 110.86 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -93.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 73.54 112.517 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 114.92 3.87 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 61.21 112.315 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.9 tt0 -119.7 158.0 27.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.911 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.94 58.25 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 65.42 111.08 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -43.56 -38.02 2.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.893 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -132.17 106.17 7.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.882 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.769 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.36 142.07 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 61.45 111.112 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -131.92 142.87 49.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.906 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.74 134.79 37.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 71.34 110.855 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.6 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 73.34 111.162 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 71.3 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -130.27 153.02 49.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 64.35 110.896 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.6 mtmt -126.45 134.2 51.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.892 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 171.73 43.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.24 112.536 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -85.64 142.95 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 71.15 111.16 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.78 144.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.151 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -31.76 11.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 50.21 110.93 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -174.72 138.56 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.54 110.917 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' HE2' HG23 ' A' ' 40' ' ' THR . 67.4 t80 -138.04 99.28 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.869 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -73.01 116.58 13.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.896 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.77 -20.34 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 75.24 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.77 -54.92 35.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -84.34 -35.61 23.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.74 39.46 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 70.34 112.458 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -143.92 163.57 33.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 72.14 110.917 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.95 175.83 43.9 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 74.32 112.498 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -141.85 128.22 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 72.4 110.846 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.5 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.9 mt -97.7 148.77 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 60.22 111.112 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -121.19 117.01 26.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.919 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.91 -166.92 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.66 -34.13 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.51 110.888 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -105.82 -17.46 14.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 72.53 110.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.24 65.93 3.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 50.22 112.509 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 63.01 112.35 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.45 90.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.866 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.628 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -107.29 144.64 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 54.51 111.141 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -99.15 119.96 38.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 64.13 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -130.52 143.33 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.44 111.109 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.499 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m170 -119.0 156.17 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 62.41 110.852 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.626 ' CZ ' HG23 ' A' ' 31' ' ' THR . 3.3 p90 -55.39 -25.12 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.871 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.626 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.5 p -94.22 22.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 71.15 111.125 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.23 -1.89 8.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 73.32 111.062 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.516 HG12 HD13 ' A' ' 41' ' ' LEU . 4.8 mp -92.3 130.72 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 71.24 111.158 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.78 86.14 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 72.42 110.884 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.25 175.36 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 70.13 111.086 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.23 74.64 10.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.32 110.9 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.71 -117.45 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 55.23 112.474 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -69.89 110.03 4.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.844 0.354 . . . . 75.12 110.874 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.56 101.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 62.01 110.867 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HE2' ' A' ' 9' ' ' PHE . 3.5 m -161.7 150.13 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 65.52 111.115 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.673 ' HG ' HG11 ' A' ' 47' ' ' VAL . 2.4 mp -109.02 170.6 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.89 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -123.3 126.69 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.861 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -58.46 119.03 6.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 45.11 110.921 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.15 6.57 58.89 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.754 -0.736 . . . . 64.23 112.494 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -105.18 159.87 15.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 64.14 110.848 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -87.82 140.58 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.11 110.842 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.1 m -157.99 139.76 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.23 111.111 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 26.6 tt0 -96.64 126.29 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.851 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 18' ' ' ILE . 20.5 p90 -120.46 143.31 48.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.861 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -105.09 97.33 7.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.32 124.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 62.5 111.129 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -108.88 157.47 36.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.624 0.726 . . . . 70.42 110.93 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.227 . . . . 60.3 112.361 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.66 57.09 4.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 51.34 112.477 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 7.1 tpt180 -132.18 -39.34 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 60.25 110.899 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -93.63 133.62 11.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.781 -0.723 . . . . 61.21 112.483 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.57 8.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 71.44 112.528 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.51 -23.9 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 75.01 110.886 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.69 -93.12 0.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.731 . . . . 51.24 112.511 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 116.59 4.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.66 2.24 . . . . 71.05 112.349 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.843 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.3 tm0? -122.3 150.89 41.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.23 110.909 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -74.52 59.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 55.43 111.135 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -46.44 -37.87 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.5 110.897 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 104.51 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.03 110.86 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.79 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.18 140.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 63.53 111.12 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -131.58 143.37 50.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.2 110.889 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 6.4 ptm180 -78.87 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.891 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.164 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.849 0.357 . . . . 73.51 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -132.37 151.11 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 62.21 110.938 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.8 mtmp? -125.94 133.3 51.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.13 110.922 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.11 171.42 42.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 64.31 112.529 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -87.34 145.88 26.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 71.55 111.166 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.6 145.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.107 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.8 tptt -99.49 -29.79 12.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 64.34 110.918 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -175.72 137.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 64.45 110.937 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' HE2' HG22 ' A' ' 40' ' ' THR . 54.5 t80 -135.12 97.93 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.52 110.876 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.51 92.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 70.12 110.844 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.95 74.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 51.31 111.111 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.11 -43.9 90.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.874 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -78.83 -38.37 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.887 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 25.9 7.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 62.3 112.485 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -140.87 169.66 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 75.42 110.978 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.94 172.39 45.06 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.746 . . . . 52.2 112.499 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 74.03 110.879 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.504 ' CD1' HG11 ' A' ' 28' ' ' VAL . 26.2 mt -98.19 152.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 73.35 111.165 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 11.9 mm100 -123.9 124.03 41.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.31 110.92 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -166.9 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.924 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -47.68 -33.58 7.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 61.34 110.915 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -106.77 -16.6 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.21 110.867 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.41 63.55 4.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 75.01 112.534 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.697 2.265 . . . . 71.2 112.355 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.68 101.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.922 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.657 ' CG2' HG12 ' A' ' 51' ' ' VAL . 2.2 p -117.42 139.5 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 74.45 111.148 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.8 115.73 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 35.42 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -125.88 144.64 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 65.34 111.145 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.456 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m-70 -121.23 156.77 31.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.4 110.828 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -54.69 -24.71 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 71.21 110.826 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -94.98 24.95 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.22 111.112 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.71 -0.38 6.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 74.13 111.127 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -91.43 126.74 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 61.13 111.148 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -112.98 86.36 2.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 70.11 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.81 -179.73 3.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.057 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -99.1 74.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.21 110.886 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.54 -118.42 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 75.51 112.525 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.2 114.02 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 71.3 110.928 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 40' ' ' THR . 17.7 mmt180 -77.82 90.43 4.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 63.21 110.871 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.622 HG22 ' HE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -161.94 164.35 28.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 62.4 111.105 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.69 153.92 30.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 70.23 110.909 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' H ' HD13 ' A' ' 41' ' ' LEU . 39.6 m-80 -109.94 125.94 53.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 52.23 110.901 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 72.04 110.894 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.27 8.27 60.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.12 112.511 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.7 158.56 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.918 0.389 . . . . 60.53 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.538 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-70 -88.29 140.25 29.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.806 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.82 140.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 75.43 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.7 tt0 -95.66 125.07 39.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.874 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CD1' HG21 ' A' ' 18' ' ' ILE . 25.5 p90 -118.86 144.33 46.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.859 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.1 mm-40 -105.9 97.79 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 74.53 110.889 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.849 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.5 m -64.13 117.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 43.3 111.125 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -108.65 160.17 28.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.662 0.744 . . . . 73.55 110.92 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 51.34 112.325 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 55.79 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 73.25 112.522 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -130.72 -41.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 73.1 110.895 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.01 142.19 15.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 64.34 112.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.51 -47.1 29.51 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 71.32 112.504 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.8 -22.72 34.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 74.34 110.916 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.13 -89.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 62.54 112.484 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 116.51 4.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.646 2.231 . . . . 75.52 112.367 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.9 tt0 -123.79 157.6 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.33 57.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.31 111.109 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -44.44 -37.57 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 62.51 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -130.67 104.86 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 71.42 110.927 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -107.76 141.55 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.12 111.155 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -131.43 142.7 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.837 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.765 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.1 ppt_? -78.44 134.37 37.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.896 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.571 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.2 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 70.32 111.163 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.85 0.357 . . . . 74.44 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -125.52 152.18 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 74.13 110.915 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 14.9 mttp -133.06 137.88 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.956 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.96 171.51 44.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.702 -0.761 . . . . 74.42 112.461 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 p -85.55 144.12 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 74.1 111.109 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.3 144.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 54.44 111.123 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -99.48 -30.2 12.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 71.04 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -175.19 139.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.8 99.41 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 74.14 110.901 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -69.59 93.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.03 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.53 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 62.02 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -67.16 -35.86 80.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.845 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -94.04 -36.97 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.14 32.53 4.92 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 74.45 112.477 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -146.28 168.12 21.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.888 0.375 . . . . 74.25 110.947 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.66 179.03 46.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.746 -0.74 . . . . 71.51 112.464 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -142.35 130.69 22.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 71.31 110.895 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.594 HD13 ' CD1' ' A' ' 49' ' ' PHE . 28.5 mt -97.09 144.21 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 74.02 111.117 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.25 110.99 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.9 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.64 -167.34 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 51.41 110.912 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -49.69 -31.92 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.44 110.956 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -106.68 -21.48 13.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 42.02 110.862 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.47 69.33 1.37 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 32.42 112.48 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.634 2.223 . . . . 74.41 112.369 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.78 94.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.4 142.77 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.35 111.127 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.26 116.3 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.897 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.766 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.6 m -122.99 141.33 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 71.23 111.133 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -121.55 159.83 25.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 70.52 110.819 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -56.66 -22.32 33.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.853 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -94.37 19.78 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.12 111.12 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.83 -7.97 8.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.43 111.117 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -88.66 132.79 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.23 111.149 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -112.98 86.11 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.35 178.64 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 75.15 111.07 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.91 75.32 7.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 62.34 110.887 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.72 -117.66 3.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 54.41 112.503 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.3 110.05 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 73.51 110.869 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 33' ' ' ILE . 30.6 mtm180 -76.7 67.33 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 71.51 110.842 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.4 p -146.24 166.09 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 53.55 111.175 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.76 HD22 HG11 ' A' ' 47' ' ' VAL . 10.6 mt -108.91 -175.93 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -126.1 127.99 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 61.35 110.918 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.68 117.64 4.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.875 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.88 7.06 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 44.54 112.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.15 160.41 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 75.55 110.892 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.521 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.4 m-70 -89.05 141.78 28.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.53 110.812 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.9 m -158.37 139.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 53.12 111.178 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.8 tt0 -98.17 126.4 43.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.88 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 18' ' ' ILE . 34.5 p90 -119.72 146.65 45.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.85 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 38.4 mt-10 -105.0 98.88 8.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 75.11 110.857 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -52.04 128.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 72.23 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.477 ' H ' ' H ' ' A' ' 61' ' ' GLN . 3.0 tp10 -112.58 138.57 22.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.661 0.743 . . . . 74.25 110.874 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 72.14 112.372 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.32 53.71 4.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 72.35 112.437 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -134.74 -40.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 71.52 110.854 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.53 134.59 13.91 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.735 . . . . 75.24 112.504 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.66 -36.81 13.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 41.44 112.504 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -100.62 -19.31 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 61.01 110.895 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.88 -103.07 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 52.11 112.5 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 113.22 3.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.695 2.263 . . . . 71.4 112.324 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.0 pt20 -119.32 175.99 5.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.03 110.944 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -93.23 62.6 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.43 111.075 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -46.21 -38.82 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.22 110.934 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 5.7 tmtt? -132.12 104.92 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.14 110.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.53 141.38 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 70.23 111.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -131.65 142.08 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 71.32 110.879 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.764 ' HA ' HG12 ' A' ' 47' ' ' VAL . 22.8 ptt85 -77.62 135.64 38.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.866 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.1 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.146 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttm . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.799 0.333 . . . . 54.12 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -127.36 155.8 43.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 62.32 110.928 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.3 mtmm -127.05 131.17 51.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.13 172.29 39.91 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.738 -0.744 . . . . 54.13 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.5 p -86.49 141.13 29.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 64.22 111.11 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -81.58 144.83 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.04 111.14 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -30.59 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 70.22 110.881 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -175.9 138.9 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.945 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' HE1' HD11 ' A' ' 33' ' ' ILE . 62.2 t80 -131.74 99.08 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -68.62 90.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 55.35 110.868 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.14 67.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.04 111.078 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -65.73 -46.73 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 63.15 110.875 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -77.21 -34.13 56.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.887 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.1 19.46 14.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 60.12 112.481 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -138.87 173.78 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 65.35 110.876 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.82 174.59 45.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 52.25 112.465 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -141.38 125.26 17.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 60.45 110.845 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 HG12 HG23 ' A' ' 6' ' ' VAL . 25.2 mt -98.02 152.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 62.23 111.094 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -109.42 128.76 55.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.89 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.51 150.71 48.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 71.12 110.895 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.32 -6.59 58.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 71.4 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -115.32 2.15 13.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 44.31 110.907 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.22 77.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 74.21 112.501 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -161.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 75.35 112.366 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.1 t0 55.44 77.2 0.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 75.35 110.875 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.624 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -125.68 148.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 60.31 111.113 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.5 118.96 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.87 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -131.06 142.29 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 73.0 111.11 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 4.5 m170 -121.54 157.58 30.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.843 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CZ ' HG23 ' A' ' 31' ' ' THR . 6.1 p90 -56.28 -24.28 42.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.883 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -93.93 20.28 7.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.2 111.147 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.91 -5.47 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.11 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.5 mp -89.38 132.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 72.21 111.154 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -113.85 86.36 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.11 110.912 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.21 177.19 6.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 74.43 111.118 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.58 75.36 4.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 61.54 110.882 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.06 1.75 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 61.44 112.515 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -75.66 112.75 12.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 73.01 110.872 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -67.86 99.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 72.24 110.904 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -177.43 162.58 1.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.13 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD13 HG21 ' A' ' 47' ' ' VAL . 13.0 mt -108.87 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 71.14 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -129.07 129.67 45.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.909 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.03 119.77 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 54.41 110.868 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.65 64.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.512 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -106.89 160.79 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 74.11 110.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.535 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -89.37 142.31 27.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 61.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.917 HG21 HD13 ' A' ' 41' ' ' LEU . 2.5 m -159.09 140.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.086 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.9 tt0 -96.07 125.73 40.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.34 110.855 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 25.0 p90 -121.27 143.23 49.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.12 110.861 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.94 98.06 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 55.34 110.894 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.7 m -64.19 118.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 73.05 111.156 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.91 158.16 33.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.629 0.728 . . . . 71.41 110.909 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -88.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 2.252 . . . . 70.13 112.339 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.96 55.92 3.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 70.45 112.454 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -133.35 -41.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 74.51 110.885 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.44 134.91 12.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 53.12 112.494 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.87 -34.32 11.02 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.742 -0.742 . . . . 54.45 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -21.38 16.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.34 110.922 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.44 -93.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 74.25 112.518 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.6 4.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.644 2.23 . . . . 71.32 112.373 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -122.23 154.34 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.3 110.899 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.779 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.26 57.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 64.22 111.099 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -38.81 5.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.911 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 11.7 tttp -129.61 103.35 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.905 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.779 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.59 142.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.34 111.103 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -132.8 143.02 49.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.927 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 35.7 mtp180 -78.66 134.23 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.854 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.1 111.118 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.819 0.342 . . . . 53.22 110.881 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -131.97 155.83 47.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 51.44 110.907 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -128.41 137.62 51.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 52.42 110.872 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.57 171.45 44.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 63.32 112.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 p -81.52 156.65 25.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 70.14 111.162 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -99.57 143.41 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 63.31 111.124 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -97.35 -28.68 13.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.9 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -174.77 138.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 72.1 110.901 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.473 ' CE1' HD11 ' A' ' 33' ' ' ILE . 69.7 t80 -136.11 98.96 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.869 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.35 110.908 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.52 -27.85 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.082 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.67 -40.9 96.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.872 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -94.88 -37.33 11.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 55.32 110.938 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 46.31 1.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 53.11 112.466 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -157.53 142.94 17.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 72.12 110.905 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.62 -176.41 25.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 63.15 112.494 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -141.2 132.57 26.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 74.21 110.866 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.7 mt -106.53 149.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 73.2 111.159 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.36 116.75 8.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 64.53 110.912 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -82.85 -162.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.2 110.902 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.14 -35.6 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.888 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -91.68 -30.79 16.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.886 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.36 64.32 4.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 73.44 112.495 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.728 2.285 . . . . 62.24 112.322 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.53 100.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 53.4 110.866 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.688 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -121.68 141.46 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.02 111.146 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.31 116.29 31.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.882 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -121.05 145.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 75.55 111.128 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 m-70 -124.64 159.36 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.88 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -55.48 -23.18 24.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.903 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -95.81 23.81 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 72.52 111.121 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.23 -3.0 6.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 60.21 111.094 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.517 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -91.74 131.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.103 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.27 86.26 2.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 62.51 110.897 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.3 -179.51 4.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 74.24 111.102 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.5 74.97 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.862 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.61 -117.65 1.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 62.23 112.481 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -84.98 118.52 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.03 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 104.1 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.31 110.859 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 t -178.13 159.81 1.33 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.107 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 47' ' ' VAL . 25.9 mt -108.92 -176.31 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -126.12 127.84 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 62.32 110.931 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.83 122.7 13.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 61.54 110.9 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.38 76.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 63.03 112.492 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -106.73 160.39 15.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.947 0.403 . . . . 74.43 110.838 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -89.1 141.07 28.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 73.5 110.826 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 41' ' ' LEU . 3.5 m -158.5 140.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.01 111.136 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.2 tt0 -95.39 127.54 41.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 64.14 110.887 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -119.73 144.58 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 74.22 110.86 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -106.8 97.18 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.863 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.829 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.1 m -60.8 127.81 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 75.42 111.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -121.69 158.86 53.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.632 0.73 . . . . 55.34 110.903 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -88.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.732 2.288 . . . . 64.21 112.312 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.83 57.43 3.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 73.22 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.62 -42.01 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 75.41 110.858 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.91 138.24 13.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 71.25 112.517 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -39.88 21.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 54.22 112.455 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.46 -25.04 25.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 71.01 110.862 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.54 -92.67 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 65.13 112.475 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.11 3.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.677 2.251 . . . . 71.13 112.32 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.829 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -118.24 158.12 25.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.892 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.91 57.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 70.31 111.121 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -39.67 -43.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 53.23 110.937 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.8 mttt -126.63 108.35 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.918 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG11 HD21 ' A' ' 41' ' ' LEU . 1.2 t -108.32 141.44 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 52.52 111.152 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -131.6 142.28 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 62.14 110.88 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.749 ' HA ' HG12 ' A' ' 47' ' ' VAL . 45.2 ttt-85 -79.22 134.92 36.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 62.41 110.889 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.3 111.126 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.833 0.349 . . . . 71.44 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -123.53 149.24 45.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 52.33 110.906 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 12.3 mtpt -133.37 133.78 42.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.898 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.55 171.53 44.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 73.44 112.453 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -85.61 142.12 29.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 72.23 111.168 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.82 144.57 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 64.12 111.118 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -30.77 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.879 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -176.51 137.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.913 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -134.83 98.9 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.87 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.15 93.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 62.41 110.855 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.33 -31.46 70.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.42 111.097 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -65.47 -41.41 93.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 65.43 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -83.63 -38.5 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.909 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 26.64 7.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 61.51 112.472 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.91 169.01 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 74.14 110.9 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.66 173.63 45.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 51.14 112.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -141.93 128.92 20.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 61.22 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 49' ' ' PHE . 29.1 mt -97.08 146.5 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 42.2 111.094 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -121.69 123.21 41.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 64.34 110.877 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.41 -167.06 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 73.13 110.871 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.23 -33.61 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.926 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -106.36 -22.69 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.12 110.885 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.13 67.89 1.82 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 62.13 112.444 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -89.69 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 71.12 112.343 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 169.9 95.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 60.32 110.874 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.478 ' CG2' HG12 ' A' ' 51' ' ' VAL . 3.1 p -113.27 138.39 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.35 111.179 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.75 115.89 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.17 143.42 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.12 111.107 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -118.39 158.52 25.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 63.4 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -56.0 -25.09 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.858 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.47 22.09 5.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.17 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.18 -0.99 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 52.22 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 65' ' ' VAL . 5.0 mp -93.13 130.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.2 111.146 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.62 86.48 2.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.876 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.43 -179.11 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 72.2 111.128 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.94 75.01 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 73.11 110.887 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.67 -117.64 3.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.797 -0.716 . . . . 73.45 112.523 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -74.11 110.06 8.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 64.54 110.867 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -68.16 108.13 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 75.25 110.923 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -160.67 148.5 16.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.144 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -109.23 152.96 24.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.54 110.906 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' H ' HD13 ' A' ' 41' ' ' LEU . 18.5 m-80 -112.57 126.2 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 60.11 110.905 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -59.75 118.38 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.25 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 6.62 57.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 73.32 112.527 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.66 158.4 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 70.32 110.86 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.531 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.0 m-70 -87.5 141.54 28.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 62.03 110.874 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.57 139.97 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.091 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 28.4 tt0 -97.47 125.11 41.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 65.42 110.875 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 18' ' ' ILE . 27.6 p90 -120.57 144.41 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.887 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.63 97.36 7.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.02 110.899 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.852 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -62.91 122.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 73.11 111.102 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -111.98 159.18 34.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.658 0.742 . . . . 74.11 110.921 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 71.5 112.356 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.96 57.92 4.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 74.44 112.455 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -130.52 -41.88 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.34 110.855 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.93 137.08 13.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 50.11 112.468 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -35.52 14.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.724 -0.75 . . . . 61.44 112.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -91.34 -25.24 19.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 73.42 110.949 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.28 -91.79 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.742 -0.742 . . . . 72.43 112.501 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 116.55 4.62 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.653 2.236 . . . . 71.12 112.354 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.852 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 tt0 -118.26 156.51 28.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.01 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.54 58.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 41.4 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -40.89 -42.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.21 110.911 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 16.0 tttp -134.03 108.26 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.33 110.901 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -107.11 141.8 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.133 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -131.75 142.75 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.3 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -77.96 134.89 37.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.912 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.5 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.123 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.867 0.365 . . . . 65.43 110.849 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -129.35 155.66 45.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 64.31 110.892 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.6 mttt -129.9 137.37 50.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.899 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.45 171.35 44.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 61.42 112.504 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -88.82 138.99 30.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 65.11 111.112 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 145.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 64.3 111.136 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -101.05 -27.78 13.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.918 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -176.01 140.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 65.34 110.891 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -135.78 99.41 4.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 73.12 110.849 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -67.66 117.4 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.3 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.41 18.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.53 111.115 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -59.93 -31.85 70.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.32 110.898 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -107.88 -33.78 7.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.92 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.95 40.37 2.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 71.13 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.3 p90 -142.52 173.85 11.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 74.34 110.932 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.06 174.61 46.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 74.22 112.487 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -140.58 126.65 19.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 62.52 110.89 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 28' ' ' VAL . 24.2 mt -98.44 151.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 71.45 111.127 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -127.63 132.75 49.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -98.01 -164.84 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 73.02 110.903 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -48.85 -31.44 7.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 64.02 110.875 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.33 -26.41 11.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 75.34 110.87 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.0 66.88 2.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 64.51 112.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -90.59 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 73.14 112.345 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 169.39 100.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 75.1 110.877 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -118.3 145.25 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.21 111.157 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.97 33.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 71.23 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -124.97 142.32 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 74.42 111.119 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -122.3 161.03 24.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.02 110.857 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.03 -21.97 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.855 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -94.16 19.74 8.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.31 111.125 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.7 -22.03 7.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 73.31 111.099 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -71.08 127.39 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 71.5 111.138 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.2 84.78 7.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.51 110.86 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.99 154.44 51.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.31 111.129 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.35 72.98 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.926 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.83 152.51 9.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 73.31 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -51.56 115.54 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 73.24 110.905 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 mmt-85 -153.09 -175.75 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 70.21 110.86 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.2 p -131.61 -167.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.32 111.18 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 47' ' ' VAL . 80.9 mt -107.16 177.17 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 70.2 110.926 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 63.32 110.934 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -62.22 120.38 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 5.09 68.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.729 . . . . 73.45 112.537 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.6 158.33 15.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 75.23 110.922 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.0 m-70 -86.92 139.39 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.44 110.829 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.4 m -158.54 139.93 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.13 111.144 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 tt0 -97.0 125.06 41.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.883 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.5 p90 -118.44 145.82 44.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.1 110.902 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -106.49 98.35 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 53.4 110.895 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.7 m -62.92 124.87 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 45.43 111.117 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.64 160.67 35.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.63 0.729 . . . . 75.1 110.879 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -88.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 73.45 112.339 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.06 57.07 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 61.23 112.465 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.51 -41.71 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 74.32 110.835 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.64 136.59 12.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 60.24 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.67 -34.83 15.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 42.34 112.501 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -22.94 18.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.339 . . . . 74.43 110.818 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.22 -93.36 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.732 . . . . 62.14 112.48 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.66 3.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.716 2.278 . . . . 74.12 112.356 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.855 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 9.4 tt0 -120.05 157.92 27.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 72.34 110.93 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.805 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.97 57.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 60.43 111.087 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.49 -38.85 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.67 104.75 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.22 110.881 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.805 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.15 141.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 53.41 111.14 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -131.33 141.9 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.2 110.848 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.756 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.52 134.85 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 71.12 111.115 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 mtp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.863 0.363 . . . . 75.24 110.853 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -127.97 154.89 45.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 63.11 110.875 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 25.4 mttt -127.52 133.88 49.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.01 110.895 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.46 171.75 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.774 -0.727 . . . . 74.41 112.48 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.5 p -85.41 144.88 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 72.34 111.153 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -84.88 147.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 75.31 111.135 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.08 -32.36 10.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.04 110.902 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -174.74 141.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 73.54 110.929 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -141.15 98.94 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.861 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -65.21 119.22 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.01 110.949 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.24 21.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 61.34 111.071 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.5 -38.41 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 63.33 110.895 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -97.88 -38.03 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 70.53 110.904 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 44.67 1.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 65.31 112.474 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.48 168.47 25.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 73.2 110.96 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.77 -179.37 45.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 72.24 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -141.01 126.27 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 70.13 110.874 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 6' ' ' VAL . 23.2 mt -98.76 150.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 54.25 111.142 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 11.1 mm100 -121.75 125.8 47.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.86 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -91.86 -166.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.42 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -46.92 -34.1 5.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -105.88 -19.85 13.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.52 110.896 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.2 64.57 3.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 73.43 112.487 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -88.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 63.01 112.326 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 94.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.906 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.77 142.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.23 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.63 116.37 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -121.42 142.52 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.41 111.099 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.472 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -123.53 160.07 27.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 75.24 110.849 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -56.93 -21.43 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.896 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.6 t -95.0 19.81 9.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.134 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.67 -24.2 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 52.31 111.061 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -70.47 124.07 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.152 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.41 84.42 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.919 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.49 144.4 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 53.24 111.135 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.49 73.11 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 65.44 110.859 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.17 166.25 13.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 65.11 112.482 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -57.07 109.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 74.54 110.943 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -144.49 -170.73 3.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.12 110.855 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 t -146.24 -170.35 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.138 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -107.25 164.01 12.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 52.03 110.909 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -109.68 125.66 52.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.899 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.18 121.87 14.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.01 110.871 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.92 72.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 64.03 112.497 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.31 157.43 15.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 62.3 110.894 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.2 m-70 -85.91 138.36 32.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.843 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.0 m -158.22 140.39 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 55.45 111.148 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 39.7 tt0 -95.86 125.95 40.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.917 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -118.3 145.54 45.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.881 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -106.71 97.73 7.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 63.32 110.848 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.1 m -62.0 123.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 71.54 111.083 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -113.97 161.16 29.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.622 0.725 . . . . 71.04 110.883 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 74.04 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.23 57.27 4.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 74.24 112.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 4.0 mpt_? -128.96 -41.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 71.12 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.96 14.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 65.24 112.467 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.27 -41.93 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 51.55 112.463 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.44 -22.52 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 55.55 110.927 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.56 -89.87 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 61.43 112.478 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 114.82 3.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.658 2.239 . . . . 64.55 112.338 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.851 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.8 tt0 -119.23 156.55 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 71.2 110.921 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.738 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.03 57.09 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.22 111.144 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -41.74 -49.89 4.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 32.44 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.3 tttp -120.06 108.23 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.94 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.726 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.08 142.23 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.42 111.162 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -131.0 142.83 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.44 110.86 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HA ' HG12 ' A' ' 47' ' ' VAL . 38.4 ptt180 -78.75 134.88 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 75.04 110.852 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 43.3 111.122 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.865 0.364 . . . . 74.11 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -120.75 150.82 40.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.42 110.892 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.0 mtpp -132.02 133.17 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 55.33 110.895 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.8 171.14 43.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 72.43 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.8 p -82.46 146.62 29.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 71.01 111.105 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.69 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -87.68 145.89 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.117 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -36.74 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 64.41 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -170.52 141.6 1.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 71.23 110.904 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -136.49 99.29 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 75.05 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 103.2 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 52.24 110.919 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.3 47.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 54.34 111.113 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.46 -47.63 69.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.883 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.21 -36.08 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.862 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.13 2.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 53.4 112.513 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -152.74 151.35 30.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 64.12 110.91 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.28 176.53 32.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 73.44 112.451 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.53 122.93 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.43 110.883 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 6' ' ' VAL . 17.6 mt -97.99 154.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.03 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 18' ' ' ILE . 6.0 mm100 -130.38 147.08 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.63 -165.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 74.04 110.925 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -48.56 -32.3 7.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 55.02 110.891 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -102.35 -29.85 11.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 64.15 110.852 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.98 2.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 14.54 112.472 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.728 2.285 . . . . 61.31 112.323 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p30 168.71 100.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 61.33 110.835 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' CD2' ' A' ' 49' ' ' PHE . 3.4 p -113.69 136.05 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 54.41 111.121 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.71 115.4 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.41 110.938 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -124.97 143.72 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.03 111.133 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' HD12 ' A' ' 33' ' ' ILE . 18.0 m170 -122.4 158.87 28.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 62.32 110.867 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.96 -24.42 38.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -94.72 23.01 5.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.44 111.153 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.75 -2.02 7.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.32 111.095 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 65' ' ' VAL . 4.8 mp -91.39 131.97 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.31 111.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.22 86.5 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.894 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.34 179.93 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 74.45 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.12 74.91 7.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 54.13 110.886 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.49 -118.69 3.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 71.2 112.494 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.3 112.61 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 53.15 110.875 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.404 ' O ' HD13 ' A' ' 33' ' ' ILE . 65.4 mtt85 -77.79 66.59 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.879 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.0 p -146.61 167.06 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 61.11 111.175 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.672 HD12 HG11 ' A' ' 47' ' ' VAL . 1.3 mm? -110.03 -176.5 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 72.53 110.919 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -127.43 126.92 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 61.02 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.94 121.23 9.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.85 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.54 7.27 67.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 24.42 112.511 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -106.84 160.62 15.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.851 0.358 . . . . 75.35 110.893 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -88.74 141.96 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -158.63 140.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 54.31 111.142 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 33.4 tt0 -94.62 126.8 40.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 63.41 110.905 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG21 ' A' ' 26' ' ' VAL . 14.0 p90 -120.7 142.03 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 73.15 110.851 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.03 97.58 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 73.42 110.902 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.846 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.5 m -63.0 126.9 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 73.23 111.141 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.68 159.47 46.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.679 0.752 . . . . 73.25 110.906 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -87.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.725 2.283 . . . . 71.53 112.354 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.36 55.92 4.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 52.33 112.45 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.0 -41.76 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 72.14 110.887 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.53 137.68 13.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 12.14 112.474 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.87 -38.36 23.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 73.23 112.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.98 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 70.04 110.876 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.32 -93.96 0.15 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 73.42 112.456 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 112.77 3.16 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 42.52 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.846 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.6 tt0 -117.86 156.77 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.915 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.39 59.11 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 60.43 111.1 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -41.82 -38.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 54.11 110.949 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -130.85 109.63 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 52.51 110.863 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.3 141.24 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 65.45 111.13 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -131.52 141.14 49.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.898 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 15.2 ptm180 -78.67 133.45 37.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 62.2 110.857 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.135 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' H1 ' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.816 0.341 . . . . 72.44 110.923 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -123.37 156.29 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 72.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -130.99 137.13 49.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.91 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.22 41.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.22 112.51 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p -84.91 138.04 32.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 74.42 111.13 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.95 144.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 71.03 111.106 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -99.66 -30.49 12.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.872 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -175.41 136.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 73.32 110.894 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -135.48 98.92 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.892 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -69.19 112.32 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.54 110.929 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.47 -30.13 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.41 111.113 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -62.94 -53.89 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 64.44 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -75.03 -32.14 61.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.914 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.1 30.84 8.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 64.25 112.482 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -139.93 169.13 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 64.13 110.926 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.67 173.59 46.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.754 -0.736 . . . . 74.4 112.491 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -140.91 126.81 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 74.53 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.756 HG12 HG23 ' A' ' 6' ' ' VAL . 24.4 mt -102.03 152.98 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.04 111.122 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' ILE . 59.3 mm-40 -110.73 134.52 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.43 110.932 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.4 149.04 52.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 64.1 110.877 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -87.02 -6.4 58.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.847 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -118.98 -5.78 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.03 74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 74.15 112.511 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -161.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 74.13 112.374 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 51.78 82.27 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.846 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.612 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -132.67 143.21 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.23 111.141 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.38 120.28 34.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -130.42 142.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 70.01 111.104 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 6.2 m170 -122.95 157.92 31.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 71.41 110.869 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.66 -23.51 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.35 110.848 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.0 t -94.51 19.46 9.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.173 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -120.36 -8.75 9.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 44.31 111.056 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG23 HG12 ' A' ' 65' ' ' VAL . 4.6 mp -85.47 131.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 62.22 111.142 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -115.37 86.32 2.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 72.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.41 -179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.093 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.95 74.55 3.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.12 110.893 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.33 -117.58 1.74 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 61.02 112.473 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -77.0 110.22 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 70.04 110.895 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -66.2 102.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 75.44 110.887 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -176.9 159.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.165 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.789 HD22 HG11 ' A' ' 47' ' ' VAL . 14.9 mt -108.72 -175.8 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 74.02 110.925 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.0 128.05 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.899 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -57.06 122.38 12.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.4 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.01 5.68 67.73 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 61.22 112.506 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -106.71 160.48 15.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 65.31 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.497 ' O ' HG13 ' A' ' 47' ' ' VAL . 13.4 m-70 -89.82 142.34 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 63.3 110.869 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.789 HG11 HD22 ' A' ' 41' ' ' LEU . 2.4 m -157.71 140.2 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 70.34 111.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 tt0 -96.75 125.11 40.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 62.42 110.913 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -119.09 144.17 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.14 110.936 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' ' H1 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -102.57 98.07 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.22 110.94 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.7 m -61.89 118.23 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.115 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -107.51 156.46 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.44 110.854 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.5 Cg_endo -69.78 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.717 2.278 . . . . 55.21 112.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 56.51 3.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 40.41 112.483 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -132.28 -41.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 71.21 110.871 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.94 134.02 12.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 65.12 112.475 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.3 7.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 70.42 112.454 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -23.2 15.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 65.24 110.939 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.51 -93.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 72.31 112.497 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 117.07 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 72.21 112.339 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 15.1 tt0 -120.99 157.38 30.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.53 110.932 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.788 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.59 56.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.12 111.131 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -40.68 -46.04 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.907 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.5 tttp -126.44 105.82 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.926 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.788 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -105.87 142.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.54 111.108 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -132.38 146.14 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 133.93 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.895 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 63.41 111.14 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.843 0.354 . . . . 74.34 110.836 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -132.59 154.17 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.912 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 18.3 mtmt -131.06 135.71 47.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.857 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.91 171.48 44.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 73.12 112.466 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -82.77 143.95 30.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 71.2 111.112 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.7 144.58 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.03 111.13 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -31.11 12.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 74.04 110.911 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -175.09 140.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 73.04 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -139.27 98.85 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.914 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -70.74 109.39 4.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.65 35.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 53.44 111.103 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.24 -48.19 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.43 110.889 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -87.88 -37.36 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 71.11 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.17 41.2 2.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 61.02 112.484 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.97 167.77 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 75.21 110.905 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.09 46.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.31 112.477 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -141.88 124.77 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 72.12 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.8 mt -98.09 151.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 74.1 111.151 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -127.66 130.9 49.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.2 110.914 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -96.2 -164.93 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.949 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.02 -31.79 5.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 72.34 110.86 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -106.39 -23.93 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 73.21 110.863 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.18 67.13 2.11 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.698 -0.763 . . . . 54.52 112.46 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 62.21 112.345 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.96 95.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 71.41 110.877 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -112.38 146.02 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.145 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -100.44 116.68 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.43 110.886 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -124.72 144.04 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 71.44 111.125 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.9 m170 -123.12 159.29 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.05 110.869 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -56.25 -21.99 27.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -96.11 22.12 7.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 42.15 111.138 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.6 -4.53 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 50.42 111.103 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.9 mp -89.98 132.41 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 64.11 111.118 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.65 86.56 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.32 110.882 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.46 -179.37 4.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 70.42 111.079 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -87.95 74.33 8.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 75.21 110.848 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.7 -117.68 2.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 73.41 112.499 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -63.17 120.1 10.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 73.41 110.848 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -81.55 70.35 8.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 75.12 110.852 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 p -147.39 163.05 37.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 51.35 111.119 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.808 HD22 HG11 ' A' ' 47' ' ' VAL . 19.7 mt -109.44 -178.26 3.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 72.31 110.892 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -126.82 127.22 44.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.32 110.897 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -57.17 120.19 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.883 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.06 62.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 74.44 112.462 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -106.87 160.32 15.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 73.2 110.897 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.9 m-70 -89.62 141.64 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.9 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.808 HG11 HD22 ' A' ' 41' ' ' LEU . 2.7 m -158.52 140.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 70.22 111.156 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -98.03 125.85 43.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.928 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.1 p90 -119.91 143.43 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 70.42 110.867 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 2.3 mt-10 -99.79 99.05 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.53 110.863 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.4 m -56.45 122.78 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 62.51 111.13 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.8 tt0 -101.87 140.79 21.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.25 110.9 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.68 -92.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.688 2.259 . . . . 55.11 112.373 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.15 53.95 4.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 74.24 112.479 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -39.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 71.35 110.863 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 134.43 16.83 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 71.21 112.508 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.91 -36.67 8.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 61.11 112.494 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.66 -14.36 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 72.31 110.873 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.52 -104.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 52.35 112.486 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 53.1 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.652 2.235 . . . . 63.04 112.326 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.7 pt20 -115.16 171.03 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.55 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -85.6 61.62 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 54.35 111.142 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 14.3 ttmt -42.02 -46.37 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 74.55 110.885 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 107.14 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 72.35 110.895 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.6 141.03 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 75.4 111.116 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -132.02 142.18 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.838 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.76 ' HA ' HG12 ' A' ' 47' ' ' VAL . 62.1 ttt180 -77.57 134.2 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.876 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 67' ' ' ARG . 9.0 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 62.23 111.13 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.36 . . . . 74.24 110.867 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -123.78 152.42 42.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.871 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.8 mtpt -127.23 134.11 50.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.884 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.53 172.37 44.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.787 -0.721 . . . . 74.43 112.538 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 76.2 p -83.39 144.93 29.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 75.41 111.161 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.21 145.15 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 75.53 111.116 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -31.06 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 71.45 110.885 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -175.69 137.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.884 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.2 99.19 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -74.16 113.04 10.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 65.11 110.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.76 -34.43 30.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 72.01 111.116 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -56.6 -48.48 77.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.855 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.28 -28.91 26.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 72.51 110.922 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.38 19.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 75.42 112.468 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -133.59 169.21 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 55.31 110.906 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.25 173.59 45.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 65.21 112.487 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -142.39 128.4 19.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 73.31 110.903 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.6 mt -97.7 149.24 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 61.44 111.081 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -121.74 119.33 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.42 110.914 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.54 -167.23 1.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -47.75 -34.24 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 71.22 110.905 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.34 -18.2 14.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.889 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.19 66.29 2.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 73.53 112.499 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -89.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 73.15 112.347 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.7 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 61.21 110.877 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -106.73 144.93 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.31 111.174 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.93 122.18 41.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.907 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -132.87 141.81 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 63.41 111.15 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -115.78 155.4 27.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -54.88 -25.06 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.886 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -93.74 23.62 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.121 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.24 -1.2 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 65.33 111.039 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.689 HG12 HD23 ' A' ' 41' ' ' LEU . 4.3 mp -90.21 126.4 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.42 111.12 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.18 86.65 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.912 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.16 -179.86 3.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 61.14 111.11 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.18 75.58 6.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 63.4 110.908 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.79 -117.62 3.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 74.44 112.487 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -78.83 110.17 13.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 50.43 110.87 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -63.86 134.6 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 60.33 110.885 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -177.19 144.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 65.14 111.135 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -109.04 148.56 30.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 54.01 110.869 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -115.75 125.94 53.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.03 110.861 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.06 118.81 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 65.44 110.858 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.77 4.17 58.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.754 . . . . 71.22 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -101.6 155.51 18.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 72.44 110.879 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.534 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.9 m-70 -85.63 140.86 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.889 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.77 140.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 21.7 tt0 -98.07 126.35 43.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.854 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' HD13 ' A' ' 18' ' ' ILE . 22.8 p90 -118.42 146.88 44.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 65.32 110.883 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -105.97 96.32 6.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 74.31 110.893 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.1 m -63.4 123.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.3 111.114 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -115.55 160.33 35.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.674 0.749 . . . . 73.34 110.875 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 52.34 112.338 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.7 57.01 3.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.74 . . . . 33.24 112.507 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 5.0 mpt_? -132.79 -41.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 64.21 110.865 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 134.53 12.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 75.54 112.508 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.89 -33.93 10.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.31 112.475 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.32 -22.35 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 73.44 110.851 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.37 -92.5 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.691 -0.766 . . . . 73.12 112.476 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 115.06 3.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.267 . . . . 63.12 112.346 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -118.92 154.29 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.879 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -76.85 56.5 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.43 111.128 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.38 -47.08 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 52.33 110.92 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -126.54 108.33 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 70.41 110.92 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -110.21 141.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 72.54 111.156 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -131.3 143.24 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.866 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.755 ' HA ' HG12 ' A' ' 47' ' ' VAL . 18.2 mmm-85 -78.06 135.78 37.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.855 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.8 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.33 111.121 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.801 0.334 . . . . 55.43 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -124.05 151.42 43.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.908 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 mtpt -130.32 133.44 46.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.01 110.932 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.86 171.63 44.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 63.11 112.479 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -85.63 142.96 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.334 . . . . 73.23 111.163 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -77.81 144.06 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 61.05 111.156 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -29.41 13.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.51 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -177.41 145.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 74.04 110.958 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -138.13 103.37 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 72.5 110.876 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -72.36 106.72 4.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.13 110.886 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.02 -35.95 41.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.12 111.081 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -57.17 -42.58 81.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.889 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -86.77 -33.68 19.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.901 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 22.46 16.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 55.45 112.499 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -130.56 176.39 8.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.958 0.409 . . . . 75.41 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.98 44.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.521 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -141.27 125.25 17.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 75.43 110.872 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 6' ' ' VAL . 21.0 mt -98.06 151.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 72.51 111.095 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.71 123.03 40.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 72.55 110.941 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.52 -165.96 1.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.9 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.88 -35.28 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.862 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.44 -16.19 14.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 53.12 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.87 64.45 4.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 73.5 112.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -88.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 73.41 112.321 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 t70 172.61 93.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.44 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.59 143.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 64.34 111.184 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.36 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 54.32 110.874 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -128.75 143.3 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.125 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -118.1 157.14 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.865 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -54.83 -25.45 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.9 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 t -93.62 25.0 3.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 52.4 111.129 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.26 -1.08 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 31.34 111.121 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 65' ' ' VAL . 4.0 mp -88.92 123.3 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 53.02 111.132 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -116.27 86.64 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.859 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.52 -179.7 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 63.14 111.103 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.7 73.1 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 54.44 110.879 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.69 101.74 1.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.773 -0.727 . . . . 70.04 112.491 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -64.3 133.74 53.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 74.21 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -179.63 -71.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -175.63 179.48 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.154 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HG11 ' A' ' 47' ' ' VAL . 1.5 tp -108.17 -176.76 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.3 110.884 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -118.58 125.51 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.867 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.45 120.19 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.874 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.14 3.2 60.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 74.35 112.437 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.41 156.71 16.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.22 110.909 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.0 m-70 -84.71 139.22 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.42 110.888 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 41' ' ' LEU . 3.8 m -158.43 140.17 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.115 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -94.28 126.34 39.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 75.3 110.919 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 16.8 p90 -119.89 143.52 47.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 65.41 110.843 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.62 98.5 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.904 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.874 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.8 m -63.21 125.46 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.3 mm-40 -112.57 160.73 29.38 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 73.03 110.906 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -90.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 62.12 112.354 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.91 58.93 4.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 73.01 112.453 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -41.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 61.22 110.906 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.81 136.1 13.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 44.43 112.525 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.93 -31.81 8.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 65.03 112.463 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -100.41 -22.6 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 73.1 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.58 -91.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 75.03 112.468 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.667 2.244 . . . . 72.11 112.328 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.874 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -119.36 154.81 33.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.53 110.903 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -80.1 61.16 3.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.41 111.111 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -46.75 -41.4 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.13 110.884 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 56.2 mmtt -125.6 110.74 14.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.35 110.909 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -111.97 141.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 62.35 111.133 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -130.87 141.87 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 70.11 110.871 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.753 ' HA ' HG12 ' A' ' 47' ' ' VAL . 23.6 mtp180 -78.38 134.28 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.54 110.918 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.4 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 63.31 111.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 63.53 110.895 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -123.94 148.85 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.24 110.894 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.3 mtmt -129.45 129.25 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 41.21 110.891 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.85 41.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 40.04 112.446 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -85.04 145.97 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 70.01 111.147 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -86.72 144.54 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.154 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.0 tppt? -99.25 -30.08 12.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.14 110.875 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -175.34 137.17 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 70.44 110.893 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.33 98.88 3.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 73.1 110.861 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -65.98 115.96 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.12 110.888 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.05 -25.34 23.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 63.33 111.077 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.98 -40.57 75.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.879 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -87.02 -38.77 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 64.11 110.918 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.55 34.74 4.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 71.41 112.487 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 2.8 p90 -146.87 169.0 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 71.43 110.913 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.66 177.06 46.15 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 64.23 112.525 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.99 126.29 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 75.45 110.869 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 6' ' ' VAL . 26.4 mt -99.87 152.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 65.34 111.095 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 13.5 mm100 -116.58 126.11 52.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.12 110.929 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.3 155.94 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 64.45 110.911 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.94 -5.48 58.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 64.04 110.878 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -111.52 -1.86 15.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 71.21 110.887 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.39 80.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.474 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -161.67 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 74.15 112.352 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.72 80.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 73.01 110.874 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -134.26 144.59 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 40.23 111.131 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.11 119.04 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.53 110.85 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -127.73 140.27 49.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 71.12 111.103 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.537 ' O ' HD12 ' A' ' 33' ' ' ILE . 14.3 m170 -119.98 157.78 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 72.13 110.854 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' HG23 ' A' ' 31' ' ' THR . 2.5 p90 -56.43 -23.93 41.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.915 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.617 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.0 p -93.93 19.96 8.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 64.42 111.153 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.07 -7.93 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 42.34 111.088 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.537 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -87.09 132.24 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 73.14 111.095 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -117.11 86.56 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 62.01 110.873 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.2 177.75 6.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 71.14 111.12 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -101.23 90.57 4.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.893 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.86 -118.06 1.88 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 71.15 112.504 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.05 110.08 19.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.53 110.908 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.28 96.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 t -178.6 162.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.21 111.158 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.724 HD22 HG11 ' A' ' 47' ' ' VAL . 13.8 mt -108.27 -178.42 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 62.44 110.92 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -127.0 127.32 44.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.861 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.49 121.29 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 74.3 110.842 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.58 65.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.487 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -106.57 159.93 15.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 65.24 110.854 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.1 m-70 -87.91 141.53 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 63.44 110.82 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.63 139.77 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 70.22 111.146 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.76 125.67 42.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 61.1 110.854 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.2 p90 -120.99 144.6 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.895 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.43 99.2 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.877 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -62.8 121.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 72.13 111.168 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -103.38 148.98 36.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.666 0.746 . . . . 75.43 110.892 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 64.52 112.383 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 58.13 5.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 73.35 112.491 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -135.38 -40.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 61.21 110.911 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 61' ' ' GLN . . . -83.19 142.3 21.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 62.43 112.501 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.56 -38.05 27.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.768 -0.73 . . . . 64.22 112.504 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -100.45 -17.74 17.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 73.03 110.901 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.12 -98.44 0.21 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 61.15 112.471 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 111.77 2.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 55.34 112.292 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -119.46 165.79 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.31 110.911 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -82.67 58.79 4.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 64.54 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 10.0 ttpt -43.66 -38.81 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.21 110.918 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -133.9 104.94 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 53.22 110.898 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.801 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -106.6 142.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 52.02 111.125 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.8 141.29 48.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.1 110.896 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 29.6 ttt180 -77.39 134.58 38.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.846 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.3 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.55 111.115 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.887 0.375 . . . . 65.109999999999999 110.928 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -135.42 134.26 39.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.949 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 171.66 44.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 72.030000000000001 112.48 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.9 p -83.72 145.25 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 65.150000000000006 111.097 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.443 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -85.56 145.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.141 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.3 -29.19 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 62.450000000000003 110.88 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -175.57 137.6 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 63.310000000000002 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -139.55 98.85 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.25 113.39 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.903 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.12 -21.81 27.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.46 -51.08 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 110.917 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -85.23 -36.68 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.923 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.5 40.2 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.150000000000006 112.522 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 20.4 p90 -144.57 166.71 24.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 73.5 110.911 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 175.41 46.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 32.409999999999997 112.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -141.28 126.68 18.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 61.509999999999998 110.859 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.527 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.4 mt -98.28 152.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 63.350000000000001 111.133 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.402 ' N ' HG22 ' A' ' 18' ' ' ILE . 45.4 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 110.887 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.842 0.353 . . . . 75.530000000000001 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -119.1 143.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.124 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -98.59 117.7 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.915 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -126.31 142.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 72.439999999999998 111.104 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.524 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.4 m170 -123.15 158.95 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.400000000000006 110.829 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG23 ' A' ' 31' ' ' THR . 7.5 p90 -56.36 -22.19 29.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -95.53 20.62 9.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 111.161 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.41 -6.16 8.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 70.519999999999996 111.102 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -88.82 132.5 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 111.11 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.937 179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 70.340000000000003 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.62 120.42 8.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 45.409999999999997 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.84 7.62 66.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 52.340000000000003 112.494 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -107.0 160.54 15.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 63.310000000000002 110.919 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m-70 -88.8 141.26 28.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.049999999999997 110.837 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.22 140.15 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 50.409999999999997 111.161 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.54 125.97 42.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 64.200000000000003 110.875 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.7 p90 -119.94 146.56 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 74.140000000000001 110.864 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -107.55 99.3 8.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 73.049999999999997 110.92 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.6 m -63.01 124.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 111.135 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.06 158.13 40.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.688 0.756 . . . . 75.530000000000001 110.85 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.4 Cg_endo -69.8 -88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.652 2.234 . . . . 53.509999999999998 112.33 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 56.78 3.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 73.540000000000006 112.484 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -132.02 -41.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 74.140000000000001 110.864 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.21 135.93 12.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 73.099999999999994 112.483 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.76 -34.21 14.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.739 . . . . 71.439999999999998 112.467 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -22.37 17.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 74.25 110.941 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.77 -94.38 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 41.439999999999998 112.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 114.93 3.87 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 61.130000000000003 112.394 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 11.9 tt0 -119.93 157.86 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.927 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.785 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.64 57.54 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.12 -37.8 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 110.895 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -131.08 104.27 7.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 62.310000000000002 110.859 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.785 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.48 141.71 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 60.439999999999998 111.103 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -132.32 143.05 49.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.9 tmm_? -78.76 135.48 37.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.879 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 62.140000000000001 111.141 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 72.299999999999997 110.866 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 26.8 mtmt -132.71 134.86 45.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.876 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.72 171.65 44.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.776 -0.726 . . . . 72.409999999999997 112.507 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 p -80.99 145.42 31.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 50.020000000000003 111.143 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.87 144.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 73.25 111.106 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -96.96 -31.28 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.879 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -175.43 139.98 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 110.916 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HE1' HD11 ' A' ' 33' ' ' ILE . 65.3 t80 -133.63 99.11 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.519999999999996 110.88 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.64 101.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 110.902 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.81 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 111.053 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -70.26 -43.93 69.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 64.030000000000001 110.894 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -93.37 -34.72 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 110.882 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.1 45.73 2.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.75 -0.738 . . . . 54.420000000000002 112.474 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -157.64 143.24 17.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 74.040000000000006 110.976 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.76 -174.21 22.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 72.209999999999994 112.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -142.49 127.59 18.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 72.099999999999994 110.887 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.9 mt -98.5 151.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 31.6 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 71.040000000000006 110.899 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.836 0.35 . . . . 73.219999999999999 110.868 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.57 142.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.133 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.34 115.75 29.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 63.350000000000001 110.889 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.793 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.5 m -121.53 144.41 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 65.420000000000002 111.127 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.519 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -123.6 159.04 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.881 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -56.16 -21.76 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 110.892 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 m -97.0 22.57 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.239999999999995 111.143 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.67 -6.38 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.086 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.9 mp -89.66 132.43 34.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 51.43 111.132 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 33.509999999999998 110.871 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.784 0.325 . . . . 74.129999999999995 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -58.0 119.35 6.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 52.039999999999999 110.878 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.67 6.19 62.52 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.689 -0.767 . . . . 63.409999999999997 112.502 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -106.83 160.11 15.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.530000000000001 110.885 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.8 m-70 -88.69 141.79 28.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.868 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.6 m -158.48 140.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 71.25 111.177 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.6 tt0 -99.03 127.0 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 71.219999999999999 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.8 p90 -118.07 149.05 41.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 64.319999999999993 110.88 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -106.42 98.82 8.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 70.239999999999995 110.865 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.838 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -53.29 125.38 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 54.119999999999997 111.153 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.6 tp10 -111.1 138.95 21.36 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 71.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -90.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.65 2.234 . . . . 64.209999999999994 112.325 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.72 53.84 4.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 42.299999999999997 112.515 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 -40.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 70.140000000000001 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.62 135.58 15.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 73.230000000000004 112.486 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.33 -36.85 17.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.734 . . . . 62.350000000000001 112.501 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -19.37 16.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.209999999999994 110.877 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.11 -102.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 44.43 112.439 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 113.3 3.32 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 42.210000000000001 112.33 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.838 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 pt20 -119.28 174.86 6.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.878 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -91.1 59.18 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 111.106 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 13.9 tppt? -40.79 -44.42 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 71.540000000000006 110.869 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -129.0 107.63 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 63.399999999999999 110.864 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.78 142.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 63.210000000000001 111.13 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -132.0 141.53 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 110.86 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.758 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.01 136.03 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.85 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.9 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 111.147 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.855 0.36 . . . . 72.439999999999998 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 21.3 mtmm -127.53 134.15 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 72.299999999999997 110.926 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.81 171.53 42.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.738 . . . . 61.439999999999998 112.465 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.6 p -83.28 146.32 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 74.010000000000005 111.149 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 144.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 111.106 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -29.51 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.239999999999995 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -172.79 138.95 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.530000000000001 110.899 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 33' ' ' ILE . 62.8 t80 -140.57 98.05 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 70.219999999999999 110.898 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.16 105.33 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 54.109999999999999 110.903 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.19 -30.26 43.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.299999999999997 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -71.46 -37.1 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.905 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.2 -40.21 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.319999999999993 110.907 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.89 5.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 44.32 112.458 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -149.96 170.74 18.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 73.400000000000006 110.913 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.99 178.46 46.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 62.229999999999997 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -142.93 125.13 15.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 63.420000000000002 110.885 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.563 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.2 mt -98.24 150.9 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 74.319999999999993 111.111 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 110.923 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.862 0.363 . . . . 72.040000000000006 110.852 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.2 142.37 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 75.219999999999999 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.97 116.76 31.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.864 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.9 m -122.54 140.78 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 62.140000000000001 111.133 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.7 m-70 -119.15 158.49 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -56.08 -23.23 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 70.129999999999995 110.89 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m -95.74 22.19 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.18 -6.41 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 55.109999999999999 111.097 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -89.18 131.97 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 75.319999999999993 111.139 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 110.923 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.775 0.322 . . . . 65.430000000000007 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.8 121.46 10.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 71.420000000000002 110.927 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.71 68.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.310000000000002 112.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.68 160.56 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.36 . . . . 71.140000000000001 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.6 m-70 -89.32 142.25 27.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 110.877 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -158.74 140.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.092 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -97.14 127.85 43.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 60.009999999999998 110.87 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.88 146.71 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 65.340000000000003 110.912 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.02 97.25 7.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.209999999999994 110.911 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 61.4 t -52.05 130.14 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 73.340000000000003 111.183 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.1 tp10 -118.11 137.7 24.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 74.219999999999999 110.871 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -91.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 71.439999999999998 112.349 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.38 4.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.721 . . . . 73.310000000000002 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -39.98 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 75.329999999999998 110.884 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.2 136.79 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 72.409999999999997 112.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.41 -35.2 14.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 63.399999999999999 112.446 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -18.7 14.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 73.319999999999993 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.05 -103.44 0.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 72.430000000000007 112.481 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' CB ' HG13 ' A' ' 51' ' ' VAL . 53.3 Cg_endo -69.79 110.64 2.61 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 61.210000000000001 112.33 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.793 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.2 pt20 -118.35 173.68 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.109999999999999 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -90.87 61.55 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 55.420000000000002 111.089 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -39.12 -42.78 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 110.903 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 1.3 tttt -131.54 110.74 11.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.909 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.77 142.11 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 73.400000000000006 111.151 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 110.884 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 52.0 ttt180 -78.06 134.76 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 64.450000000000003 110.92 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.340000000000003 111.115 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.902 0.382 . . . . 72.430000000000007 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.6 mtmt -128.66 134.72 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 62.210000000000001 110.893 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.56 44.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 73.239999999999995 112.482 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 p -85.15 148.49 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 45.32 111.146 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.27 144.8 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 73.230000000000004 111.114 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.07 -29.65 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.899 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -176.16 137.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.929 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -136.67 99.39 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 74.340000000000003 110.878 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -72.37 111.39 7.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.349999999999994 110.85 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.45 -32.78 42.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 111.118 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.84 -50.81 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -77.77 -29.81 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.868 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.83 32.7 10.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 73.540000000000006 112.477 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -140.12 169.19 18.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 64.310000000000002 110.917 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.32 172.97 45.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 70.019999999999996 112.512 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -141.45 129.11 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 74.549999999999997 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 49' ' ' PHE . 27.8 mt -97.22 144.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 53.509999999999998 111.103 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.340000000000003 110.88 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 73.420000000000002 110.921 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -116.87 145.91 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 72.040000000000006 111.151 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.02 117.52 35.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 30.420000000000002 110.84 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.676 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.47 142.44 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 55.229999999999997 111.147 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.436 ' O ' HD12 ' A' ' 33' ' ' ILE . 7.4 m170 -116.92 157.08 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 55.219999999999999 110.894 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -56.01 -24.55 39.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 63.350000000000001 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -93.83 20.88 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 111.099 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.74 -1.88 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 64.209999999999994 111.11 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG13 HG11 ' A' ' 65' ' ' VAL . 4.7 mp -90.3 127.97 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 63.520000000000003 111.106 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.310000000000002 110.92 179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 64.420000000000002 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -58.68 115.99 3.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 110.871 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.15 7.42 54.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.150000000000006 112.49 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.97 158.95 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.539999999999999 110.889 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.533 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.7 m-70 -88.48 141.56 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.32 110.866 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -158.85 139.86 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 73.439999999999998 111.131 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.2 tt0 -97.42 126.18 42.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.871 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.7 p90 -121.14 147.08 46.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 55.219999999999999 110.885 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 9.8 mt-10 -107.53 99.03 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 70.340000000000003 110.891 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.0 m -64.65 125.38 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 111.106 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -114.3 158.96 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 71.400000000000006 110.918 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -89.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.244 . . . . 74.409999999999997 112.33 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.57 57.19 3.79 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 64.430000000000007 112.438 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 5.9 tpp180 -132.51 -41.6 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 75.310000000000002 110.878 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.23 139.04 14.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 62.450000000000003 112.529 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -38.59 23.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 60.020000000000003 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -22.09 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 75.409999999999997 110.886 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.2 -93.16 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 71.109999999999999 112.487 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 114.42 3.7 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 52.310000000000002 112.352 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.1 tt0 -119.5 157.06 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 72.120000000000005 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.62 58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -43.67 3.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 60.329999999999998 110.887 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.0 mtpp -129.53 109.06 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.340000000000003 110.897 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.22 142.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.299999999999997 111.134 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -131.87 143.39 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.912 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.7 mtm105 -78.17 135.92 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.120000000000005 110.821 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 111.115 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.839 0.352 . . . . 75.319999999999993 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.3 mtpm? -129.24 136.72 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 110.875 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.9 172.08 44.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 75.549999999999997 112.438 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -82.65 151.06 26.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 64.239999999999995 111.138 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.37 147.05 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 63.340000000000003 111.137 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -98.95 -34.51 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.299999999999997 110.919 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -168.5 139.19 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.319999999999993 110.912 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.29 98.53 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 74.310000000000002 110.889 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.69 115.13 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 74.140000000000001 110.924 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.94 -33.09 24.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 70.239999999999995 111.099 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.75 -49.92 71.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 110.884 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -77.72 -29.67 51.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.913 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 33.4 10.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 71.120000000000005 112.484 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.7 169.95 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 74.109999999999999 110.924 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 170.81 43.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 63.210000000000001 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -141.4 125.18 16.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 71.230000000000004 110.886 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -98.85 151.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 75.230000000000004 111.142 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 40.4 mm-40 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 70.450000000000003 110.942 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.832 0.349 . . . . 60.409999999999997 110.838 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.6 143.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 111.071 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.8 118.73 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.879 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -129.39 143.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 64.109999999999999 111.12 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 33' ' ' ILE . 13.9 m170 -120.39 157.31 29.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 75.319999999999993 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -55.72 -24.68 36.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 62.210000000000001 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -94.43 22.74 5.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 61.340000000000003 111.169 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.19 -0.14 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 50.210000000000001 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.8 mp -91.16 130.61 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 72.040000000000006 111.149 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 55.009999999999998 110.856 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.761 0.315 . . . . 73.239999999999995 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 124.09 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 55.520000000000003 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.03 6.41 69.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 62.509999999999998 112.509 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -102.47 157.31 17.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 70.530000000000001 110.872 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.3 m-70 -87.93 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 71.109999999999999 110.835 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -159.11 141.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 61.329999999999998 111.12 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.3 tt0 -94.24 125.42 38.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -118.37 142.61 47.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 64.219999999999999 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 78.1 mt-10 -106.2 98.07 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.896 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.0 m -63.79 122.5 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.147 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.86 160.39 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.661 0.743 . . . . 62.32 110.845 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 75.219999999999999 112.305 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 55.7 3.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 74.219999999999999 112.446 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -130.59 -41.68 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 73.150000000000006 110.866 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.13 140.42 15.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 75.040000000000006 112.478 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.52 -44.95 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 55.450000000000003 112.479 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -85.15 -22.18 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 72.040000000000006 110.851 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -90.88 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 75.120000000000005 112.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 114.2 3.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 74.239999999999995 112.353 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.856 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -121.96 156.53 33.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 74.420000000000002 110.915 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.709 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.3 58.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -44.56 -36.19 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 4.2 ttpt -130.74 106.95 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.709 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.25 142.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 54.509999999999998 111.104 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -131.15 142.61 50.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.897 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.757 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.19 133.15 36.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 71.150000000000006 110.856 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.430000000000007 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.806 0.336 . . . . 73.099999999999994 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.2 mtpt -135.16 134.74 40.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.426 . . . . 62.219999999999999 110.901 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.23 171.8 44.89 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 72.409999999999997 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.5 p -81.46 146.31 30.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 73.409999999999997 111.124 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.71 145.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.430000000000007 111.084 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -97.96 -29.31 13.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 65.319999999999993 110.908 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -175.57 144.73 0.68 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 72.25 110.917 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -144.94 98.85 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 72.430000000000007 110.853 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -68.84 117.64 10.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.68 -24.02 21.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 111.121 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.38 -45.01 93.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 110.842 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -90.79 -37.84 13.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.944 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 42.53 2.21 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.731 -0.747 . . . . 50.439999999999998 112.505 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -144.75 168.18 20.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 70.400000000000006 110.936 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 174.43 46.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 71.400000000000006 112.475 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -142.32 125.34 16.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.3 mt -98.44 152.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.540000000000006 111.103 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 18' ' ' ILE . 36.4 mm-40 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.85 0.357 . . . . 60.399999999999999 110.844 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -112.61 145.25 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 74.129999999999995 111.102 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.19 116.85 33.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -125.14 143.39 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 61.229999999999997 111.18 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.3 m170 -121.71 159.41 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 60.210000000000001 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -56.63 -22.46 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 62.119999999999997 110.875 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -95.48 21.46 8.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 111.126 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.65 -3.63 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.450000000000003 111.086 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 29' ' ' HIS . 5.0 mp -90.24 132.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 111.175 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.109999999999999 110.899 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.774 0.321 . . . . 75.129999999999995 110.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.16 130.24 45.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 72.340000000000003 110.894 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 6.77 88.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 44.009999999999998 112.493 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.36 160.3 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 54.219999999999999 110.891 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.5 m-70 -87.03 141.0 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 73.010000000000005 110.857 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.56 140.79 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 111.118 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 24.8 tt0 -97.65 125.75 42.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 64.209999999999994 110.871 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.1 p90 -119.54 146.05 45.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.349999999999994 110.907 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -106.07 98.22 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.91 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 21.9 m -63.66 124.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 71.510000000000005 111.143 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.61 160.67 35.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.618 0.723 . . . . 34.210000000000001 110.863 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.692 2.261 . . . . 72.120000000000005 112.328 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.43 57.3 3.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 73.030000000000001 112.477 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.6 -41.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 71.510000000000005 110.875 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.86 137.54 13.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.76 . . . . 71.219999999999999 112.487 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.39 18.1 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 24.050000000000001 112.477 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.7 -22.89 19.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 74.340000000000003 110.86 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -93.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 73.540000000000006 112.517 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 114.92 3.87 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 61.210000000000001 112.315 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.9 tt0 -119.7 158.0 27.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.911 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.94 58.25 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 65.420000000000002 111.08 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -43.56 -38.02 2.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 72.340000000000003 110.893 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -132.17 106.17 7.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.882 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.769 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.36 142.07 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 61.450000000000003 111.112 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -131.92 142.87 49.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.906 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.74 134.79 37.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 71.340000000000003 110.855 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.6 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 73.340000000000003 111.162 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.848 0.356 . . . . 64.349999999999994 110.896 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.6 mtmt -126.45 134.2 51.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 110.892 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 171.73 43.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.239999999999995 112.536 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -85.64 142.95 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 71.150000000000006 111.16 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.78 144.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.219999999999999 111.151 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -31.76 11.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 50.210000000000001 110.93 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -174.72 138.56 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 110.917 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -138.04 99.28 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.869 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -73.01 116.58 13.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.896 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.77 -20.34 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 75.239999999999995 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.77 -54.92 35.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 72.420000000000002 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -84.34 -35.61 23.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 73.209999999999994 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.74 39.46 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 70.340000000000003 112.458 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -143.92 163.57 33.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 72.140000000000001 110.917 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.95 175.83 43.9 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 74.319999999999993 112.498 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -141.85 128.22 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 72.400000000000006 110.846 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.9 mt -97.7 148.77 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 60.219999999999999 111.112 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.919 179.925 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.87 0.367 . . . . 74.329999999999998 110.866 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.628 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -107.29 144.64 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 54.509999999999998 111.141 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -99.15 119.96 38.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 64.129999999999995 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -130.52 143.33 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.439999999999998 111.109 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.499 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m170 -119.0 156.17 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 110.852 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.626 ' CZ ' HG23 ' A' ' 31' ' ' THR . 3.3 p90 -55.39 -25.12 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.049999999999997 110.871 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.626 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.5 p -94.22 22.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 111.125 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.23 -1.89 8.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 73.319999999999993 111.062 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 65' ' ' VAL . 4.8 mp -92.3 130.72 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 71.239999999999995 111.158 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.884 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.867 0.365 . . . . 63.43 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -58.46 119.03 6.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 45.109999999999999 110.921 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.15 6.57 58.89 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.754 -0.736 . . . . 64.230000000000004 112.494 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -105.18 159.87 15.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.848 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -87.82 140.58 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.109999999999999 110.842 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.1 m -157.99 139.76 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 111.111 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 26.6 tt0 -96.64 126.29 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.851 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 18' ' ' ILE . 20.5 p90 -120.46 143.31 48.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.861 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -105.09 97.33 7.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.32 124.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 62.5 111.129 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -108.88 157.47 36.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.624 0.726 . . . . 70.420000000000002 110.93 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.227 . . . . 60.299999999999997 112.361 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.66 57.09 4.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 51.340000000000003 112.477 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 7.1 tpt180 -132.18 -39.34 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 60.25 110.899 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -93.63 133.62 11.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.781 -0.723 . . . . 61.210000000000001 112.483 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.57 8.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 71.439999999999998 112.528 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.51 -23.9 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 75.010000000000005 110.886 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.69 -93.12 0.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.731 . . . . 51.240000000000002 112.511 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 116.59 4.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.66 2.24 . . . . 71.049999999999997 112.349 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.843 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.3 tm0? -122.3 150.89 41.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 110.909 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -74.52 59.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 55.43 111.135 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -46.44 -37.87 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.5 110.897 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 104.51 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.030000000000001 110.86 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.79 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.18 140.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 63.530000000000001 111.12 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -131.58 143.37 50.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.200000000000003 110.889 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 6.4 ptm180 -78.87 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.519999999999996 110.891 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.439999999999998 111.164 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.803 0.335 . . . . 62.210000000000001 110.938 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.8 mtmp? -125.94 133.3 51.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.129999999999995 110.922 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.11 171.42 42.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 64.310000000000002 112.529 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -87.34 145.88 26.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 71.549999999999997 111.166 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.6 145.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.010000000000005 111.107 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.8 tptt -99.49 -29.79 12.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 64.340000000000003 110.918 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -175.72 137.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 64.450000000000003 110.937 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -135.12 97.93 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.519999999999996 110.876 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.51 92.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 70.120000000000005 110.844 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.95 74.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 51.310000000000002 111.111 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.11 -43.9 90.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.874 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -78.83 -38.37 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.887 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 25.9 7.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 62.299999999999997 112.485 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -140.87 169.66 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 75.420000000000002 110.978 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.94 172.39 45.06 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.746 . . . . 52.200000000000003 112.499 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 74.030000000000001 110.879 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.504 ' CD1' HG11 ' A' ' 28' ' ' VAL . 26.2 mt -98.19 152.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 73.349999999999994 111.165 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 43.8 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.310000000000002 110.92 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.82 0.343 . . . . 75.340000000000003 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.657 ' CG2' HG12 ' A' ' 51' ' ' VAL . 2.2 p -117.42 139.5 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 111.148 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.8 115.73 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 35.420000000000002 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -125.88 144.64 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 65.340000000000003 111.145 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.456 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m-70 -121.23 156.77 31.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 110.828 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -54.69 -24.71 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 71.209999999999994 110.826 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -94.98 24.95 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.219999999999999 111.112 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.71 -0.38 6.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 74.129999999999995 111.127 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -91.43 126.74 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 61.130000000000003 111.148 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 70.109999999999999 110.89 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.806 0.336 . . . . 52.229999999999997 110.901 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 72.040000000000006 110.894 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.27 8.27 60.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.120000000000005 112.511 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.7 158.56 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.918 0.389 . . . . 60.530000000000001 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.538 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-70 -88.29 140.25 29.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 75.140000000000001 110.806 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.82 140.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.7 tt0 -95.66 125.07 39.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.874 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CD1' HG21 ' A' ' 18' ' ' ILE . 25.5 p90 -118.86 144.33 46.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.239999999999995 110.859 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.1 mm-40 -105.9 97.79 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 74.530000000000001 110.889 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.849 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.5 m -64.13 117.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 43.299999999999997 111.125 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -108.65 160.17 28.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.662 0.744 . . . . 73.549999999999997 110.92 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 51.340000000000003 112.325 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 55.79 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 73.25 112.522 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -130.72 -41.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 73.099999999999994 110.895 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.01 142.19 15.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 64.340000000000003 112.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.51 -47.1 29.51 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 71.319999999999993 112.504 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.8 -22.72 34.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 74.340000000000003 110.916 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.13 -89.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 62.539999999999999 112.484 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 116.51 4.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.646 2.231 . . . . 75.519999999999996 112.367 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.9 tt0 -123.79 157.6 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.33 57.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.310000000000002 111.109 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -44.44 -37.57 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 62.509999999999998 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -130.67 104.86 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 71.420000000000002 110.927 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -107.76 141.55 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.155 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -131.43 142.7 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.837 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.765 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.1 ppt_? -78.44 134.37 37.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 71.310000000000002 110.896 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.571 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.2 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 70.319999999999993 111.163 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.866 0.365 . . . . 74.129999999999995 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 14.9 mttp -133.06 137.88 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.956 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.96 171.51 44.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.702 -0.761 . . . . 74.420000000000002 112.461 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 p -85.55 144.12 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 74.099999999999994 111.109 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.3 144.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 54.439999999999998 111.123 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -99.48 -30.2 12.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 71.040000000000006 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -175.19 139.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 110.907 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.8 99.41 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 74.140000000000001 110.901 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -69.59 93.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.53 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 62.020000000000003 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -67.16 -35.86 80.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 110.845 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -94.04 -36.97 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.14 32.53 4.92 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 74.450000000000003 112.477 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -146.28 168.12 21.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.888 0.375 . . . . 74.25 110.947 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.66 179.03 46.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.746 -0.74 . . . . 71.510000000000005 112.464 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -142.35 130.69 22.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 71.310000000000002 110.895 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.594 HD13 ' CD1' ' A' ' 49' ' ' PHE . 28.5 mt -97.09 144.21 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 74.019999999999996 111.117 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 72.120000000000005 110.9 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.826 0.346 . . . . 74.420000000000002 110.871 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.4 142.77 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.350000000000001 111.127 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.26 116.3 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.340000000000003 110.897 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.766 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.6 m -122.99 141.33 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 71.230000000000004 111.133 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -121.55 159.83 25.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 70.519999999999996 110.819 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -56.66 -22.32 33.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 110.853 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -94.37 19.78 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.119999999999997 111.12 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.83 -7.97 8.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.430000000000007 111.117 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -88.66 132.79 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.230000000000004 111.149 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.891 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.824 0.345 . . . . 61.350000000000001 110.918 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.68 117.64 4.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 73.109999999999999 110.875 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.88 7.06 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 44.539999999999999 112.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.15 160.41 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 75.549999999999997 110.892 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.521 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.4 m-70 -89.05 141.78 28.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.530000000000001 110.812 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.9 m -158.37 139.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 53.119999999999997 111.178 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.8 tt0 -98.17 126.4 43.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.88 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 18' ' ' ILE . 34.5 p90 -119.72 146.65 45.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.85 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 38.4 mt-10 -105.0 98.88 8.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 110.857 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -52.04 128.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 72.230000000000004 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.477 ' H ' ' H ' ' A' ' 61' ' ' GLN . 3.0 tp10 -112.58 138.57 22.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.661 0.743 . . . . 74.25 110.874 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 72.140000000000001 112.372 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.32 53.71 4.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 72.349999999999994 112.437 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -134.74 -40.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 71.519999999999996 110.854 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.53 134.59 13.91 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.735 . . . . 75.239999999999995 112.504 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.66 -36.81 13.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 41.439999999999998 112.504 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -100.62 -19.31 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 61.009999999999998 110.895 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.88 -103.07 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 52.109999999999999 112.5 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 113.22 3.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.695 2.263 . . . . 71.400000000000006 112.324 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.0 pt20 -119.32 175.99 5.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.030000000000001 110.944 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -93.23 62.6 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.43 111.075 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -46.21 -38.82 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.934 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 5.7 tmtt? -132.12 104.92 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 110.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.53 141.38 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 70.230000000000004 111.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -131.65 142.08 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 71.319999999999993 110.879 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.764 ' HA ' HG12 ' A' ' 47' ' ' VAL . 22.8 ptt85 -77.62 135.64 38.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.866 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.1 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 111.146 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.889 0.376 . . . . 62.32 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.3 mtmm -127.05 131.17 51.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.13 172.29 39.91 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.738 -0.744 . . . . 54.130000000000003 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.5 p -86.49 141.13 29.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 64.219999999999999 111.11 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.661 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -81.58 144.83 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.040000000000006 111.14 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -30.59 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 70.219999999999999 110.881 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -175.9 138.9 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.246 -0.434 . . . . 73.530000000000001 110.945 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.436 ' HE1' HD11 ' A' ' 33' ' ' ILE . 62.2 t80 -131.74 99.08 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 72.420000000000002 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -68.62 90.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 55.350000000000001 110.868 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.14 67.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.040000000000006 111.078 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -65.73 -46.73 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 63.149999999999999 110.875 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -77.21 -34.13 56.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.887 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.1 19.46 14.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 60.119999999999997 112.481 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -138.87 173.78 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 65.349999999999994 110.876 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.82 174.59 45.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 52.25 112.465 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -141.38 125.26 17.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 60.450000000000003 110.845 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 HG12 HG23 ' A' ' 6' ' ' VAL . 25.2 mt -98.02 152.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 111.094 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.89 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.842 0.353 . . . . 75.349999999999994 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.624 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -125.68 148.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 60.310000000000002 111.113 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.5 118.96 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 73.019999999999996 110.87 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -131.06 142.29 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 73.0 111.11 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 4.5 m170 -121.54 157.58 30.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 110.843 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CZ ' HG23 ' A' ' 31' ' ' THR . 6.1 p90 -56.28 -24.28 42.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.883 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -93.93 20.28 7.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 111.147 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.91 -5.47 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.11 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.5 mp -89.38 132.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 111.154 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.109999999999999 110.912 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.776 0.322 . . . . 73.439999999999998 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.03 119.77 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 54.409999999999997 110.868 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.65 64.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.512 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -106.89 160.79 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 74.109999999999999 110.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.535 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -89.37 142.31 27.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 61.539999999999999 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -159.09 140.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 111.086 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.9 tt0 -96.07 125.73 40.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.340000000000003 110.855 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 25.0 p90 -121.27 143.23 49.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 110.861 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.94 98.06 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 55.340000000000003 110.894 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.7 m -64.19 118.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 73.049999999999997 111.156 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.91 158.16 33.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.629 0.728 . . . . 71.409999999999997 110.909 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -88.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 2.252 . . . . 70.129999999999995 112.339 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.96 55.92 3.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 70.450000000000003 112.454 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -133.35 -41.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 74.510000000000005 110.885 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.44 134.91 12.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 53.119999999999997 112.494 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.87 -34.32 11.02 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.742 -0.742 . . . . 54.450000000000003 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -21.38 16.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.340000000000003 110.922 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.44 -93.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 74.25 112.518 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.6 4.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.644 2.23 . . . . 71.319999999999993 112.373 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -122.23 154.34 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.299999999999997 110.899 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.779 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.26 57.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 64.219999999999999 111.099 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -38.81 5.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 110.911 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 11.7 tttp -129.61 103.35 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.905 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.779 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.59 142.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 111.103 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -132.8 143.02 49.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.219999999999999 110.927 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 35.7 mtp180 -78.66 134.23 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 74.129999999999995 110.854 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.099999999999994 111.118 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.847 0.356 . . . . 51.439999999999998 110.907 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -128.41 137.62 51.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 52.420000000000002 110.872 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.57 171.45 44.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 63.32 112.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 p -81.52 156.65 25.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 70.140000000000001 111.162 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -99.57 143.41 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 111.124 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -97.35 -28.68 13.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.9 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -174.77 138.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 72.099999999999994 110.901 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.473 ' CE1' HD11 ' A' ' 33' ' ' ILE . 69.7 t80 -136.11 98.96 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.869 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.908 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.52 -27.85 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.082 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.67 -40.9 96.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.872 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -94.88 -37.33 11.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 55.32 110.938 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 46.31 1.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 53.109999999999999 112.466 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -157.53 142.94 17.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 72.120000000000005 110.905 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.62 -176.41 25.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 63.149999999999999 112.494 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -141.2 132.57 26.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 74.209999999999994 110.866 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.7 mt -106.53 149.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 73.200000000000003 111.159 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 64.530000000000001 110.912 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.847 0.356 . . . . 53.399999999999999 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.688 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -121.68 141.46 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 111.146 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.31 116.29 31.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.120000000000005 110.882 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -121.05 145.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 75.549999999999997 111.128 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 m-70 -124.64 159.36 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.88 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -55.48 -23.18 24.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.120000000000005 110.903 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -95.81 23.81 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 72.519999999999996 111.121 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.23 -3.0 6.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 60.210000000000001 111.094 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.517 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -91.74 131.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 111.103 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 62.509999999999998 110.897 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.781 0.324 . . . . 62.32 110.931 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.83 122.7 13.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.9 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.38 76.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 63.030000000000001 112.492 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -106.73 160.39 15.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.947 0.403 . . . . 74.430000000000007 110.838 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -89.1 141.07 28.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 73.5 110.826 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.5 140.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 111.136 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.2 tt0 -95.39 127.54 41.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 64.140000000000001 110.887 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -119.73 144.58 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 74.219999999999999 110.86 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -106.8 97.18 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.863 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.829 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.1 m -60.8 127.81 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 75.420000000000002 111.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -121.69 158.86 53.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.632 0.73 . . . . 55.340000000000003 110.903 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -88.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.732 2.288 . . . . 64.209999999999994 112.312 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.83 57.43 3.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 73.219999999999999 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.62 -42.01 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 75.409999999999997 110.858 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.91 138.24 13.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 71.25 112.517 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -39.88 21.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 54.219999999999999 112.455 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.46 -25.04 25.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 71.010000000000005 110.862 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.54 -92.67 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 65.129999999999995 112.475 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.11 3.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.677 2.251 . . . . 71.129999999999995 112.32 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.829 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -118.24 158.12 25.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.892 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.91 57.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 70.310000000000002 111.121 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -39.67 -43.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 53.229999999999997 110.937 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.8 mttt -126.63 108.35 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.918 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.695 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.32 141.44 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 52.520000000000003 111.152 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -131.6 142.28 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 62.140000000000001 110.88 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.749 ' HA ' HG12 ' A' ' 47' ' ' VAL . 45.2 ttt-85 -79.22 134.92 36.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 62.409999999999997 110.889 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.299999999999997 111.126 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.853 0.359 . . . . 52.329999999999998 110.906 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 12.3 mtpt -133.37 133.78 42.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.898 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.55 171.53 44.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 73.439999999999998 112.453 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -85.61 142.12 29.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 111.168 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.82 144.57 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 111.118 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -30.77 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 110.879 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -176.51 137.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.913 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -134.83 98.9 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.329999999999998 110.87 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.15 93.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 62.409999999999997 110.855 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.33 -31.46 70.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 111.097 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -65.47 -41.41 93.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 65.430000000000007 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -83.63 -38.5 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 110.909 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 26.64 7.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 61.509999999999998 112.472 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.91 169.01 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 110.9 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.66 173.63 45.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 51.140000000000001 112.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -141.93 128.92 20.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 61.219999999999999 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 49' ' ' PHE . 29.1 mt -97.08 146.5 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 42.200000000000003 111.094 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 64.340000000000003 110.877 179.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 60.32 110.874 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.478 ' CG2' HG12 ' A' ' 51' ' ' VAL . 3.1 p -113.27 138.39 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.349999999999994 111.179 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.75 115.89 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.17 143.42 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.120000000000005 111.107 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -118.39 158.52 25.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 63.399999999999999 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -56.0 -25.09 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.858 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.47 22.09 5.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.17 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.18 -0.99 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 52.219999999999999 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 65' ' ' VAL . 5.0 mp -93.13 130.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 111.146 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.876 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.771 0.32 . . . . 60.109999999999999 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -59.75 118.38 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.25 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 6.62 57.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 73.319999999999993 112.527 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.66 158.4 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 70.319999999999993 110.86 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.531 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.0 m-70 -87.5 141.54 28.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 62.030000000000001 110.874 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.57 139.97 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.091 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 28.4 tt0 -97.47 125.11 41.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 65.420000000000002 110.875 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 18' ' ' ILE . 27.6 p90 -120.57 144.41 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.887 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.63 97.36 7.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.019999999999996 110.899 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.852 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -62.91 122.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.102 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -111.98 159.18 34.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.658 0.742 . . . . 74.109999999999999 110.921 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 71.5 112.356 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.96 57.92 4.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 74.439999999999998 112.455 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -130.52 -41.88 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.340000000000003 110.855 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.93 137.08 13.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 50.109999999999999 112.468 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -35.52 14.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.724 -0.75 . . . . 61.439999999999998 112.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -91.34 -25.24 19.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 73.420000000000002 110.949 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.28 -91.79 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.742 -0.742 . . . . 72.430000000000007 112.501 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 116.55 4.62 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.653 2.236 . . . . 71.120000000000005 112.354 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.852 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 tt0 -118.26 156.51 28.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.010000000000005 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.54 58.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 41.399999999999999 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -40.89 -42.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.209999999999994 110.911 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 16.0 tttp -134.03 108.26 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.329999999999998 110.901 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -107.11 141.8 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.133 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -131.75 142.75 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.299999999999997 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -77.96 134.89 37.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.912 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.5 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.420000000000002 111.123 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.844 0.354 . . . . 64.310000000000002 110.892 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.6 mttt -129.9 137.37 50.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.899 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.45 171.35 44.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 61.420000000000002 112.504 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -88.82 138.99 30.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 65.109999999999999 111.112 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 145.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 64.299999999999997 111.136 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -101.05 -27.78 13.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.319999999999993 110.918 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -176.01 140.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 65.340000000000003 110.891 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -135.78 99.41 4.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 73.120000000000005 110.849 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -67.66 117.4 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.299999999999997 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.41 18.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.530000000000001 111.115 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -59.93 -31.85 70.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 110.898 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -107.88 -33.78 7.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.92 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.95 40.37 2.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 71.129999999999995 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.3 p90 -142.52 173.85 11.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 74.340000000000003 110.932 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.06 174.61 46.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 74.219999999999999 112.487 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -140.58 126.65 19.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 62.520000000000003 110.89 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 28' ' ' VAL . 24.2 mt -98.44 151.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 71.450000000000003 111.127 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.0 110.951 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.917 0.389 . . . . 75.099999999999994 110.877 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.662 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -118.3 145.25 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.157 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.97 33.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 71.230000000000004 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -124.97 142.32 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 74.420000000000002 111.119 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -122.3 161.03 24.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.019999999999996 110.857 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.03 -21.97 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 110.855 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -94.16 19.74 8.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.310000000000002 111.125 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.7 -22.03 7.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 73.310000000000002 111.099 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -71.08 127.39 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 71.5 111.138 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.510000000000005 110.86 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.754 0.311 . . . . 63.32 110.934 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -62.22 120.38 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.894 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 5.09 68.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.729 . . . . 73.450000000000003 112.537 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.6 158.33 15.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 75.230000000000004 110.922 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.0 m-70 -86.92 139.39 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.439999999999998 110.829 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.4 m -158.54 139.93 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 111.144 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 tt0 -97.0 125.06 41.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 110.883 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.5 p90 -118.44 145.82 44.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.099999999999994 110.902 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -106.49 98.35 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 53.399999999999999 110.895 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.7 m -62.92 124.87 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 45.43 111.117 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.64 160.67 35.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.63 0.729 . . . . 75.099999999999994 110.879 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -88.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 73.450000000000003 112.339 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.06 57.07 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 61.229999999999997 112.465 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.51 -41.71 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 74.319999999999993 110.835 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.64 136.59 12.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 60.240000000000002 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.67 -34.83 15.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 42.340000000000003 112.501 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -22.94 18.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.339 . . . . 74.430000000000007 110.818 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.22 -93.36 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.732 . . . . 62.140000000000001 112.48 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.66 3.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.356 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.855 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 9.4 tt0 -120.05 157.92 27.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 110.93 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.805 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.97 57.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 60.43 111.087 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.49 -38.85 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.886 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.67 104.75 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.881 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.805 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.15 141.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 53.409999999999997 111.14 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -131.33 141.9 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.200000000000003 110.848 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.756 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.52 134.85 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 111.115 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.872 0.368 . . . . 63.109999999999999 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 25.4 mttt -127.52 133.88 49.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.010000000000005 110.895 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.46 171.75 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.774 -0.727 . . . . 74.409999999999997 112.48 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.5 p -85.41 144.88 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 72.340000000000003 111.153 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -84.88 147.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 75.310000000000002 111.135 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.08 -32.36 10.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.040000000000006 110.902 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -174.74 141.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 73.540000000000006 110.929 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -141.15 98.94 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.519999999999996 110.861 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -65.21 119.22 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.009999999999998 110.949 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.24 21.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 61.340000000000003 111.071 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.5 -38.41 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 63.329999999999998 110.895 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -97.88 -38.03 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 70.530000000000001 110.904 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 44.67 1.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 65.310000000000002 112.474 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.48 168.47 25.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 73.200000000000003 110.96 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.77 -179.37 45.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 72.239999999999995 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -141.01 126.27 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 70.129999999999995 110.874 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 6' ' ' VAL . 23.2 mt -98.76 150.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 54.25 111.142 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 43.8 mm-40 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 110.86 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.856 0.36 . . . . 71.439999999999998 110.906 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.77 142.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.63 116.37 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.239999999999995 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -121.42 142.52 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 111.099 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.472 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -123.53 160.07 27.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 75.239999999999995 110.849 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -56.93 -21.43 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.896 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.6 t -95.0 19.81 9.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 111.134 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.67 -24.2 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 52.310000000000002 111.061 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -70.47 124.07 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.152 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.919 179.913 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.805 0.335 . . . . 73.310000000000002 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.18 121.87 14.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.010000000000005 110.871 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.92 72.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 64.030000000000001 112.497 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.31 157.43 15.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 62.299999999999997 110.894 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.2 m-70 -85.91 138.36 32.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.843 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.0 m -158.22 140.39 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 55.450000000000003 111.148 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 39.7 tt0 -95.86 125.95 40.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.917 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -118.3 145.54 45.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.881 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -106.71 97.73 7.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 63.32 110.848 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.1 m -62.0 123.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 71.540000000000006 111.083 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -113.97 161.16 29.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.622 0.725 . . . . 71.040000000000006 110.883 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 74.040000000000006 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.23 57.27 4.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 74.239999999999995 112.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 4.0 mpt_? -128.96 -41.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 71.120000000000005 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.96 14.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 65.239999999999995 112.467 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.27 -41.93 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 51.549999999999997 112.463 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.44 -22.52 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 55.549999999999997 110.927 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.56 -89.87 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 61.43 112.478 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 114.82 3.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.658 2.239 . . . . 64.549999999999997 112.338 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.851 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.8 tt0 -119.23 156.55 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 71.200000000000003 110.921 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.738 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.03 57.09 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.219999999999999 111.144 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -41.74 -49.89 4.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 32.439999999999998 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.3 tttp -120.06 108.23 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 62.109999999999999 110.94 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.726 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.08 142.23 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.420000000000002 111.162 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -131.0 142.83 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 110.86 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HA ' HG12 ' A' ' 47' ' ' VAL . 38.4 ptt180 -78.75 134.88 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 75.040000000000006 110.852 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 43.299999999999997 111.122 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.0 mtpp -132.02 133.17 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 55.329999999999998 110.895 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.8 171.14 43.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 72.430000000000007 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.8 p -82.46 146.62 29.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 71.010000000000005 111.105 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.69 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -87.68 145.89 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 111.117 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -36.74 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 64.409999999999997 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -170.52 141.6 1.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 71.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -136.49 99.29 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 75.049999999999997 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 103.2 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 52.240000000000002 110.919 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.3 47.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 54.340000000000003 111.113 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.46 -47.63 69.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.883 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.21 -36.08 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.862 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.13 2.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 53.399999999999999 112.513 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -152.74 151.35 30.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 64.120000000000005 110.91 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.28 176.53 32.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 73.439999999999998 112.451 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.53 122.93 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.430000000000007 110.883 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 6' ' ' VAL . 17.6 mt -97.99 154.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.030000000000001 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 18' ' ' ILE . 23.1 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.926 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.818 0.342 . . . . 61.329999999999998 110.835 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' CD2' ' A' ' 49' ' ' PHE . 3.4 p -113.69 136.05 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 54.409999999999997 111.121 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.71 115.4 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.409999999999997 110.938 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -124.97 143.72 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.030000000000001 111.133 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' HD12 ' A' ' 33' ' ' ILE . 18.0 m170 -122.4 158.87 28.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 62.32 110.867 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.96 -24.42 38.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -94.72 23.01 5.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.439999999999998 111.153 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.75 -2.02 7.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.319999999999993 111.095 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 65' ' ' VAL . 4.8 mp -91.39 131.97 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 111.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.894 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.798 0.333 . . . . 61.020000000000003 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.94 121.23 9.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.230000000000004 110.85 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.54 7.27 67.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 24.420000000000002 112.511 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -106.84 160.62 15.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.851 0.358 . . . . 75.349999999999994 110.893 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -88.74 141.96 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -158.63 140.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 54.310000000000002 111.142 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 33.4 tt0 -94.62 126.8 40.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 110.905 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG21 ' A' ' 26' ' ' VAL . 14.0 p90 -120.7 142.03 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.851 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.03 97.58 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 73.420000000000002 110.902 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.846 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.5 m -63.0 126.9 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 73.230000000000004 111.141 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.68 159.47 46.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.679 0.752 . . . . 73.25 110.906 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -87.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.725 2.283 . . . . 71.530000000000001 112.354 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.36 55.92 4.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 52.329999999999998 112.45 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.0 -41.76 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 72.140000000000001 110.887 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.53 137.68 13.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 12.140000000000001 112.474 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.87 -38.36 23.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 73.230000000000004 112.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.98 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 70.040000000000006 110.876 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.32 -93.96 0.15 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 73.420000000000002 112.456 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 112.77 3.16 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 42.520000000000003 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.846 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.6 tt0 -117.86 156.77 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.915 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.39 59.11 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 60.43 111.1 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -41.82 -38.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 54.109999999999999 110.949 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -130.85 109.63 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 52.509999999999998 110.863 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.3 141.24 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 65.450000000000003 111.13 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -131.52 141.14 49.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.898 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 15.2 ptm180 -78.67 133.45 37.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 62.200000000000003 110.857 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.135 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.887 0.375 . . . . 72.510000000000005 110.882 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -130.99 137.13 49.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.91 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.22 41.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.219999999999999 112.51 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p -84.91 138.04 32.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 74.420000000000002 111.13 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.95 144.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 71.030000000000001 111.106 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -99.66 -30.49 12.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.872 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -175.41 136.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 110.894 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -135.48 98.92 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.892 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -69.19 112.32 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.540000000000006 110.929 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.47 -30.13 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.409999999999997 111.113 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -62.94 -53.89 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -75.03 -32.14 61.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 72.209999999999994 110.914 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.1 30.84 8.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 64.25 112.482 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -139.93 169.13 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 64.129999999999995 110.926 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.67 173.59 46.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.754 -0.736 . . . . 74.400000000000006 112.491 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -140.91 126.81 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 74.530000000000001 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.756 HG12 HG23 ' A' ' 6' ' ' VAL . 24.4 mt -102.03 152.98 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.040000000000006 111.122 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' ILE . 59.3 mm-40 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.932 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.842 0.353 . . . . 74.140000000000001 110.846 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.612 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -132.67 143.21 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 111.141 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.38 120.28 34.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -130.42 142.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 70.010000000000005 111.104 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 6.2 m170 -122.95 157.92 31.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 71.409999999999997 110.869 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.66 -23.51 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.349999999999994 110.848 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.0 t -94.51 19.46 9.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 111.173 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -120.36 -8.75 9.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 44.310000000000002 111.056 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG23 HG12 ' A' ' 65' ' ' VAL . 4.6 mp -85.47 131.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 62.219999999999999 111.142 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 72.0 110.885 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.792 0.33 . . . . 74.340000000000003 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -57.06 122.38 12.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.400000000000006 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.01 5.68 67.73 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 61.219999999999999 112.506 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -106.71 160.48 15.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 65.310000000000002 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.497 ' O ' HG13 ' A' ' 47' ' ' VAL . 13.4 m-70 -89.82 142.34 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 63.299999999999997 110.869 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.4 m -157.71 140.2 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 70.340000000000003 111.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 tt0 -96.75 125.11 40.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 62.420000000000002 110.913 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -119.09 144.17 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.140000000000001 110.936 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.426 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -102.57 98.07 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.94 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.7 m -61.89 118.23 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.450000000000003 111.115 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -107.51 156.46 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.439999999999998 110.854 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.5 Cg_endo -69.78 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.717 2.278 . . . . 55.210000000000001 112.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 56.51 3.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 40.409999999999997 112.483 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -132.28 -41.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 71.209999999999994 110.871 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.94 134.02 12.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 65.120000000000005 112.475 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.3 7.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 70.420000000000002 112.454 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -23.2 15.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 65.239999999999995 110.939 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.51 -93.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 72.310000000000002 112.497 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 117.07 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 72.209999999999994 112.339 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 15.1 tt0 -120.99 157.38 30.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.530000000000001 110.932 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.788 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.59 56.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.120000000000005 111.131 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -40.68 -46.04 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.907 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.5 tttp -126.44 105.82 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.400000000000006 110.926 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.788 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -105.87 142.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.540000000000006 111.108 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -132.38 146.14 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 133.93 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.420000000000002 110.895 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 63.409999999999997 111.14 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.835 0.35 . . . . 71.340000000000003 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 18.3 mtmt -131.06 135.71 47.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.857 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.91 171.48 44.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 73.120000000000005 112.466 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -82.77 143.95 30.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 71.200000000000003 111.112 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.7 144.58 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.030000000000001 111.13 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -31.11 12.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 74.040000000000006 110.911 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -175.09 140.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -139.27 98.85 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.109999999999999 110.914 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -70.74 109.39 4.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.65 35.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 53.439999999999998 111.103 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.24 -48.19 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.430000000000007 110.889 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -87.88 -37.36 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 71.109999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.17 41.2 2.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 61.020000000000003 112.484 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.97 167.77 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 75.209999999999994 110.905 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.09 46.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.310000000000002 112.477 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -141.88 124.77 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 72.120000000000005 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.8 mt -98.09 151.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 74.099999999999994 111.151 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.200000000000003 110.914 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -112.38 146.02 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 111.145 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -100.44 116.68 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.430000000000007 110.886 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -124.72 144.04 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 71.439999999999998 111.125 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.9 m170 -123.12 159.29 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.049999999999997 110.869 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -56.25 -21.99 27.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 72.230000000000004 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -96.11 22.12 7.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 42.149999999999999 111.138 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.6 -4.53 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 50.420000000000002 111.103 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.9 mp -89.98 132.41 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 64.109999999999999 111.118 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.882 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.825 0.345 . . . . 65.319999999999993 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -57.17 120.19 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.219999999999999 110.883 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.06 62.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 74.439999999999998 112.462 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -106.87 160.32 15.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 73.200000000000003 110.897 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.9 m-70 -89.62 141.64 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.52 140.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 70.219999999999999 111.156 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -98.03 125.85 43.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.928 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.1 p90 -119.91 143.43 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 70.420000000000002 110.867 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 2.3 mt-10 -99.79 99.05 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 110.863 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.4 m -56.45 122.78 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 62.509999999999998 111.13 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.8 tt0 -101.87 140.79 21.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.25 110.9 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.68 -92.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.688 2.259 . . . . 55.109999999999999 112.373 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.15 53.95 4.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.479 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -39.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 71.349999999999994 110.863 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 134.43 16.83 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 71.209999999999994 112.508 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.91 -36.67 8.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 61.109999999999999 112.494 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.66 -14.36 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 72.310000000000002 110.873 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.52 -104.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 52.350000000000001 112.486 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 53.1 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.652 2.235 . . . . 63.039999999999999 112.326 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.7 pt20 -115.16 171.03 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.549999999999997 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -85.6 61.62 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 54.350000000000001 111.142 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 14.3 ttmt -42.02 -46.37 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 74.549999999999997 110.885 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 107.14 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 72.349999999999994 110.895 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.6 141.03 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 75.400000000000006 111.116 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -132.02 142.18 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 110.838 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.76 ' HA ' HG12 ' A' ' 47' ' ' VAL . 62.1 ttt180 -77.57 134.2 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.876 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 67' ' ' ARG . 9.0 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 62.229999999999997 111.13 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.898 0.38 . . . . 75.230000000000004 110.871 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.8 mtpt -127.23 134.11 50.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.884 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.53 172.37 44.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.787 -0.721 . . . . 74.430000000000007 112.538 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 76.2 p -83.39 144.93 29.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 75.409999999999997 111.161 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.21 145.15 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 111.116 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -31.06 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 71.450000000000003 110.885 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -175.69 137.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.884 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.2 99.19 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.420000000000002 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -74.16 113.04 10.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 65.109999999999999 110.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.76 -34.43 30.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 72.010000000000005 111.116 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -56.6 -48.48 77.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 63.310000000000002 110.855 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.28 -28.91 26.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 72.510000000000005 110.922 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.38 19.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 75.420000000000002 112.468 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -133.59 169.21 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 55.310000000000002 110.906 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.25 173.59 45.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 65.209999999999994 112.487 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -142.39 128.4 19.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 73.310000000000002 110.903 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.6 mt -97.7 149.24 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 61.439999999999998 111.081 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.420000000000002 110.914 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.836 0.35 . . . . 61.210000000000001 110.877 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -106.73 144.93 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 111.174 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.93 122.18 41.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.019999999999996 110.907 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -132.87 141.81 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 63.409999999999997 111.15 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -115.78 155.4 27.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -54.88 -25.06 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.886 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -93.74 23.62 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 72.329999999999998 111.121 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.24 -1.2 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 65.329999999999998 111.039 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.479 HG13 HG11 ' A' ' 65' ' ' VAL . 4.3 mp -90.21 126.4 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.420000000000002 111.12 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.912 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.831 0.348 . . . . 73.030000000000001 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.06 118.81 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 65.439999999999998 110.858 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.77 4.17 58.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.754 . . . . 71.219999999999999 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -101.6 155.51 18.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 72.439999999999998 110.879 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.534 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.9 m-70 -85.63 140.86 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.889 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.77 140.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 21.7 tt0 -98.07 126.35 43.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.854 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' HD13 ' A' ' 18' ' ' ILE . 22.8 p90 -118.42 146.88 44.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 65.319999999999993 110.883 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -105.97 96.32 6.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 74.310000000000002 110.893 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.1 m -63.4 123.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 111.114 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -115.55 160.33 35.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.674 0.749 . . . . 73.340000000000003 110.875 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 52.340000000000003 112.338 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.7 57.01 3.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.74 . . . . 33.240000000000002 112.507 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 5.0 mpt_? -132.79 -41.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 64.209999999999994 110.865 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 134.53 12.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 75.540000000000006 112.508 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.89 -33.93 10.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.310000000000002 112.475 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.32 -22.35 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 110.851 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.37 -92.5 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.691 -0.766 . . . . 73.120000000000005 112.476 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 115.06 3.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.267 . . . . 63.119999999999997 112.346 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -118.92 154.29 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.329999999999998 110.879 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -76.85 56.5 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.43 111.128 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.38 -47.08 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 52.329999999999998 110.92 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -126.54 108.33 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 70.409999999999997 110.92 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -110.21 141.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 72.540000000000006 111.156 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -131.3 143.24 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.866 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.755 ' HA ' HG12 ' A' ' 47' ' ' VAL . 18.2 mmm-85 -78.06 135.78 37.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 110.855 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.8 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.329999999999998 111.121 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 74.230000000000004 110.908 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 mtpt -130.32 133.44 46.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.009999999999998 110.932 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.86 171.63 44.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 63.109999999999999 112.479 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -85.63 142.96 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.334 . . . . 73.230000000000004 111.163 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -77.81 144.06 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 61.049999999999997 111.156 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -29.41 13.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -177.41 145.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 74.040000000000006 110.958 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -138.13 103.37 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 72.5 110.876 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -72.36 106.72 4.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 110.886 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.02 -35.95 41.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 111.081 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -57.17 -42.58 81.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.889 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -86.77 -33.68 19.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 73.400000000000006 110.901 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 22.46 16.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 55.450000000000003 112.499 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -130.56 176.39 8.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.98 44.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.521 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -141.27 125.25 17.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 75.430000000000007 110.872 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 6' ' ' VAL . 21.0 mt -98.06 151.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 72.510000000000005 111.095 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 72.549999999999997 110.941 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.864 0.364 . . . . 71.439999999999998 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.59 143.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 111.184 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.36 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 54.32 110.874 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -128.75 143.3 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.125 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -118.1 157.14 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.865 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -54.83 -25.45 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.9 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 t -93.62 25.0 3.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 52.399999999999999 111.129 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.26 -1.08 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 31.34 111.121 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 65' ' ' VAL . 4.0 mp -88.92 123.3 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 53.020000000000003 111.132 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.859 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.843 0.354 . . . . 70.040000000000006 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.45 120.19 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 72.209999999999994 110.874 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.14 3.2 60.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 74.349999999999994 112.437 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.41 156.71 16.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.219999999999999 110.909 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.0 m-70 -84.71 139.22 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.420000000000002 110.888 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.8 m -158.43 140.17 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.115 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -94.28 126.34 39.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 75.299999999999997 110.919 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 16.8 p90 -119.89 143.52 47.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 65.409999999999997 110.843 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.62 98.5 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.904 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.874 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.8 m -63.21 125.46 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.450000000000003 111.146 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.3 mm-40 -112.57 160.73 29.38 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 73.030000000000001 110.906 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -90.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 62.119999999999997 112.354 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.91 58.93 4.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 73.010000000000005 112.453 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -41.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 61.219999999999999 110.906 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.81 136.1 13.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 44.43 112.525 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.93 -31.81 8.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 65.030000000000001 112.463 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -100.41 -22.6 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 73.099999999999994 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.58 -91.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 75.030000000000001 112.468 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.667 2.244 . . . . 72.109999999999999 112.328 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.874 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -119.36 154.81 33.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.530000000000001 110.903 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -80.1 61.16 3.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 111.111 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -46.75 -41.4 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.129999999999995 110.884 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 56.2 mmtt -125.6 110.74 14.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.349999999999994 110.909 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -111.97 141.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 62.350000000000001 111.133 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -130.87 141.87 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 70.109999999999999 110.871 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.753 ' HA ' HG12 ' A' ' 47' ' ' VAL . 23.6 mtp180 -78.38 134.28 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.540000000000006 110.918 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.4 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 63.310000000000002 111.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 71.239999999999995 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.3 mtmt -129.45 129.25 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 41.210000000000001 110.891 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.85 41.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 40.039999999999999 112.446 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -85.04 145.97 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 70.010000000000005 111.147 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -86.72 144.54 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.154 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.0 tppt? -99.25 -30.08 12.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.875 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -175.34 137.17 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 70.439999999999998 110.893 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.33 98.88 3.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 73.099999999999994 110.861 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -65.98 115.96 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.120000000000005 110.888 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.05 -25.34 23.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 63.329999999999998 111.077 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.98 -40.57 75.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.879 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -87.02 -38.77 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 64.109999999999999 110.918 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.55 34.74 4.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 71.409999999999997 112.487 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 2.8 p90 -146.87 169.0 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 71.430000000000007 110.913 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.66 177.06 46.15 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 64.230000000000004 112.525 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.99 126.29 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 75.450000000000003 110.869 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 6' ' ' VAL . 26.4 mt -99.87 152.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 65.340000000000003 111.095 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 50.7 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.120000000000005 110.929 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.851 0.357 . . . . 73.010000000000005 110.874 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -134.26 144.59 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 40.229999999999997 111.131 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.11 119.04 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.530000000000001 110.85 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -127.73 140.27 49.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 71.120000000000005 111.103 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.537 ' O ' HD12 ' A' ' 33' ' ' ILE . 14.3 m170 -119.98 157.78 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 72.129999999999995 110.854 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' HG23 ' A' ' 31' ' ' THR . 2.5 p90 -56.43 -23.93 41.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 110.915 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.617 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.0 p -93.93 19.96 8.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 64.420000000000002 111.153 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.07 -7.93 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 42.340000000000003 111.088 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.537 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -87.09 132.24 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 73.140000000000001 111.095 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 62.009999999999998 110.873 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.785 0.326 . . . . 73.510000000000005 110.861 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.49 121.29 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 74.299999999999997 110.842 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.58 65.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 71.409999999999997 112.487 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -106.57 159.93 15.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 65.239999999999995 110.854 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.1 m-70 -87.91 141.53 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 63.439999999999998 110.82 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.63 139.77 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 70.219999999999999 111.146 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.76 125.67 42.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 61.100000000000001 110.854 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.2 p90 -120.99 144.6 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 62.130000000000003 110.895 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.43 99.2 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 63.210000000000001 110.877 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -62.8 121.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 72.129999999999995 111.168 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -103.38 148.98 36.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.666 0.746 . . . . 75.430000000000007 110.892 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 64.519999999999996 112.383 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 58.13 5.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 73.349999999999994 112.491 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -135.38 -40.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 61.210000000000001 110.911 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 61' ' ' GLN . . . -83.19 142.3 21.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 62.43 112.501 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.56 -38.05 27.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.768 -0.73 . . . . 64.219999999999999 112.504 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -100.45 -17.74 17.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 73.030000000000001 110.901 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.12 -98.44 0.21 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 61.149999999999999 112.471 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 111.77 2.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 55.340000000000003 112.292 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -119.46 165.79 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.310000000000002 110.911 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -82.67 58.79 4.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 64.540000000000006 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 10.0 ttpt -43.66 -38.81 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.918 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -133.9 104.94 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 53.219999999999999 110.898 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.801 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -106.6 142.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 52.020000000000003 111.125 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.8 141.29 48.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.896 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 29.6 ttt180 -77.39 134.58 38.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 72.439999999999998 110.846 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.3 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.549999999999997 111.115 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.826 0.346 . . . . 52.329999999999998 110.865 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -122.0 148.84 44.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 65.109999999999999 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -135.42 134.26 39.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.949 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.21 171.66 44.72 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.714 -0.755 . . . . 72.030000000000001 112.48 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.9 p -83.72 145.25 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 65.150000000000006 111.097 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.443 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -85.56 145.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.141 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.3 -29.19 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 62.450000000000003 110.88 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -175.57 137.6 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 63.310000000000002 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -139.55 98.85 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 110.845 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -69.25 113.39 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.903 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.12 -21.81 27.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -63.46 -51.08 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 110.917 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -85.23 -36.68 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.923 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.5 40.2 2.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.150000000000006 112.522 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 20.4 p90 -144.57 166.71 24.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 73.5 110.911 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.67 175.41 46.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 32.409999999999997 112.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -141.28 126.68 18.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 61.509999999999998 110.859 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.527 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.4 mt -98.28 152.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 63.350000000000001 111.133 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.402 ' N ' HG22 ' A' ' 18' ' ' ILE . 45.4 mm-40 -124.86 140.48 52.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 110.887 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -104.21 -165.96 1.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 65.200000000000003 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -49.52 -29.83 7.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 110.899 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -107.76 -34.45 6.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 110.886 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 66.15 1.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 72.430000000000007 112.489 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -91.59 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.685 2.257 . . . . 73.329999999999998 112.375 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 168.07 101.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 75.530000000000001 110.874 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.666 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -119.1 143.92 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.124 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -98.59 117.7 33.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.915 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.724 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -126.31 142.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 72.439999999999998 111.104 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.524 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.4 m170 -123.15 158.95 29.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.400000000000006 110.829 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' HG23 ' A' ' 31' ' ' THR . 7.5 p90 -56.36 -22.19 29.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 73.409999999999997 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.511 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -95.53 20.62 9.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 111.161 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.41 -6.16 8.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 70.519999999999996 111.102 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -88.82 132.5 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 111.11 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.38 86.19 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.937 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.3 -179.35 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 71.450000000000003 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.23 74.81 2.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 75.329999999999998 110.841 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.56 -117.62 0.9 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 73.329999999999998 112.488 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 40' ' ' THR . 34.6 m-85 -89.92 112.76 24.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 73.349999999999994 110.88 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.2 mtm-85 -57.76 100.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.299999999999997 110.863 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 38' ' ' PHE . 1.8 t -178.14 159.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 111.151 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD21 HG11 ' A' ' 65' ' ' VAL . 15.1 mt -108.91 -175.36 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.908 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -128.32 127.91 43.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 70.340000000000003 110.858 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.62 120.42 8.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 45.409999999999997 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.84 7.62 66.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 52.340000000000003 112.494 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -107.0 160.54 15.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 63.310000000000002 110.919 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.7 m-70 -88.8 141.26 28.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.049999999999997 110.837 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.22 140.15 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 50.409999999999997 111.161 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.54 125.97 42.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 64.200000000000003 110.875 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.7 p90 -119.94 146.56 45.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 74.140000000000001 110.864 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -107.55 99.3 8.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 73.049999999999997 110.92 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.6 m -63.01 124.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 111.135 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.06 158.13 40.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.688 0.756 . . . . 75.530000000000001 110.85 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.4 Cg_endo -69.8 -88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.652 2.234 . . . . 53.509999999999998 112.33 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.85 56.78 3.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 73.540000000000006 112.484 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -132.02 -41.68 1.01 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 74.140000000000001 110.864 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.21 135.93 12.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 73.099999999999994 112.483 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.76 -34.21 14.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.747 -0.739 . . . . 71.439999999999998 112.467 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -22.37 17.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 74.25 110.941 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.77 -94.38 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 41.439999999999998 112.51 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 114.93 3.87 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 61.130000000000003 112.394 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 11.9 tt0 -119.93 157.86 27.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.927 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.785 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.64 57.54 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 111.098 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.12 -37.8 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 110.895 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -131.08 104.27 7.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 62.310000000000002 110.859 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.785 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.48 141.71 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 60.439999999999998 111.103 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -132.32 143.05 49.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.865 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.9 tmm_? -78.76 135.48 37.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.879 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 62.140000000000001 111.141 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.827 0.346 . . . . 43.140000000000001 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -129.35 152.45 48.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 110.866 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 26.8 mtmt -132.71 134.86 45.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.876 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.72 171.65 44.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.776 -0.726 . . . . 72.409999999999997 112.507 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 p -80.99 145.42 31.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.824 0.345 . . . . 50.020000000000003 111.143 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.87 144.32 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 73.25 111.106 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -96.96 -31.28 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.879 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -175.43 139.98 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 110.916 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HE1' HD11 ' A' ' 33' ' ' ILE . 65.3 t80 -133.63 99.11 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.519999999999996 110.88 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.64 101.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 110.902 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.81 43.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 111.053 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -70.26 -43.93 69.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 64.030000000000001 110.894 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -93.37 -34.72 13.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 110.882 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.1 45.73 2.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.75 -0.738 . . . . 54.420000000000002 112.474 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -157.64 143.24 17.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 74.040000000000006 110.976 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.76 -174.21 22.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 72.209999999999994 112.49 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -142.49 127.59 18.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 72.099999999999994 110.887 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.9 mt -98.5 151.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 31.6 mm-40 -127.64 131.65 49.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 71.040000000000006 110.899 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -95.93 -165.18 1.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 110.939 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -48.93 -31.55 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 64.510000000000005 110.857 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -106.79 -27.69 10.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 73.129999999999995 110.919 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.62 68.83 1.51 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 72.5 112.507 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -90.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.733 2.289 . . . . 72.230000000000004 112.343 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.7 96.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.868 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.57 142.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.133 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.34 115.75 29.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 63.350000000000001 110.889 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.793 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.5 m -121.53 144.41 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 65.420000000000002 111.127 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.519 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -123.6 159.04 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.881 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -56.16 -21.76 24.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 110.892 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 m -97.0 22.57 8.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.239999999999995 111.143 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.67 -6.38 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.086 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.9 mp -89.66 132.43 34.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 51.43 111.132 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -116.49 86.52 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 33.509999999999998 110.871 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.3 179.57 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 74.299999999999997 111.118 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -87.23 78.12 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 45.299999999999997 110.864 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.46 -118.17 3.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 52.409999999999997 112.451 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -64.35 110.16 2.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 71.430000000000007 110.894 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -75.07 76.34 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 74.040000000000006 110.841 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.6 p -149.44 170.2 19.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.040000000000006 111.146 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD22 HG11 ' A' ' 47' ' ' VAL . 17.6 mt -114.59 177.78 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.913 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -124.46 127.72 47.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 74.129999999999995 110.897 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -58.0 119.35 6.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 52.039999999999999 110.878 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.67 6.19 62.52 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.689 -0.767 . . . . 63.409999999999997 112.502 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -106.83 160.11 15.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.530000000000001 110.885 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.8 m-70 -88.69 141.79 28.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.868 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.6 m -158.48 140.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 71.25 111.177 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 30.6 tt0 -99.03 127.0 44.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 71.219999999999999 110.874 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.8 p90 -118.07 149.05 41.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 64.319999999999993 110.88 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -106.42 98.82 8.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 70.239999999999995 110.865 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.838 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -53.29 125.38 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 54.119999999999997 111.153 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.6 tp10 -111.1 138.95 21.36 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 71.25 110.895 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -90.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.65 2.234 . . . . 64.209999999999994 112.325 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.72 53.84 4.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 42.299999999999997 112.515 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 -40.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 70.140000000000001 110.859 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.62 135.58 15.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 73.230000000000004 112.486 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.33 -36.85 17.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.734 . . . . 62.350000000000001 112.501 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -19.37 16.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.209999999999994 110.877 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.11 -102.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 44.43 112.439 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 113.3 3.32 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.675 2.25 . . . . 42.210000000000001 112.33 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.838 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.5 pt20 -119.28 174.86 6.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.878 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.793 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -91.1 59.18 3.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 111.106 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 13.9 tppt? -40.79 -44.42 2.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 71.540000000000006 110.869 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -129.0 107.63 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 63.399999999999999 110.864 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.78 142.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 63.210000000000001 111.13 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -132.0 141.53 49.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 110.86 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.758 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.01 136.03 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.85 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.9 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 111.147 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.348 . . . . 63.439999999999998 110.85 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -135.02 153.96 51.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 72.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 21.3 mtmm -127.53 134.15 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 72.299999999999997 110.926 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.81 171.53 42.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.738 . . . . 61.439999999999998 112.465 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.6 p -83.28 146.32 28.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 74.010000000000005 111.149 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 144.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 111.106 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 -29.51 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.239999999999995 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -172.79 138.95 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.530000000000001 110.899 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 33' ' ' ILE . 62.8 t80 -140.57 98.05 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 70.219999999999999 110.898 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.16 105.33 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 54.109999999999999 110.903 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.19 -30.26 43.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.299999999999997 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -71.46 -37.1 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.905 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.2 -40.21 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.319999999999993 110.907 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.36 32.89 5.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 44.32 112.458 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -149.96 170.74 18.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 73.400000000000006 110.913 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.99 178.46 46.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 62.229999999999997 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -142.93 125.13 15.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 63.420000000000002 110.885 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.2 mt -98.24 150.9 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 74.319999999999993 111.111 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -122.94 127.13 48.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 110.923 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -94.67 -167.54 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.958 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -46.72 -35.07 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 110.925 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -103.76 -17.52 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 110.874 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.32 64.43 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 71.420000000000002 112.496 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.712 2.274 . . . . 73.430000000000007 112.345 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.66 95.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 72.040000000000006 110.852 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.2 142.37 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 75.219999999999999 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.97 116.76 31.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.864 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.9 m -122.54 140.78 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 62.140000000000001 111.133 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.7 m-70 -119.15 158.49 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -56.08 -23.23 32.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 70.129999999999995 110.89 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 m -95.74 22.19 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 111.164 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.18 -6.41 8.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 55.109999999999999 111.097 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -89.18 131.97 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 75.319999999999993 111.139 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.85 86.41 2.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 110.923 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.92 179.72 5.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 72.310000000000002 111.083 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -96.49 74.46 2.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 75.040000000000006 110.838 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.12 -117.76 0.82 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 65.109999999999999 112.498 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' O ' HG22 ' A' ' 40' ' ' THR . 10.6 m-85 -94.71 120.07 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 75.030000000000001 110.903 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -59.52 97.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.539999999999999 110.901 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 38' ' ' PHE . 2.0 t -178.24 159.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 64.420000000000002 111.141 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.82 HD13 HG21 ' A' ' 47' ' ' VAL . 13.0 mt -108.78 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.922 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -127.95 128.91 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.430000000000007 110.898 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.8 121.46 10.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 71.420000000000002 110.927 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.23 6.71 68.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.310000000000002 112.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.68 160.56 15.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.36 . . . . 71.140000000000001 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.6 m-70 -89.32 142.25 27.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 110.877 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.82 HG21 HD13 ' A' ' 41' ' ' LEU . 2.4 m -158.74 140.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.092 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -97.14 127.85 43.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 60.009999999999998 110.87 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -118.88 146.71 44.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 65.340000000000003 110.912 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -105.02 97.25 7.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.209999999999994 110.911 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 61.4 t -52.05 130.14 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 73.340000000000003 111.183 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 61' ' ' GLN . 2.1 tp10 -118.11 137.7 24.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 74.219999999999999 110.871 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -91.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.699 2.266 . . . . 71.439999999999998 112.349 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.22 53.38 4.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.785 -0.721 . . . . 73.310000000000002 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -39.98 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 75.329999999999998 110.884 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.2 136.79 18.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 72.409999999999997 112.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.41 -35.2 14.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 63.399999999999999 112.446 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -18.7 14.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 73.319999999999993 110.904 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.05 -103.44 0.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 72.430000000000007 112.481 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' CB ' HG13 ' A' ' 51' ' ' VAL . 53.3 Cg_endo -69.79 110.64 2.61 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 61.210000000000001 112.33 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.793 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.2 pt20 -118.35 173.68 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.109999999999999 110.903 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -90.87 61.55 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 55.420000000000002 111.089 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -39.12 -42.78 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 110.903 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 1.3 tttt -131.54 110.74 11.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.909 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.721 HG11 HD21 ' A' ' 41' ' ' LEU . 1.1 t -108.77 142.11 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 73.400000000000006 111.151 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 110.884 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 52.0 ttt180 -78.06 134.76 37.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 64.450000000000003 110.92 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.7 mm . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.340000000000003 111.115 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.812 0.339 . . . . 64.200000000000003 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -129.98 153.73 48.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 72.430000000000007 110.875 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.6 mtmt -128.66 134.72 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 62.210000000000001 110.893 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.56 44.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 73.239999999999995 112.482 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 p -85.15 148.49 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 45.32 111.146 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.27 144.8 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 73.230000000000004 111.114 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -99.07 -29.65 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.899 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -176.16 137.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.929 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -136.67 99.39 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 74.340000000000003 110.878 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -72.37 111.39 7.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.349999999999994 110.85 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.45 -32.78 42.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 111.118 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.84 -50.81 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.878 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -77.77 -29.81 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 70.519999999999996 110.868 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.83 32.7 10.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 73.540000000000006 112.477 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -140.12 169.19 18.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 64.310000000000002 110.917 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.32 172.97 45.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 70.019999999999996 112.512 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -141.45 129.11 21.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.342 . . . . 74.549999999999997 110.89 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 49' ' ' PHE . 27.8 mt -97.22 144.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 53.509999999999998 111.103 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.71 112.35 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 63.340000000000003 110.88 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -77.99 -166.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 71.099999999999994 110.884 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -48.03 -33.71 8.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 73.299999999999997 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -106.23 -22.4 12.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 72.329999999999998 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.8 69.7 1.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 55.219999999999999 112.501 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -89.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.695 2.263 . . . . 63.450000000000003 112.307 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.33 96.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 110.921 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -116.87 145.91 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 72.040000000000006 111.151 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.02 117.52 35.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 30.420000000000002 110.84 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.676 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.47 142.44 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 55.229999999999997 111.147 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.436 ' O ' HD12 ' A' ' 33' ' ' ILE . 7.4 m170 -116.92 157.08 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 55.219999999999999 110.894 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -56.01 -24.55 39.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 63.350000000000001 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 m -93.83 20.88 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 111.099 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.74 -1.88 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 64.209999999999994 111.11 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.631 HG12 HD13 ' A' ' 41' ' ' LEU . 4.7 mp -90.3 127.97 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 63.520000000000003 111.106 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -100.45 85.83 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.310000000000002 110.92 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' HB1' ' HE ' ' A' ' 67' ' ' ARG . . . -120.23 166.35 13.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.150000000000006 111.084 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.83 74.91 10.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.519999999999996 110.896 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.44 -117.64 3.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 74.209999999999994 112.502 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -67.93 109.94 3.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 73.329999999999998 110.843 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -76.4 117.84 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.049999999999997 110.862 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.1 t -177.84 154.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 111.133 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 33' ' ' ILE . 3.4 mp -110.2 170.04 8.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 62.43 110.906 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -121.06 126.39 49.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 110.868 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -58.68 115.99 3.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 110.871 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.15 7.42 54.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 71.150000000000006 112.49 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -105.97 158.95 16.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 63.539999999999999 110.889 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.533 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.7 m-70 -88.48 141.56 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.32 110.866 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.1 m -158.85 139.86 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 73.439999999999998 111.131 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 43.2 tt0 -97.42 126.18 42.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.871 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.7 p90 -121.14 147.08 46.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 55.219999999999999 110.885 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 9.8 mt-10 -107.53 99.03 8.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 70.340000000000003 110.891 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.891 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.0 m -64.65 125.38 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 62.140000000000001 111.106 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -114.3 158.96 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 71.400000000000006 110.918 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -89.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.244 . . . . 74.409999999999997 112.33 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.57 57.19 3.79 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 64.430000000000007 112.438 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 61' ' ' GLN . 5.9 tpp180 -132.51 -41.6 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 75.310000000000002 110.878 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.23 139.04 14.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 62.450000000000003 112.529 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.84 -38.59 23.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 60.020000000000003 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -22.09 19.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.78 0.324 . . . . 75.409999999999997 110.886 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.2 -93.16 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 71.109999999999999 112.487 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 114.42 3.7 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.704 2.269 . . . . 52.310000000000002 112.352 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.891 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.1 tt0 -119.5 157.06 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 72.120000000000005 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.62 58.7 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 111.079 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -43.67 3.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 60.329999999999998 110.887 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.0 mtpp -129.53 109.06 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.340000000000003 110.897 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.22 142.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.299999999999997 111.134 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -131.87 143.39 50.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.912 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.759 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.7 mtm105 -78.17 135.92 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.120000000000005 110.821 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 111.115 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.817 0.341 . . . . 75.299999999999997 110.874 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -134.87 156.48 48.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.319999999999993 110.877 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 2.3 mtpm? -129.24 136.72 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 110.875 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.9 172.08 44.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 75.549999999999997 112.438 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 p -82.65 151.06 26.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 64.239999999999995 111.138 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.37 147.05 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 63.340000000000003 111.137 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -98.95 -34.51 10.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 65.299999999999997 110.919 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -168.5 139.19 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.319999999999993 110.912 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.425 ' HE2' ' HG1' ' A' ' 40' ' ' THR . 68.3 t80 -138.29 98.53 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 74.310000000000002 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.69 115.13 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 74.140000000000001 110.924 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.94 -33.09 24.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 70.239999999999995 111.099 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.75 -49.92 71.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 110.884 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -77.72 -29.67 51.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.913 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 33.4 10.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 71.120000000000005 112.484 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.7 169.95 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 74.109999999999999 110.924 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 170.81 43.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.754 -0.736 . . . . 63.210000000000001 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -141.4 125.18 16.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 71.230000000000004 110.886 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CD1' HG11 ' A' ' 28' ' ' VAL . 19.5 mt -98.85 151.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 75.230000000000004 111.142 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 40.4 mm-40 -124.12 121.53 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 70.450000000000003 110.942 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.69 -166.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.219999999999999 110.911 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.05 -34.45 4.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.899 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -105.4 -18.58 14.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.918 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.7 64.73 3.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.741 . . . . 70.129999999999995 112.505 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.254 . . . . 73.310000000000002 112.364 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.69 94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 60.409999999999997 110.838 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.681 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.6 143.89 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 111.071 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.8 118.73 36.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.879 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.6 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -129.39 143.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 64.109999999999999 111.12 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 33' ' ' ILE . 13.9 m170 -120.39 157.31 29.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 75.319999999999993 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -55.72 -24.68 36.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 62.210000000000001 110.886 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -94.43 22.74 5.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 61.340000000000003 111.169 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.19 -0.14 8.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 50.210000000000001 111.113 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.8 mp -91.16 130.61 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 72.040000000000006 111.149 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -116.88 86.68 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 55.009999999999998 110.856 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.68 179.83 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -110.21 93.6 4.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 110.874 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.31 -117.63 3.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 54.340000000000003 112.508 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.11 110.13 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 64.239999999999995 110.887 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -76.7 78.5 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 110.836 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.425 ' HG1' ' HE2' ' A' ' 9' ' ' PHE . 8.8 t -172.13 167.06 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 62.229999999999997 111.157 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.042 HD21 HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -108.69 172.51 6.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.931 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -125.8 126.6 44.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.903 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.96 124.09 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 55.520000000000003 110.919 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.03 6.41 69.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 62.509999999999998 112.509 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -102.47 157.31 17.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.382 . . . . 70.530000000000001 110.872 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.3 m-70 -87.93 140.77 29.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 71.109999999999999 110.835 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.042 HG21 HD21 ' A' ' 41' ' ' LEU . 3.1 m -159.11 141.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 61.329999999999998 111.12 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.3 tt0 -94.24 125.42 38.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -118.37 142.61 47.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 64.219999999999999 110.887 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 78.1 mt-10 -106.2 98.07 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.896 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 18.0 m -63.79 122.5 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.147 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.86 160.39 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.661 0.743 . . . . 62.32 110.845 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -88.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 75.219999999999999 112.305 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 55.7 3.92 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 74.219999999999999 112.446 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -130.59 -41.68 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 73.150000000000006 110.866 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.13 140.42 15.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 75.040000000000006 112.478 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.52 -44.95 29.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 55.450000000000003 112.479 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -85.15 -22.18 28.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 72.040000000000006 110.851 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -90.88 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 75.120000000000005 112.44 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 114.2 3.63 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 74.239999999999995 112.353 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.856 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -121.96 156.53 33.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 74.420000000000002 110.915 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.709 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.3 58.19 1.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.107 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -44.56 -36.19 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 4.2 ttpt -130.74 106.95 8.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.709 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.25 142.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 54.509999999999998 111.104 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -131.15 142.61 50.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.897 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.757 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -79.19 133.15 36.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 71.150000000000006 110.856 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.430000000000007 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.4 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.83 0.348 . . . . 44.140000000000001 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -132.07 152.95 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.099999999999994 110.924 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.2 mtpt -135.16 134.74 40.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.426 . . . . 62.219999999999999 110.901 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.23 171.8 44.89 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 72.409999999999997 112.524 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.5 p -81.46 146.31 30.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.332 . . . . 73.409999999999997 111.124 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.791 HG21 ' CD1' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -87.71 145.88 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.430000000000007 111.084 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -97.96 -29.31 13.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 65.319999999999993 110.908 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.0 p90 -175.57 144.73 0.68 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 72.25 110.917 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' HD21 ' A' ' 41' ' ' LEU . 71.7 t80 -144.94 98.85 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 72.430000000000007 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -68.84 117.64 10.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.68 -24.02 21.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 111.121 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.38 -45.01 93.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 110.842 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -90.79 -37.84 13.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.944 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.16 42.53 2.21 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.731 -0.747 . . . . 50.439999999999998 112.505 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -144.75 168.18 20.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.939 0.4 . . . . 70.400000000000006 110.936 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.62 174.43 46.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 71.400000000000006 112.475 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -142.32 125.34 16.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 74.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 28' ' ' VAL . 18.3 mt -98.44 152.15 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.540000000000006 111.103 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 18' ' ' ILE . 36.4 mm-40 -127.83 135.05 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 110.914 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -100.24 -165.76 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 70.010000000000005 110.907 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -48.19 -32.14 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 60.219999999999999 110.866 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -104.69 -26.76 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 64.019999999999996 110.86 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.66 66.86 2.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 63.439999999999998 112.521 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -90.22 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.695 2.264 . . . . 71.400000000000006 112.354 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.93 96.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 60.399999999999999 110.844 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -112.61 145.25 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 74.129999999999995 111.102 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.19 116.85 33.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -125.14 143.39 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 61.229999999999997 111.18 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.3 m170 -121.71 159.41 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 60.210000000000001 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -56.63 -22.46 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 62.119999999999997 110.875 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -95.48 21.46 8.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 111.126 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -122.65 -3.63 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.450000000000003 111.086 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 29' ' ' HIS . 5.0 mp -90.24 132.61 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 111.175 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.37 86.27 2.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.109999999999999 110.899 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.88 -179.33 3.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 111.117 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.04 77.09 4.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 72.209999999999994 110.864 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.9 -117.62 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 73.099999999999994 112.493 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -57.67 137.51 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.363 . . . . 73.530000000000001 110.916 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -96.92 94.09 7.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 110.848 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 t -174.59 157.26 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 111.133 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.791 ' CD1' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -112.75 -178.03 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 110.912 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -121.37 127.44 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 110.866 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.16 130.24 45.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 72.340000000000003 110.894 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.64 6.77 88.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 44.009999999999998 112.493 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.36 160.3 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 54.219999999999999 110.891 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.5 m-70 -87.03 141.0 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 73.010000000000005 110.857 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.0 m -158.56 140.79 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 111.118 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 24.8 tt0 -97.65 125.75 42.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 64.209999999999994 110.871 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD1' HD13 ' A' ' 18' ' ' ILE . 26.1 p90 -119.54 146.05 45.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.349999999999994 110.907 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -106.07 98.22 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.91 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 21.9 m -63.66 124.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 71.510000000000005 111.143 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.61 160.67 35.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.618 0.723 . . . . 34.210000000000001 110.863 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.692 2.261 . . . . 72.120000000000005 112.328 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.43 57.3 3.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 73.030000000000001 112.477 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.6 -41.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 71.510000000000005 110.875 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.86 137.54 13.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.76 . . . . 71.219999999999999 112.487 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.98 -35.39 18.1 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 24.050000000000001 112.477 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -91.7 -22.89 19.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 74.340000000000003 110.86 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.69 -93.06 0.15 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 73.540000000000006 112.517 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 114.92 3.87 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 61.210000000000001 112.315 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.9 tt0 -119.7 158.0 27.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.911 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.94 58.25 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 65.420000000000002 111.08 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -43.56 -38.02 2.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 72.340000000000003 110.893 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -132.17 106.17 7.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.882 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.769 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.36 142.07 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 61.450000000000003 111.112 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -131.92 142.87 49.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.906 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.74 134.79 37.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 71.340000000000003 110.855 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.6 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 73.340000000000003 111.162 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 71.299999999999997 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -130.27 153.02 49.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 64.349999999999994 110.896 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 13.6 mtmt -126.45 134.2 51.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 110.892 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 171.73 43.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 73.239999999999995 112.536 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.9 p -85.64 142.95 28.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 71.150000000000006 111.16 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.485 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -79.78 144.28 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.219999999999999 111.151 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -31.76 11.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 50.210000000000001 110.93 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -174.72 138.56 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 110.917 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' HE2' HG23 ' A' ' 40' ' ' THR . 67.4 t80 -138.04 99.28 3.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.869 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -73.01 116.58 13.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.896 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.77 -20.34 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 75.239999999999995 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.77 -54.92 35.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 72.420000000000002 110.884 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -84.34 -35.61 23.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 73.209999999999994 110.906 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.74 39.46 2.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 70.340000000000003 112.458 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -143.92 163.57 33.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.939 0.399 . . . . 72.140000000000001 110.917 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.95 175.83 43.9 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 74.319999999999993 112.498 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -141.85 128.22 19.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 72.400000000000006 110.846 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.5 ' CD1' HG11 ' A' ' 28' ' ' VAL . 23.9 mt -97.7 148.77 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 60.219999999999999 111.112 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -121.19 117.01 26.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.919 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.91 -166.92 1.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.299999999999997 110.924 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.66 -34.13 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.888 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -105.82 -17.46 14.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 72.530000000000001 110.922 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.24 65.93 3.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 50.219999999999999 112.509 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 63.009999999999998 112.35 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.45 90.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.866 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.628 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -107.29 144.64 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 54.509999999999998 111.141 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -99.15 119.96 38.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 64.129999999999995 110.875 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.631 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -130.52 143.33 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.439999999999998 111.109 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.499 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m170 -119.0 156.17 30.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 110.852 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.626 ' CZ ' HG23 ' A' ' 31' ' ' THR . 3.3 p90 -55.39 -25.12 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 73.049999999999997 110.871 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.626 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.5 p -94.22 22.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 71.150000000000006 111.125 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.23 -1.89 8.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 73.319999999999993 111.062 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.516 HG12 HD13 ' A' ' 41' ' ' LEU . 4.8 mp -92.3 130.72 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 71.239999999999995 111.158 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -112.78 86.14 2.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 110.884 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.25 175.36 5.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 70.129999999999995 111.086 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -83.23 74.64 10.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 63.32 110.9 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.71 -117.45 3.41 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 55.229999999999997 112.474 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -69.89 110.03 4.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.844 0.354 . . . . 75.120000000000005 110.874 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.56 101.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 62.009999999999998 110.867 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.484 HG23 ' HE2' ' A' ' 9' ' ' PHE . 3.5 m -161.7 150.13 15.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 65.519999999999996 111.115 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.673 ' HG ' HG11 ' A' ' 47' ' ' VAL . 2.4 mp -109.02 170.6 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 110.89 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -123.3 126.69 47.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.861 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -58.46 119.03 6.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 45.109999999999999 110.921 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.15 6.57 58.89 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.754 -0.736 . . . . 64.230000000000004 112.494 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -105.18 159.87 15.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.848 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -87.82 140.58 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.109999999999999 110.842 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.1 m -157.99 139.76 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 111.111 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 26.6 tt0 -96.64 126.29 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.851 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CD1' HD13 ' A' ' 18' ' ' ILE . 20.5 p90 -120.46 143.31 48.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.861 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -105.09 97.33 7.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.877 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.2 m -62.32 124.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 62.5 111.129 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -108.88 157.47 36.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.624 0.726 . . . . 70.420000000000002 110.93 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -89.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.227 . . . . 60.299999999999997 112.361 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.66 57.09 4.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 51.340000000000003 112.477 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 7.1 tpt180 -132.18 -39.34 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 60.25 110.899 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' A' ' 61' ' ' GLN . . . -93.63 133.62 11.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.781 -0.723 . . . . 61.210000000000001 112.483 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.57 8.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 71.439999999999998 112.528 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.51 -23.9 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.869 0.366 . . . . 75.010000000000005 110.886 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.69 -93.12 0.15 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.731 . . . . 51.240000000000002 112.511 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 116.59 4.63 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.66 2.24 . . . . 71.049999999999997 112.349 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.843 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.3 tm0? -122.3 150.89 41.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 110.909 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -74.52 59.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 55.43 111.135 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -46.44 -37.87 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 72.5 110.897 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.42 104.51 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.030000000000001 110.86 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.79 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.18 140.76 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 63.530000000000001 111.12 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -131.58 143.37 50.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.200000000000003 110.889 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 6.4 ptm180 -78.87 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.519999999999996 110.891 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.5 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.439999999999998 111.164 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.849 0.357 . . . . 73.510000000000005 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -132.37 151.11 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 62.210000000000001 110.938 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 3.8 mtmp? -125.94 133.3 51.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.129999999999995 110.922 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.11 171.42 42.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 64.310000000000002 112.529 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -87.34 145.88 26.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 71.549999999999997 111.166 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.6 145.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.010000000000005 111.107 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.8 tptt -99.49 -29.79 12.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 64.340000000000003 110.918 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -175.72 137.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 64.450000000000003 110.937 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' HE2' HG22 ' A' ' 40' ' ' THR . 54.5 t80 -135.12 97.93 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 72.519999999999996 110.876 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.51 92.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 70.120000000000005 110.844 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.95 74.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 51.310000000000002 111.111 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.11 -43.9 90.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.874 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -78.83 -38.37 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.887 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 25.9 7.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 62.299999999999997 112.485 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -140.87 169.66 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.904 0.383 . . . . 75.420000000000002 110.978 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.94 172.39 45.06 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.746 . . . . 52.200000000000003 112.499 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 74.030000000000001 110.879 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.504 ' CD1' HG11 ' A' ' 28' ' ' VAL . 26.2 mt -98.19 152.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 73.349999999999994 111.165 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 43.8 mm-40 -123.9 124.03 41.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 70.310000000000002 110.92 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -166.9 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.924 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -47.68 -33.58 7.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 61.340000000000003 110.915 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -106.77 -16.6 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.209999999999994 110.867 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.41 63.55 4.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 75.010000000000005 112.534 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.53 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.697 2.265 . . . . 71.200000000000003 112.355 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.68 101.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 110.922 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.657 ' CG2' HG12 ' A' ' 51' ' ' VAL . 2.2 p -117.42 139.5 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 111.148 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.8 115.73 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 35.420000000000002 110.892 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -125.88 144.64 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 65.340000000000003 111.145 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.456 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 m-70 -121.23 156.77 31.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 110.828 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -54.69 -24.71 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 71.209999999999994 110.826 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -94.98 24.95 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.219999999999999 111.112 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.71 -0.38 6.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 74.129999999999995 111.127 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -91.43 126.74 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 61.130000000000003 111.148 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -112.98 86.36 2.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 70.109999999999999 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.81 -179.73 3.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.530000000000001 111.057 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -99.1 74.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.886 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.54 -118.42 2.48 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.735 -0.745 . . . . 75.510000000000005 112.525 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.2 114.02 4.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 71.299999999999997 110.928 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 40' ' ' THR . 17.7 mmt180 -77.82 90.43 4.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 63.210000000000001 110.871 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.622 HG22 ' HE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -161.94 164.35 28.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 62.399999999999999 111.105 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.69 153.92 30.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 70.230000000000004 110.909 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' H ' HD13 ' A' ' 41' ' ' LEU . 39.6 m-80 -109.94 125.94 53.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 52.229999999999997 110.901 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 72.040000000000006 110.894 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.27 8.27 60.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.120000000000005 112.511 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.7 158.56 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.918 0.389 . . . . 60.530000000000001 110.867 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.538 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.6 m-70 -88.29 140.25 29.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.49 . . . . 75.140000000000001 110.806 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.5 m -158.82 140.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 29.7 tt0 -95.66 125.07 39.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.874 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CD1' HG21 ' A' ' 18' ' ' ILE . 25.5 p90 -118.86 144.33 46.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.239999999999995 110.859 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 7.1 mm-40 -105.9 97.79 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 74.530000000000001 110.889 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.849 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 31.5 m -64.13 117.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 43.299999999999997 111.125 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -108.65 160.17 28.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.662 0.744 . . . . 73.549999999999997 110.92 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -87.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 51.340000000000003 112.325 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.52 55.79 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 73.25 112.522 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -130.72 -41.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 73.099999999999994 110.895 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.01 142.19 15.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 64.340000000000003 112.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.51 -47.1 29.51 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 71.319999999999993 112.504 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.8 -22.72 34.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 74.340000000000003 110.916 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.13 -89.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 62.539999999999999 112.484 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 116.51 4.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.646 2.231 . . . . 75.519999999999996 112.367 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.849 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.9 tt0 -123.79 157.6 33.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.33 57.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.310000000000002 111.109 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -44.44 -37.57 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 62.509999999999998 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -130.67 104.86 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 71.420000000000002 110.927 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -107.76 141.55 22.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.155 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -131.43 142.7 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.837 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.765 ' HA ' HG12 ' A' ' 47' ' ' VAL . 1.1 ppt_? -78.44 134.37 37.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 71.310000000000002 110.896 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.571 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.2 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 70.319999999999993 111.163 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.85 0.357 . . . . 74.439999999999998 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -125.52 152.18 45.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 74.129999999999995 110.915 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 14.9 mttp -133.06 137.88 46.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.956 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.96 171.51 44.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.702 -0.761 . . . . 74.420000000000002 112.461 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.8 p -85.55 144.12 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 74.099999999999994 111.109 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.3 144.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 54.439999999999998 111.123 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -99.48 -30.2 12.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 71.040000000000006 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -175.19 139.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 110.907 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.8 99.41 3.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 74.140000000000001 110.901 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -69.59 93.18 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.53 63.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 62.020000000000003 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -67.16 -35.86 80.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 110.845 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -94.04 -36.97 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.14 32.53 4.92 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 74.450000000000003 112.477 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -146.28 168.12 21.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.888 0.375 . . . . 74.25 110.947 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.66 179.03 46.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.746 -0.74 . . . . 71.510000000000005 112.464 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -142.35 130.69 22.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 71.310000000000002 110.895 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.594 HD13 ' CD1' ' A' ' 49' ' ' PHE . 28.5 mt -97.09 144.21 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 74.019999999999996 111.117 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.25 110.99 16.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 72.120000000000005 110.9 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.64 -167.34 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 51.409999999999997 110.912 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -49.69 -31.92 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 110.956 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -106.68 -21.48 13.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 42.020000000000003 110.862 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.47 69.33 1.37 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 32.420000000000002 112.48 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.634 2.223 . . . . 74.409999999999997 112.369 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.78 94.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.4 142.77 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.350000000000001 111.127 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.26 116.3 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 74.340000000000003 110.897 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.766 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.6 m -122.99 141.33 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 71.230000000000004 111.133 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -121.55 159.83 25.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 70.519999999999996 110.819 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -56.66 -22.32 33.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 110.853 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -94.37 19.78 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.119999999999997 111.12 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.83 -7.97 8.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.430000000000007 111.117 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -88.66 132.79 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.230000000000004 111.149 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -112.98 86.11 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.891 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.35 178.64 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 75.150000000000006 111.07 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.91 75.32 7.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 62.340000000000003 110.887 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.72 -117.66 3.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 54.409999999999997 112.503 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.3 110.05 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 73.510000000000005 110.869 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 33' ' ' ILE . 30.6 mtm180 -76.7 67.33 2.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 71.510000000000005 110.842 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.4 p -146.24 166.09 27.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 53.549999999999997 111.175 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.76 HD22 HG11 ' A' ' 47' ' ' VAL . 10.6 mt -108.91 -175.93 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.230000000000004 110.922 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -126.1 127.99 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 61.350000000000001 110.918 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -57.68 117.64 4.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 73.109999999999999 110.875 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.88 7.06 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 44.539999999999999 112.484 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -107.15 160.41 15.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 75.549999999999997 110.892 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.521 ' O ' HG13 ' A' ' 47' ' ' VAL . 10.4 m-70 -89.05 141.78 28.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.530000000000001 110.812 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.9 m -158.37 139.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 53.119999999999997 111.178 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 37.8 tt0 -98.17 126.4 43.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.88 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CD1' HD13 ' A' ' 18' ' ' ILE . 34.5 p90 -119.72 146.65 45.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.85 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 64' ' ' LYS . 38.4 mt-10 -105.0 98.88 8.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 110.857 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.848 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.0 m -52.04 128.5 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 72.230000000000004 111.139 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.477 ' H ' ' H ' ' A' ' 61' ' ' GLN . 3.0 tp10 -112.58 138.57 22.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.661 0.743 . . . . 74.25 110.874 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 72.140000000000001 112.372 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.32 53.71 4.81 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 72.349999999999994 112.437 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -134.74 -40.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 71.519999999999996 110.854 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.53 134.59 13.91 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.735 . . . . 75.239999999999995 112.504 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.66 -36.81 13.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 41.439999999999998 112.504 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -100.62 -19.31 16.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 61.009999999999998 110.895 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.88 -103.07 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 52.109999999999999 112.5 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 113.22 3.3 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.695 2.263 . . . . 71.400000000000006 112.324 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.848 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 2.0 pt20 -119.32 175.99 5.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.030000000000001 110.944 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -93.23 62.6 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.43 111.075 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -46.21 -38.82 8.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.934 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 50' ' ' GLU . 5.7 tmtt? -132.12 104.92 7.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 110.893 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -108.53 141.38 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 70.230000000000004 111.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -131.65 142.08 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 71.319999999999993 110.879 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.764 ' HA ' HG12 ' A' ' 47' ' ' VAL . 22.8 ptt85 -77.62 135.64 38.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.866 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.1 mm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.200000000000003 111.146 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttm . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.799 0.333 . . . . 54.119999999999997 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -127.36 155.8 43.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 62.32 110.928 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 19.3 mtmm -127.05 131.17 51.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.13 172.29 39.91 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.738 -0.744 . . . . 54.130000000000003 112.431 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.5 p -86.49 141.13 29.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 64.219999999999999 111.11 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.661 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -81.58 144.83 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.040000000000006 111.14 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.16 -30.59 12.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 70.219999999999999 110.881 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -175.9 138.9 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.246 -0.434 . . . . 73.530000000000001 110.945 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.436 ' HE1' HD11 ' A' ' 33' ' ' ILE . 62.2 t80 -131.74 99.08 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 72.420000000000002 110.934 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -68.62 90.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 55.350000000000001 110.868 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.14 67.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.040000000000006 111.078 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -65.73 -46.73 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 63.149999999999999 110.875 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -77.21 -34.13 56.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.887 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.1 19.46 14.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 60.119999999999997 112.481 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -138.87 173.78 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 65.349999999999994 110.876 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.82 174.59 45.24 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 52.25 112.465 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -141.38 125.26 17.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 60.450000000000003 110.845 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 HG12 HG23 ' A' ' 6' ' ' VAL . 25.2 mt -98.02 152.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 111.094 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -109.42 128.76 55.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.89 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.51 150.71 48.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 71.120000000000005 110.895 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.32 -6.59 58.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -115.32 2.15 13.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 44.310000000000002 110.907 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.22 77.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 74.209999999999994 112.501 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -161.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 75.349999999999994 112.366 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.1 t0 55.44 77.2 0.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 75.349999999999994 110.875 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.624 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -125.68 148.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 60.310000000000002 111.113 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.5 118.96 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 73.019999999999996 110.87 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -131.06 142.29 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 73.0 111.11 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 4.5 m170 -121.54 157.58 30.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 110.843 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.561 ' CZ ' HG23 ' A' ' 31' ' ' THR . 6.1 p90 -56.28 -24.28 42.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.883 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p -93.93 20.28 7.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 111.147 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.91 -5.47 9.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.11 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.5 mp -89.38 132.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 111.154 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -113.85 86.36 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.109999999999999 110.912 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.21 177.19 6.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 111.118 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.58 75.36 4.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 61.539999999999999 110.882 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.06 1.75 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 61.439999999999998 112.515 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -75.66 112.75 12.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 73.010000000000005 110.872 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -67.86 99.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.904 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -177.43 162.58 1.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.13 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD13 HG21 ' A' ' 47' ' ' VAL . 13.0 mt -108.87 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 71.140000000000001 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -129.07 129.67 45.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.909 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.03 119.77 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 54.409999999999997 110.868 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.65 64.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.512 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -106.89 160.79 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 74.109999999999999 110.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.535 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.8 m-70 -89.37 142.31 27.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 61.539999999999999 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.917 HG21 HD13 ' A' ' 41' ' ' LEU . 2.5 m -159.09 140.03 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 111.086 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 31.9 tt0 -96.07 125.73 40.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 63.340000000000003 110.855 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 25.0 p90 -121.27 143.23 49.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 110.861 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.94 98.06 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 55.340000000000003 110.894 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.859 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 27.7 m -64.19 118.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 73.049999999999997 111.156 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.91 158.16 33.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.629 0.728 . . . . 71.409999999999997 110.909 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -88.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 2.252 . . . . 70.129999999999995 112.339 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.96 55.92 3.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 70.450000000000003 112.454 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -133.35 -41.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 74.510000000000005 110.885 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.44 134.91 12.59 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.752 -0.737 . . . . 53.119999999999997 112.494 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.87 -34.32 11.02 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.742 -0.742 . . . . 54.450000000000003 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -21.38 16.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 74.340000000000003 110.922 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.44 -93.12 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 74.25 112.518 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.6 4.64 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.644 2.23 . . . . 71.319999999999993 112.373 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.859 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.6 tt0 -122.23 154.34 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.299999999999997 110.899 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.779 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.26 57.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 64.219999999999999 111.099 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -38.81 5.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 110.911 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 11.7 tttp -129.61 103.35 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.905 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.779 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -106.59 142.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 111.103 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -132.8 143.02 49.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.219999999999999 110.927 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 35.7 mtp180 -78.66 134.23 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 74.129999999999995 110.854 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.4 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.099999999999994 111.118 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.819 0.342 . . . . 53.219999999999999 110.881 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -131.97 155.83 47.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 51.439999999999998 110.907 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -128.41 137.62 51.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 52.420000000000002 110.872 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.57 171.45 44.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 63.32 112.494 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 p -81.52 156.65 25.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 70.140000000000001 111.162 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -99.57 143.41 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 111.124 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -97.35 -28.68 13.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.9 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -174.77 138.32 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 72.099999999999994 110.901 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.473 ' CE1' HD11 ' A' ' 33' ' ' ILE . 69.7 t80 -136.11 98.96 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.869 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.908 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.52 -27.85 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.082 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.67 -40.9 96.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.872 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -94.88 -37.33 11.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 55.32 110.938 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.74 46.31 1.96 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 53.109999999999999 112.466 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -157.53 142.94 17.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.933 0.397 . . . . 72.120000000000005 110.905 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.62 -176.41 25.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 63.149999999999999 112.494 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -141.2 132.57 26.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 74.209999999999994 110.866 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG11 ' A' ' 28' ' ' VAL . 21.7 mt -106.53 149.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 73.200000000000003 111.159 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.36 116.75 8.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 64.530000000000001 110.912 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -82.85 -162.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.200000000000003 110.902 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.14 -35.6 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.888 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -91.68 -30.79 16.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 75.219999999999999 110.886 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.36 64.32 4.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.73 . . . . 73.439999999999998 112.495 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.728 2.285 . . . . 62.240000000000002 112.322 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.53 100.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 53.399999999999999 110.866 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.688 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -121.68 141.46 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 111.146 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.31 116.29 31.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.120000000000005 110.882 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.693 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -121.05 145.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 75.549999999999997 111.128 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 m-70 -124.64 159.36 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.88 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -55.48 -23.18 24.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.120000000000005 110.903 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -95.81 23.81 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 72.519999999999996 111.121 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -126.23 -3.0 6.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 60.210000000000001 111.094 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.517 HG23 HG12 ' A' ' 65' ' ' VAL . 4.7 mp -91.74 131.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 111.103 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.27 86.26 2.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 62.509999999999998 110.897 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.3 -179.51 4.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 111.102 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.5 74.97 2.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.862 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.61 -117.65 1.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 62.229999999999997 112.481 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -84.98 118.52 24.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.030000000000001 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 104.1 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.859 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 t -178.13 159.81 1.33 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.107 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 47' ' ' VAL . 25.9 mt -108.92 -176.31 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 62.130000000000003 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -126.12 127.84 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 62.32 110.931 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.83 122.7 13.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.9 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.89 8.38 76.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 63.030000000000001 112.492 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -106.73 160.39 15.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.947 0.403 . . . . 74.430000000000007 110.838 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -89.1 141.07 28.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.089 -0.505 . . . . 73.5 110.826 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 41' ' ' LEU . 3.5 m -158.5 140.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 111.136 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 44.2 tt0 -95.39 127.54 41.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 64.140000000000001 110.887 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -119.73 144.58 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 74.219999999999999 110.86 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -106.8 97.18 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.863 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.829 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.1 m -60.8 127.81 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 75.420000000000002 111.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -121.69 158.86 53.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.632 0.73 . . . . 55.340000000000003 110.903 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -88.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.732 2.288 . . . . 64.209999999999994 112.312 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.83 57.43 3.88 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 73.219999999999999 112.483 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.62 -42.01 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 75.409999999999997 110.858 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.91 138.24 13.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 71.25 112.517 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -39.88 21.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.756 -0.735 . . . . 54.219999999999999 112.455 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -86.46 -25.04 25.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 71.010000000000005 110.862 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.54 -92.67 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 65.129999999999995 112.475 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.11 3.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.677 2.251 . . . . 71.129999999999995 112.32 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.829 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 10.3 tt0 -118.24 158.12 25.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.892 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.91 57.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 70.310000000000002 111.121 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -39.67 -43.94 1.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 53.229999999999997 110.937 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 2.8 mttt -126.63 108.35 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.918 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.722 HG11 HD21 ' A' ' 41' ' ' LEU . 1.2 t -108.32 141.44 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 52.520000000000003 111.152 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -131.6 142.28 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 62.140000000000001 110.88 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.749 ' HA ' HG12 ' A' ' 47' ' ' VAL . 45.2 ttt-85 -79.22 134.92 36.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 62.409999999999997 110.889 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 73.299999999999997 111.126 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.833 0.349 . . . . 71.439999999999998 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -123.53 149.24 45.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 52.329999999999998 110.906 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 12.3 mtpt -133.37 133.78 42.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.898 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.55 171.53 44.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.745 -0.741 . . . . 73.439999999999998 112.453 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -85.61 142.12 29.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 111.168 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.82 144.57 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 111.118 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -30.77 12.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 110.879 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -176.51 137.41 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 110.913 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -134.83 98.9 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.329999999999998 110.87 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -70.15 93.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 62.409999999999997 110.855 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.33 -31.46 70.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 111.097 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -65.47 -41.41 93.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 65.430000000000007 110.863 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -83.63 -38.5 21.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 110.909 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.08 26.64 7.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 61.509999999999998 112.472 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.91 169.01 18.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 110.9 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.66 173.63 45.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 51.140000000000001 112.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -141.93 128.92 20.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 61.219999999999999 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 HD13 ' CD1' ' A' ' 49' ' ' PHE . 29.1 mt -97.08 146.5 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 42.200000000000003 111.094 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -121.69 123.21 41.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 64.340000000000003 110.877 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -90.41 -167.06 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 73.129999999999995 110.871 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.23 -33.61 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 75.420000000000002 110.926 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -106.36 -22.69 12.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.120000000000005 110.885 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.13 67.89 1.82 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 62.130000000000003 112.444 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -89.69 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.697 2.265 . . . . 71.120000000000005 112.343 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 169.9 95.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 60.32 110.874 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.478 ' CG2' HG12 ' A' ' 51' ' ' VAL . 3.1 p -113.27 138.39 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.349999999999994 111.179 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.75 115.89 28.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -127.17 143.42 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.120000000000005 111.107 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.449 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.7 m-70 -118.39 158.52 25.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 63.399999999999999 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -56.0 -25.09 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.858 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.47 22.09 5.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.17 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.18 -0.99 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 52.219999999999999 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 HG11 ' A' ' 65' ' ' VAL . 5.0 mp -93.13 130.21 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 75.200000000000003 111.146 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.62 86.48 2.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.876 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.43 -179.11 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 72.200000000000003 111.128 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.94 75.01 7.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 73.109999999999999 110.887 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.67 -117.64 3.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.797 -0.716 . . . . 73.450000000000003 112.523 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -74.11 110.06 8.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 64.540000000000006 110.867 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -68.16 108.13 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 75.25 110.923 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -160.67 148.5 16.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 111.144 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -109.23 152.96 24.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 74.540000000000006 110.906 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' H ' HD13 ' A' ' 41' ' ' LEU . 18.5 m-80 -112.57 126.2 55.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 60.109999999999999 110.905 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -59.75 118.38 6.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.25 110.896 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.48 6.62 57.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 73.319999999999993 112.527 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.66 158.4 16.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.934 0.397 . . . . 70.319999999999993 110.86 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.531 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.0 m-70 -87.5 141.54 28.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 62.030000000000001 110.874 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.57 139.97 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.091 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 28.4 tt0 -97.47 125.11 41.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 65.420000000000002 110.875 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 18' ' ' ILE . 27.6 p90 -120.57 144.41 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.887 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.63 97.36 7.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 71.019999999999996 110.899 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.852 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.5 m -62.91 122.71 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.102 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.473 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -111.98 159.18 34.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.658 0.742 . . . . 74.109999999999999 110.921 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -88.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.717 2.278 . . . . 71.5 112.356 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.96 57.92 4.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 74.439999999999998 112.455 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -130.52 -41.88 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.340000000000003 110.855 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.93 137.08 13.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 50.109999999999999 112.468 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.3 -35.52 14.88 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.724 -0.75 . . . . 61.439999999999998 112.443 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -91.34 -25.24 19.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 73.420000000000002 110.949 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.28 -91.79 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.742 -0.742 . . . . 72.430000000000007 112.501 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 116.55 4.62 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.653 2.236 . . . . 71.120000000000005 112.354 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.852 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 4.5 tt0 -118.26 156.51 28.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.010000000000005 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.54 58.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 41.399999999999999 111.082 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -40.89 -42.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.209999999999994 110.911 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 16.0 tttp -134.03 108.26 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.329999999999998 110.901 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -107.11 141.8 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.133 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -131.75 142.75 49.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.299999999999997 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -77.96 134.89 37.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.912 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.5 mm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.420000000000002 111.123 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.867 0.365 . . . . 65.430000000000007 110.849 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -129.35 155.66 45.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 64.310000000000002 110.892 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.6 mttt -129.9 137.37 50.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.899 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.45 171.35 44.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 61.420000000000002 112.504 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.8 p -88.82 138.99 30.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.818 0.342 . . . . 65.109999999999999 111.112 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 145.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 64.299999999999997 111.136 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -101.05 -27.78 13.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.319999999999993 110.918 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -176.01 140.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 65.340000000000003 110.891 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -135.78 99.41 4.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 73.120000000000005 110.849 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -67.66 117.4 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.299999999999997 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 -23.41 18.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 61.530000000000001 111.115 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -59.93 -31.85 70.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 110.898 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -107.88 -33.78 7.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.92 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.95 40.37 2.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 71.129999999999995 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 22.3 p90 -142.52 173.85 11.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 74.340000000000003 110.932 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.06 174.61 46.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.785 -0.721 . . . . 74.219999999999999 112.487 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -140.58 126.65 19.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 62.520000000000003 110.89 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 28' ' ' VAL . 24.2 mt -98.44 151.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 71.450000000000003 111.127 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -127.63 132.75 49.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -98.01 -164.84 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 73.019999999999996 110.903 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -48.85 -31.44 7.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 64.019999999999996 110.875 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.33 -26.41 11.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 75.340000000000003 110.87 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.0 66.88 2.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 64.510000000000005 112.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -90.59 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 73.140000000000001 112.345 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 169.39 100.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 75.099999999999994 110.877 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.662 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -118.3 145.25 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 111.157 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.97 33.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 71.230000000000004 110.865 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.2 m -124.97 142.32 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 74.420000000000002 111.119 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.47 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -122.3 161.03 24.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.019999999999996 110.857 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -57.03 -21.97 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 110.855 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -94.16 19.74 8.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.310000000000002 111.125 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.7 -22.03 7.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 73.310000000000002 111.099 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -71.08 127.39 32.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 71.5 111.138 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -87.2 84.78 7.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.510000000000005 110.86 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.99 154.44 51.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 111.129 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.35 72.98 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.926 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.83 152.51 9.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 73.310000000000002 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -51.56 115.54 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 73.239999999999995 110.905 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 mmt-85 -153.09 -175.75 5.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 70.209999999999994 110.86 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.2 p -131.61 -167.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.319999999999993 111.18 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 47' ' ' VAL . 80.9 mt -107.16 177.17 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 70.200000000000003 110.926 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 63.32 110.934 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -62.22 120.38 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.894 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 5.09 68.13 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.729 . . . . 73.450000000000003 112.537 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.6 158.33 15.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 75.230000000000004 110.922 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.0 m-70 -86.92 139.39 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 75.439999999999998 110.829 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.4 m -158.54 139.93 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 111.144 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 tt0 -97.0 125.06 41.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 110.883 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.5 p90 -118.44 145.82 44.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.099999999999994 110.902 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -106.49 98.35 8.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 53.399999999999999 110.895 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 29.7 m -62.92 124.87 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 45.43 111.117 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -116.64 160.67 35.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.63 0.729 . . . . 75.099999999999994 110.879 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -88.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.709 2.273 . . . . 73.450000000000003 112.339 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.06 57.07 3.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 61.229999999999997 112.465 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -131.51 -41.71 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 74.319999999999993 110.835 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.64 136.59 12.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 60.240000000000002 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.67 -34.83 15.39 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 42.340000000000003 112.501 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -22.94 18.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.813 0.339 . . . . 74.430000000000007 110.818 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.22 -93.36 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.732 . . . . 62.140000000000001 112.48 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.66 3.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.356 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.855 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 9.4 tt0 -120.05 157.92 27.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 110.93 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.805 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -77.97 57.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 60.43 111.087 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.49 -38.85 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.886 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -130.67 104.75 7.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.881 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.805 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -108.15 141.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 53.409999999999997 111.14 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -131.33 141.9 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.200000000000003 110.848 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.756 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -77.52 134.85 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.896 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 111.115 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 mtp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.863 0.363 . . . . 75.239999999999995 110.853 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -127.97 154.89 45.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.422 . . . . 63.109999999999999 110.875 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 25.4 mttt -127.52 133.88 49.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.010000000000005 110.895 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.46 171.75 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.774 -0.727 . . . . 74.409999999999997 112.48 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.5 p -85.41 144.88 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 72.340000000000003 111.153 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -84.88 147.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 75.310000000000002 111.135 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -100.08 -32.36 10.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 72.040000000000006 110.902 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -174.74 141.39 0.63 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 73.540000000000006 110.929 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -141.15 98.94 3.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.519999999999996 110.861 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -65.21 119.22 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.009999999999998 110.949 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.24 21.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 61.340000000000003 111.071 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -62.5 -38.41 89.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 63.329999999999998 110.895 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -97.88 -38.03 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 70.530000000000001 110.904 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.41 44.67 1.95 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 65.310000000000002 112.474 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.48 168.47 25.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 73.200000000000003 110.96 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.77 -179.37 45.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 72.239999999999995 112.507 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -141.01 126.27 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 70.129999999999995 110.874 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 HG23 ' A' ' 6' ' ' VAL . 23.2 mt -98.76 150.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 54.25 111.142 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 43.8 mm-40 -121.75 125.8 47.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 110.86 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -166.26 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.420000000000002 110.908 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -46.92 -34.1 5.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 74.409999999999997 110.918 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -105.88 -19.85 13.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.519999999999996 110.896 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.2 64.57 3.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 73.430000000000007 112.487 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -88.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 63.009999999999998 112.326 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.63 94.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.439999999999998 110.906 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -110.77 142.7 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.63 116.37 30.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 72.239999999999995 110.883 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -121.42 142.52 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 111.099 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.472 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 m-70 -123.53 160.07 27.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 75.239999999999995 110.849 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -56.93 -21.43 29.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.896 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.6 t -95.0 19.81 9.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 111.134 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -118.67 -24.2 6.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 52.310000000000002 111.061 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.6 mp -70.47 124.07 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.152 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.41 84.42 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.919 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.49 144.4 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 53.240000000000002 111.135 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.49 73.11 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 65.439999999999998 110.859 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.17 166.25 13.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 65.109999999999999 112.482 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -57.07 109.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 74.540000000000006 110.943 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -144.49 -170.73 3.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 110.855 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.7 t -146.24 -170.35 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.138 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.7 mt -107.25 164.01 12.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 52.030000000000001 110.909 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -109.68 125.66 52.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.899 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.18 121.87 14.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.010000000000005 110.871 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.92 72.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 64.030000000000001 112.497 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.31 157.43 15.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 62.299999999999997 110.894 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.2 m-70 -85.91 138.36 32.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.843 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 67' ' ' ARG . 4.0 m -158.22 140.39 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 55.450000000000003 111.148 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 39.7 tt0 -95.86 125.95 40.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.917 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -118.3 145.54 45.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.881 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -106.71 97.73 7.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 63.32 110.848 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 22.1 m -62.0 123.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 71.540000000000006 111.083 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -113.97 161.16 29.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.622 0.725 . . . . 71.040000000000006 110.883 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -90.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.678 2.252 . . . . 74.040000000000006 112.355 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.23 57.27 4.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.746 . . . . 74.239999999999995 112.55 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 4.0 mpt_? -128.96 -41.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.359 . . . . 71.120000000000005 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.96 14.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 65.239999999999995 112.467 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.27 -41.93 24.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 51.549999999999997 112.463 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.44 -22.52 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 55.549999999999997 110.927 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.56 -89.87 0.16 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 61.43 112.478 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 114.82 3.84 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.658 2.239 . . . . 64.549999999999997 112.338 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.851 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.8 tt0 -119.23 156.55 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 71.200000000000003 110.921 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.738 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.03 57.09 1.71 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 75.219999999999999 111.144 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -41.74 -49.89 4.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 32.439999999999998 110.874 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.3 tttp -120.06 108.23 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 62.109999999999999 110.94 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.726 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -110.08 142.23 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.420000000000002 111.162 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -131.0 142.83 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 110.86 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HA ' HG12 ' A' ' 47' ' ' VAL . 38.4 ptt180 -78.75 134.88 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 75.040000000000006 110.852 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.3 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 43.299999999999997 111.122 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.865 0.364 . . . . 74.109999999999999 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -120.75 150.82 40.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.420000000000002 110.892 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 9.0 mtpp -132.02 133.17 44.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 55.329999999999998 110.895 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.8 171.14 43.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 72.430000000000007 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.8 p -82.46 146.62 29.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.833 0.349 . . . . 71.010000000000005 111.105 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.69 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -87.68 145.89 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 111.117 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -36.74 10.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 64.409999999999997 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -170.52 141.6 1.95 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 71.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -136.49 99.29 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 75.049999999999997 110.89 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.34 103.2 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 52.240000000000002 110.919 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.19 -19.3 47.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 54.340000000000003 111.113 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.46 -47.63 69.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.883 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.21 -36.08 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.862 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.96 43.13 2.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 53.399999999999999 112.513 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -152.74 151.35 30.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.947 0.403 . . . . 64.120000000000005 110.91 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.28 176.53 32.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.708 -0.758 . . . . 73.439999999999998 112.451 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -140.53 122.93 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.430000000000007 110.883 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 6' ' ' VAL . 17.6 mt -97.99 154.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.030000000000001 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 18' ' ' ILE . 23.1 mm-40 -130.38 147.08 52.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.63 -165.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 74.040000000000006 110.925 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -48.56 -32.3 7.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 55.020000000000003 110.891 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -102.35 -29.85 11.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 64.150000000000006 110.852 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.35 63.98 2.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 14.539999999999999 112.472 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.728 2.285 . . . . 61.310000000000002 112.323 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p30 168.71 100.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 61.329999999999998 110.835 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG21 ' CD2' ' A' ' 49' ' ' PHE . 3.4 p -113.69 136.05 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 54.409999999999997 111.121 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.71 115.4 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.409999999999997 110.938 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -124.97 143.72 37.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.030000000000001 111.133 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' O ' HD12 ' A' ' 33' ' ' ILE . 18.0 m170 -122.4 158.87 28.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 62.32 110.867 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.96 -24.42 38.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -94.72 23.01 5.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 71.439999999999998 111.153 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.75 -2.02 7.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 70.319999999999993 111.095 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 65' ' ' VAL . 4.8 mp -91.39 131.97 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 111.154 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.22 86.5 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.894 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.34 179.93 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 74.450000000000003 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.12 74.91 7.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 54.130000000000003 110.886 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.49 -118.69 3.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 71.200000000000003 112.494 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.3 112.61 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 53.149999999999999 110.875 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.404 ' O ' HD13 ' A' ' 33' ' ' ILE . 65.4 mtt85 -77.79 66.59 3.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 74.219999999999999 110.879 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.0 p -146.61 167.06 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 61.109999999999999 111.175 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.672 HD12 HG11 ' A' ' 47' ' ' VAL . 1.3 mm? -110.03 -176.5 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 72.530000000000001 110.919 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -127.43 126.92 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 61.020000000000003 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.94 121.23 9.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.230000000000004 110.85 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.54 7.27 67.14 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 24.420000000000002 112.511 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -106.84 160.62 15.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.851 0.358 . . . . 75.349999999999994 110.893 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.9 m-70 -88.74 141.96 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.5 m -158.63 140.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 54.310000000000002 111.142 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 33.4 tt0 -94.62 126.8 40.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 110.905 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.454 ' CD2' HG21 ' A' ' 26' ' ' VAL . 14.0 p90 -120.7 142.03 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.851 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.03 97.58 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 73.420000000000002 110.902 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.846 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 19.5 m -63.0 126.9 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 73.230000000000004 111.141 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.68 159.47 46.18 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.679 0.752 . . . . 73.25 110.906 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 -87.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.725 2.283 . . . . 71.530000000000001 112.354 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.36 55.92 4.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 52.329999999999998 112.45 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.0 -41.76 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 72.140000000000001 110.887 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.53 137.68 13.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 12.140000000000001 112.474 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.87 -38.36 23.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 73.230000000000004 112.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.98 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.787 0.327 . . . . 70.040000000000006 110.876 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.32 -93.96 0.15 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 73.420000000000002 112.456 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 112.77 3.16 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 42.520000000000003 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.846 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 3.6 tt0 -117.86 156.77 27.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.915 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -78.39 59.11 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 60.43 111.1 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -41.82 -38.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 54.109999999999999 110.949 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -130.85 109.63 10.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 52.509999999999998 110.863 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.2 t -108.3 141.24 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 65.450000000000003 111.13 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -131.52 141.14 49.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.898 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HA ' HG12 ' A' ' 47' ' ' VAL . 15.2 ptm180 -78.67 133.45 37.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 62.200000000000003 110.857 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.0 mm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.135 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' H1 ' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 110.923 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -123.37 156.29 35.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 72.510000000000005 110.882 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.1 mtmt -130.99 137.13 49.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.91 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.86 172.22 41.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 71.219999999999999 112.51 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.2 p -84.91 138.04 32.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 74.420000000000002 111.13 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.95 144.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 71.030000000000001 111.106 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -99.66 -30.49 12.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.872 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -175.41 136.67 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 110.894 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -135.48 98.92 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.892 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -69.19 112.32 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.540000000000006 110.929 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.47 -30.13 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.409999999999997 111.113 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -62.94 -53.89 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -75.03 -32.14 61.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 72.209999999999994 110.914 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.1 30.84 8.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 64.25 112.482 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -139.93 169.13 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.97 0.414 . . . . 64.129999999999995 110.926 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' C ' HG22 ' A' ' 28' ' ' VAL . . . -174.67 173.59 46.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.754 -0.736 . . . . 74.400000000000006 112.491 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -140.91 126.81 19.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 74.530000000000001 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.756 HG12 HG23 ' A' ' 6' ' ' VAL . 24.4 mt -102.03 152.98 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.040000000000006 111.122 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' ILE . 59.3 mm-40 -110.73 134.52 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.932 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.4 149.04 52.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 64.099999999999994 110.877 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -87.02 -6.4 58.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 71.519999999999996 110.847 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -118.98 -5.78 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.03 74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 74.150000000000006 112.511 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -161.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 74.129999999999995 112.374 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 51.78 82.27 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.846 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.612 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -132.67 143.21 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 111.141 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.38 120.28 34.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -130.42 142.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 70.010000000000005 111.104 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.536 ' O ' HD12 ' A' ' 33' ' ' ILE . 6.2 m170 -122.95 157.92 31.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 71.409999999999997 110.869 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -56.66 -23.51 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.349999999999994 110.848 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.0 t -94.51 19.46 9.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 111.173 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -120.36 -8.75 9.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 44.310000000000002 111.056 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG23 HG12 ' A' ' 65' ' ' VAL . 4.6 mp -85.47 131.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 62.219999999999999 111.142 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -115.37 86.32 2.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 72.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.41 -179.47 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 111.093 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.95 74.55 3.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.120000000000005 110.893 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.33 -117.58 1.74 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 61.020000000000003 112.473 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -77.0 110.22 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 70.040000000000006 110.895 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -66.2 102.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.887 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t -176.9 159.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.165 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.789 HD22 HG11 ' A' ' 47' ' ' VAL . 14.9 mt -108.72 -175.8 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 74.019999999999996 110.925 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -131.0 128.05 39.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 74.340000000000003 110.899 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -57.06 122.38 12.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.400000000000006 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.01 5.68 67.73 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 61.219999999999999 112.506 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -106.71 160.48 15.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 65.310000000000002 110.885 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.497 ' O ' HG13 ' A' ' 47' ' ' VAL . 13.4 m-70 -89.82 142.34 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 63.299999999999997 110.869 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.789 HG11 HD22 ' A' ' 41' ' ' LEU . 2.4 m -157.71 140.2 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 70.340000000000003 111.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.8 tt0 -96.75 125.11 40.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 62.420000000000002 110.913 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -119.09 144.17 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.140000000000001 110.936 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' ' H1 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -102.57 98.07 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.94 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 28.7 m -61.89 118.23 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.450000000000003 111.115 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -107.51 156.46 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.643 0.735 . . . . 74.439999999999998 110.854 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 52' ' ' GLU . 53.5 Cg_endo -69.78 -89.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.717 2.278 . . . . 55.210000000000001 112.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.46 56.51 3.74 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 40.409999999999997 112.483 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -132.28 -41.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 71.209999999999994 110.871 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.94 134.02 12.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 65.120000000000005 112.475 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.62 -32.3 7.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 70.420000000000002 112.454 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -23.2 15.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 65.239999999999995 110.939 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.51 -93.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 72.310000000000002 112.497 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 117.07 4.86 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.689 2.259 . . . . 72.209999999999994 112.339 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 15.1 tt0 -120.99 157.38 30.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.530000000000001 110.932 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.788 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -78.59 56.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.120000000000005 111.131 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -40.68 -46.04 2.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.907 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 8.5 tttp -126.44 105.82 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.400000000000006 110.926 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.788 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -105.87 142.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.540000000000006 111.108 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -132.38 146.14 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.763 ' HA ' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -81.51 133.93 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 71.420000000000002 110.895 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 63.409999999999997 111.14 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.836 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -132.59 154.17 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.340000000000003 110.912 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 18.3 mtmt -131.06 135.71 47.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.857 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.91 171.48 44.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 73.120000000000005 112.466 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -82.77 143.95 30.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 71.200000000000003 111.112 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.7 144.58 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.030000000000001 111.13 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -31.11 12.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 74.040000000000006 110.911 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -175.09 140.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -139.27 98.85 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.109999999999999 110.914 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -70.74 109.39 4.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.882 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.43 -22.65 35.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 53.439999999999998 111.103 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.24 -48.19 76.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.430000000000007 110.889 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -87.88 -37.36 16.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 71.109999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.17 41.2 2.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 61.020000000000003 112.484 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -144.97 167.77 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 75.209999999999994 110.905 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.0 175.09 46.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.310000000000002 112.477 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -141.88 124.77 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.804 0.335 . . . . 72.120000000000005 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CD1' HG11 ' A' ' 28' ' ' VAL . 20.8 mt -98.09 151.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 74.099999999999994 111.151 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -127.66 130.9 49.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.200000000000003 110.914 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -96.2 -164.93 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.299999999999997 110.949 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -48.02 -31.79 5.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 72.340000000000003 110.86 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -106.39 -23.93 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 73.209999999999994 110.863 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.18 67.13 2.11 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.698 -0.763 . . . . 54.520000000000003 112.46 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 62.210000000000001 112.345 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.96 95.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 110.877 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -112.38 146.02 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 111.145 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -100.44 116.68 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.430000000000007 110.886 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.801 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -124.72 144.04 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 71.439999999999998 111.125 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.9 m170 -123.12 159.29 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 65.049999999999997 110.869 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -56.25 -21.99 27.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 72.230000000000004 110.914 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -96.11 22.12 7.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 42.149999999999999 111.138 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -123.6 -4.53 8.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 50.420000000000002 111.103 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.9 mp -89.98 132.41 34.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 64.109999999999999 111.118 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.65 86.56 2.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.882 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.46 -179.37 4.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 70.420000000000002 111.079 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -87.95 74.33 8.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.848 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.7 -117.68 2.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 73.409999999999997 112.499 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -63.17 120.1 10.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 73.409999999999997 110.848 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -81.55 70.35 8.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.852 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 p -147.39 163.05 37.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 51.350000000000001 111.119 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.808 HD22 HG11 ' A' ' 47' ' ' VAL . 19.7 mt -109.44 -178.26 3.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.892 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -126.82 127.22 44.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.319999999999993 110.897 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -57.17 120.19 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 74.219999999999999 110.883 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.92 7.06 62.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 74.439999999999998 112.462 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -106.87 160.32 15.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 73.200000000000003 110.897 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' O ' HG13 ' A' ' 47' ' ' VAL . 9.9 m-70 -89.62 141.64 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.808 HG11 HD22 ' A' ' 41' ' ' LEU . 2.7 m -158.52 140.48 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 70.219999999999999 111.156 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 40.1 tt0 -98.03 125.85 43.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.928 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CD1' HD13 ' A' ' 18' ' ' ILE . 28.1 p90 -119.91 143.43 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 70.420000000000002 110.867 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 2.3 mt-10 -99.79 99.05 9.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 110.863 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.857 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 34.4 m -56.45 122.78 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 62.509999999999998 111.13 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' H ' ' H ' ' A' ' 61' ' ' GLN . 1.8 tt0 -101.87 140.79 21.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.25 110.9 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 52' ' ' GLU . 54.1 Cg_endo -69.68 -92.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.688 2.259 . . . . 55.109999999999999 112.373 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.15 53.95 4.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.479 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -39.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 71.349999999999994 110.863 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 134.43 16.83 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 71.209999999999994 112.508 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -46.91 -36.67 8.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 61.109999999999999 112.494 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.66 -14.36 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 72.310000000000002 110.873 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.52 -104.72 0.32 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.753 -0.737 . . . . 52.350000000000001 112.486 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 53.1 Cg_endo -69.8 110.92 2.68 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.652 2.235 . . . . 63.039999999999999 112.326 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.857 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 8.7 pt20 -115.16 171.03 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.549999999999997 110.903 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 28' ' ' VAL . . . -85.6 61.62 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 54.350000000000001 111.142 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 14.3 ttmt -42.02 -46.37 4.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 74.549999999999997 110.885 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 107.14 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 72.349999999999994 110.895 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -104.6 141.03 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 75.400000000000006 111.116 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -132.02 142.18 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 110.838 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.76 ' HA ' HG12 ' A' ' 47' ' ' VAL . 62.1 ttt180 -77.57 134.2 38.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.876 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 67' ' ' ARG . 9.0 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 62.229999999999997 111.13 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.36 . . . . 74.239999999999995 110.867 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.4 mmtt -123.78 152.42 42.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 110.871 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 33.8 mtpt -127.23 134.11 50.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.884 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.53 172.37 44.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.787 -0.721 . . . . 74.430000000000007 112.538 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 76.2 p -83.39 144.93 29.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 75.409999999999997 111.161 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.21 145.15 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 111.116 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.55 -31.06 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 71.450000000000003 110.885 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -175.69 137.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.884 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.2 99.19 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.420000000000002 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -74.16 113.04 10.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 65.109999999999999 110.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.76 -34.43 30.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 72.010000000000005 111.116 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -56.6 -48.48 77.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 63.310000000000002 110.855 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.28 -28.91 26.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 72.510000000000005 110.922 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.38 19.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 75.420000000000002 112.468 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -133.59 169.21 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 55.310000000000002 110.906 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.25 173.59 45.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 65.209999999999994 112.487 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -142.39 128.4 19.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 73.310000000000002 110.903 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 28' ' ' VAL . 22.6 mt -97.7 149.24 5.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 61.439999999999998 111.081 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -121.74 119.33 31.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 72.420000000000002 110.914 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.54 -167.23 1.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 110.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -47.75 -34.24 8.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 71.219999999999999 110.905 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -105.34 -18.2 14.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.889 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.19 66.29 2.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 73.530000000000001 112.499 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -89.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.347 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.7 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 61.210000000000001 110.877 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -106.73 144.93 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 111.174 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -98.93 122.18 41.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.019999999999996 110.907 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.1 m -132.87 141.81 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 63.409999999999997 111.15 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -115.78 155.4 27.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.0 110.844 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -54.88 -25.06 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.886 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -93.74 23.62 4.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 72.329999999999998 111.121 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.24 -1.2 8.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 65.329999999999998 111.039 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.689 HG12 HD23 ' A' ' 41' ' ' LEU . 4.3 mp -90.21 126.4 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 74.420000000000002 111.12 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -110.18 86.65 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.912 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.16 -179.86 3.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 61.140000000000001 111.11 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.18 75.58 6.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 110.908 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.79 -117.62 3.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 74.439999999999998 112.487 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -78.83 110.17 13.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 50.43 110.87 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -63.86 134.6 55.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 60.329999999999998 110.885 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.2 t -177.19 144.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 65.140000000000001 111.135 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -109.04 148.56 30.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 54.009999999999998 110.869 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -115.75 125.94 53.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.030000000000001 110.861 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.06 118.81 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 65.439999999999998 110.858 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.77 4.17 58.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.754 . . . . 71.219999999999999 112.491 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -101.6 155.51 18.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.38 . . . . 72.439999999999998 110.879 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.534 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.9 m-70 -85.63 140.86 30.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.889 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' A' ' 67' ' ' ARG . 3.2 m -158.77 140.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.15 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 21.7 tt0 -98.07 126.35 43.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.854 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CD1' HD13 ' A' ' 18' ' ' ILE . 22.8 p90 -118.42 146.88 44.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 65.319999999999993 110.883 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -105.97 96.32 6.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 74.310000000000002 110.893 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 35.1 m -63.4 123.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 111.114 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -115.55 160.33 35.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.674 0.749 . . . . 73.340000000000003 110.875 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 52.340000000000003 112.338 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.7 57.01 3.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.74 . . . . 33.240000000000002 112.507 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 5.0 mpt_? -132.79 -41.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 64.209999999999994 110.865 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 134.53 12.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 75.540000000000006 112.508 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.89 -33.93 10.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.310000000000002 112.475 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.32 -22.35 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 110.851 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.37 -92.5 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.691 -0.766 . . . . 73.120000000000005 112.476 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 115.06 3.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.7 2.267 . . . . 63.119999999999997 112.346 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.844 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -118.92 154.29 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.329999999999998 110.879 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -76.85 56.5 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 63.43 111.128 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.38 -47.08 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 52.329999999999998 110.92 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -126.54 108.33 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 70.409999999999997 110.92 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -110.21 141.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 72.540000000000006 111.156 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -131.3 143.24 50.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.866 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.755 ' HA ' HG12 ' A' ' 47' ' ' VAL . 18.2 mmm-85 -78.06 135.78 37.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 110.855 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.8 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 71.329999999999998 111.121 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.801 0.334 . . . . 55.43 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -124.05 151.42 43.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 110.908 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 mtpt -130.32 133.44 46.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.009999999999998 110.932 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.86 171.63 44.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.74 . . . . 63.109999999999999 112.479 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -85.63 142.96 28.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.334 . . . . 73.230000000000004 111.163 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -77.81 144.06 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 61.049999999999997 111.156 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.62 -29.41 13.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 110.903 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -177.41 145.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 74.040000000000006 110.958 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -138.13 103.37 4.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 72.5 110.876 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -72.36 106.72 4.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 110.886 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.02 -35.95 41.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 111.081 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -57.17 -42.58 81.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.889 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -86.77 -33.68 19.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 73.400000000000006 110.901 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.47 22.46 16.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 55.450000000000003 112.499 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -130.56 176.39 8.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 110.905 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.98 44.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.521 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -141.27 125.25 17.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 75.430000000000007 110.872 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 6' ' ' VAL . 21.0 mt -98.06 151.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 72.510000000000005 111.095 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.71 123.03 40.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 72.549999999999997 110.941 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.52 -165.96 1.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.049999999999997 110.9 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -46.88 -35.28 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.862 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.44 -16.19 14.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 53.119999999999997 110.899 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.87 64.45 4.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 73.5 112.458 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -88.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 73.409999999999997 112.321 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 t70 172.61 93.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 71.439999999999998 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.661 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.59 143.44 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 111.184 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.36 118.94 36.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 54.32 110.874 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -128.75 143.3 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.125 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -118.1 157.14 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.865 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -54.83 -25.45 28.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.9 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 t -93.62 25.0 3.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 52.399999999999999 111.129 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.26 -1.08 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 31.34 111.121 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 HG11 ' A' ' 65' ' ' VAL . 4.0 mp -88.92 123.3 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 53.020000000000003 111.132 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -116.27 86.64 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.859 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.52 -179.7 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 63.140000000000001 111.103 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.7 73.1 2.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 54.439999999999998 110.879 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.69 101.74 1.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.773 -0.727 . . . . 70.040000000000006 112.491 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -64.3 133.74 53.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 74.209999999999994 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -179.63 -71.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.349999999999994 110.88 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -175.63 179.48 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 111.154 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.757 HD21 HG11 ' A' ' 47' ' ' VAL . 1.5 tp -108.17 -176.76 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 110.884 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -118.58 125.51 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.040000000000006 110.867 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.45 120.19 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 72.209999999999994 110.874 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.14 3.2 60.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.776 -0.726 . . . . 74.349999999999994 112.437 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -96.41 156.71 16.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.219999999999999 110.909 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.518 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.0 m-70 -84.71 139.22 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.420000000000002 110.888 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.757 HG11 HD21 ' A' ' 41' ' ' LEU . 3.8 m -158.43 140.17 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.115 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 27.6 tt0 -94.28 126.34 39.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 75.299999999999997 110.919 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 16.8 p90 -119.89 143.52 47.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 65.409999999999997 110.843 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -105.62 98.5 8.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.904 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.874 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 24.8 m -63.21 125.46 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.450000000000003 111.146 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' H ' ' H ' ' A' ' 61' ' ' GLN . 6.3 mm-40 -112.57 160.73 29.38 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 73.030000000000001 110.906 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -90.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.716 2.277 . . . . 62.119999999999997 112.354 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.91 58.93 4.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 73.010000000000005 112.453 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.44 -41.63 0.97 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 61.219999999999999 110.906 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.81 136.1 13.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 44.43 112.525 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.93 -31.81 8.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 65.030000000000001 112.463 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -100.41 -22.6 14.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 73.099999999999994 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.58 -91.95 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 75.030000000000001 112.468 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 115.19 3.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.667 2.244 . . . . 72.109999999999999 112.328 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.874 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 tt0 -119.36 154.81 33.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.530000000000001 110.903 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -80.1 61.16 3.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 111.111 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG3' ' HG2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -46.75 -41.4 15.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 74.129999999999995 110.884 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 56.2 mmtt -125.6 110.74 14.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.349999999999994 110.909 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -111.97 141.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 62.350000000000001 111.133 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -130.87 141.87 50.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 70.109999999999999 110.871 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.753 ' HA ' HG12 ' A' ' 47' ' ' VAL . 23.6 mtp180 -78.38 134.28 37.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.540000000000006 110.918 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.574 HD13 ' O ' ' A' ' 67' ' ' ARG . 7.4 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 63.310000000000002 111.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.873 0.368 . . . . 63.530000000000001 110.895 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -123.94 148.85 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.239999999999995 110.894 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 17.3 mtmt -129.45 129.25 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 41.210000000000001 110.891 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.95 171.85 41.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 40.039999999999999 112.446 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -85.04 145.97 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 70.010000000000005 111.147 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -86.72 144.54 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.154 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 19' ' ' GLN . 6.0 tppt? -99.25 -30.08 12.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.875 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -175.34 137.17 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 70.439999999999998 110.893 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -138.33 98.88 3.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 73.099999999999994 110.861 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -65.98 115.96 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.120000000000005 110.888 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.05 -25.34 23.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 63.329999999999998 111.077 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.98 -40.57 75.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.879 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -87.02 -38.77 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 64.109999999999999 110.918 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.55 34.74 4.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 71.409999999999997 112.487 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' HIS . 2.8 p90 -146.87 169.0 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 71.430000000000007 110.913 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.66 177.06 46.15 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 64.230000000000004 112.525 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.99 126.29 18.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 75.450000000000003 110.869 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 6' ' ' VAL . 26.4 mt -99.87 152.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 65.340000000000003 111.095 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' N ' HG22 ' A' ' 18' ' ' ILE . 50.7 mm-40 -116.58 126.11 52.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.120000000000005 110.929 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.3 155.94 36.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 64.450000000000003 110.911 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.94 -5.48 58.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 64.040000000000006 110.878 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -111.52 -1.86 15.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 110.887 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.39 80.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.708 -0.758 . . . . 75.120000000000005 112.474 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -161.67 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.707 2.272 . . . . 74.150000000000006 112.352 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.72 80.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 73.010000000000005 110.874 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.664 ' CG2' HG12 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -134.26 144.59 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 40.229999999999997 111.131 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.11 119.04 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.530000000000001 110.85 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG12 ' HB2' ' A' ' 62' ' ' ALA . 1.3 m -127.73 140.27 49.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 71.120000000000005 111.103 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.537 ' O ' HD12 ' A' ' 33' ' ' ILE . 14.3 m170 -119.98 157.78 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 72.129999999999995 110.854 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CZ ' HG23 ' A' ' 31' ' ' THR . 2.5 p90 -56.43 -23.93 41.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 110.915 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.617 HG23 ' CZ ' ' A' ' 30' ' ' PHE . 2.0 p -93.93 19.96 8.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 64.420000000000002 111.153 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 62' ' ' ALA . . . -121.07 -7.93 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 42.340000000000003 111.088 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.537 HD12 ' O ' ' A' ' 29' ' ' HIS . 4.7 mp -87.09 132.24 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 73.140000000000001 111.095 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -117.11 86.56 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 62.009999999999998 110.873 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -128.2 177.75 6.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 111.12 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -101.23 90.57 4.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.209999999999994 110.893 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.86 -118.06 1.88 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 71.150000000000006 112.504 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.05 110.08 19.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 71.530000000000001 110.908 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.28 96.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.530000000000001 110.811 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 t -178.6 162.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 111.158 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.724 HD22 HG11 ' A' ' 47' ' ' VAL . 13.8 mt -108.27 -178.42 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 62.439999999999998 110.92 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -127.0 127.32 44.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 110.861 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.49 121.29 9.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 74.299999999999997 110.842 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.08 7.58 65.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 71.409999999999997 112.487 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -106.57 159.93 15.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 65.239999999999995 110.854 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 47' ' ' VAL . 11.1 m-70 -87.91 141.53 28.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 63.439999999999998 110.82 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 67' ' ' ARG . 2.7 m -158.63 139.77 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 70.219999999999999 111.146 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 25.3 tt0 -97.76 125.67 42.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 61.100000000000001 110.854 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' LYS . 27.2 p90 -120.99 144.6 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 62.130000000000003 110.895 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.43 99.2 9.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 63.210000000000001 110.877 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 61' ' ' GLN . 33.1 m -62.8 121.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 72.129999999999995 111.168 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HG3' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -103.38 148.98 36.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.666 0.746 . . . . 75.430000000000007 110.892 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 64.519999999999996 112.383 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 58.13 5.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 73.349999999999994 112.491 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -135.38 -40.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 61.210000000000001 110.911 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 61' ' ' GLN . . . -83.19 142.3 21.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 62.43 112.501 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.56 -38.05 27.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.768 -0.73 . . . . 64.219999999999999 112.504 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -100.45 -17.74 17.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 73.030000000000001 110.901 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.12 -98.44 0.21 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 61.149999999999999 112.471 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 111.77 2.91 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 55.340000000000003 112.292 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.923 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -119.46 165.79 13.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.310000000000002 110.911 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -82.67 58.79 4.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 64.540000000000006 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HD3' ' HG3' ' A' ' 52' ' ' GLU . 10.0 ttpt -43.66 -38.81 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.918 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -133.9 104.94 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 53.219999999999999 110.898 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.801 HG23 ' HB1' ' A' ' 62' ' ' ALA . 1.1 t -106.6 142.18 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 52.020000000000003 111.125 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.8 141.29 48.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.896 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HA ' HG12 ' A' ' 47' ' ' VAL . 29.6 ttt180 -77.39 134.58 38.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 72.439999999999998 110.846 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD13 ' O ' ' A' ' 67' ' ' ARG . 8.3 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.549999999999997 111.115 179.992 . . . . . . . . 1 1 . 1 stop_ save_